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Chapter 1 
 
 
Introduction 
 
 
 
1.1 Pseudomonas aeruginosa 
 
 
1.1.1  Pseudomonas aeruginosa as an opportunistic pathogen 
 
Pseudomonas aeruginosa (PA) is a Gram-negative aerobic bacterium that is commonly 
found in soils and waters. It occurs regularly on the surfaces of plants and occasionally 
on the skin of animals and is regarded as the epitome of an human opportunistic 
pathogen: this bacterium almost never infects uncompromised tissues, yet there is 
hardly any tissue that it cannot infect if the tissue defenses are compromised in some 
respect. It causes infections of the urinary tract, respiratory system, dermatitis, soft 
tissue, bacteremia, bone and joint, gastrointestinal and a variety of systemic infections, 
particularly in patients with severe burns and in cancer and AIDS patients who are 
immunosuppressed. PA infection is a serious problem in patients hospitalized with 
cancer, cystic fibrosis, and burns. The case fatality rate in these patients is 50 %.  
PA is primarily a nosocomial pathogen:  the overall incidence of its  infections in 
hospitals averages to about 0.4 %, and the bacterium is the fourth most commonly-
isolated nosocomial pathogen accounting for 10 percent of all hospital-acquired 
infections. It demands very simple nutritional requirements. In the laboratory, the 
simplest medium for its growth consists of acetate as carbon source and ammonium 
sulfate as nitrogen source. Moreover it is notorious for its resistance to antibiotics and 
is, therefore, a particularly dangerous and dreaded pathogen. The bacterium is naturally 
resistant to many antibiotics due to permeability barrier built up by its outer membrane. 
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Figure 1.1. Pseudomonas aeruginosa scanning electron micrograph: the cell is a rod measuring 0.5 to 
0.8 µm by 1.5 to 3.0 µm. Almost all strains are motile by means of a single polar flagellunm. 
 
Also, its tendency to colonize surfaces as a biofilm form makes the cells impervious to 
therapeutic antibiotics doses. Since its natural habitat is the soil, living in association 
with the bacilli, actinomycetes and molds, it has developed resistance to a variety of 
their naturally-occuring antibiotics.  
Only a few antibiotics are effective against PA, including fluoroquinolones, gentamicin 
and imipenem, and even these antibiotics are not effective against all strains. The 
futility of treating PA infections with antibiotics is most dramatically represented in 
cystic fibrosis patients that typically become infected with strains so resistant that it 
cannot be treated. 
 
 
For an opportunistic pathogen such as PA, the disease process begins with some 
alteration or circumvention of normal host defenses. The pathogenesis of PA infections 
is multifactorial, as suggested by the number and wide array of virulence determinants 
possessed by the bacterium. Multiple and diverse determinants of virulence are 
expected in the wide range of diseases caused, which include septicemia, urinary tract 
infections, pneumonia, chronic lung infections, endocarditis, dermatitis, and 
osteochondritis. A brief description of these infective diseases is reported in the 
following list.  
 
Endocarditis. PA infects prosthetic heart valves. The organism establishes itself on the 
endocardium by direct invasion from the blood stream.  
Bacteremia and Septicemia. PA causes bacteremia primarily in immunocompromised 
patients. Predisposing conditions include hematologic malignancies, immunodeficiency 
Chapter 1 
 
 3 
relating to AIDS, neutropenia, diabetes mellitus, and severe burns. Most PA bacteremia 
is acquired in hospitals and nursing homes.  
Central Nervous System infections. PA causes meningitis and brain abscesses. The 
organism invades the central nervous system from a contiguous structure such as the 
inner ear or paranasal sinus, or is inoculated directly by means of head trauma, surgery 
or invasive diagnostic procedures, or spreads from a distant site of infection such as the 
urinary tract.  
Ear infections including external otitis. PA is the predominant bacterial pathogen in 
some cases of external otitis. The bacterium is infrequently found in the normal ear, but 
often inhabits the external auditory canal in association with injury, maceration, 
inflammation, or simply wet and humid conditions.  
Eye infections. PA can cause devastating infections in the human eye. It is one of the 
most common causes of bacterial keratitis, and has been isolated as the etiologic agent 
of neonatal ophthalmia. It can colonize the ocular epithelium by means of a fimbrial 
attachment to sialic acid receptors. If the defenses of the environment are compromised 
in any way the bacterium can proliferate rapidly and, through the production of lytic 
enzymes cause a rapidly destructive infection that can lead to loss of the entire eye.  
Bone and joint infections. PA infections of bones and joints result from direct 
inoculation of the bacteria or the hematogenous spread of the bacteria from other 
primary sites of infection. Blood-borne infections are most often seen in conjunction 
with urinary tract or pelvic infections. PA has a particular tropism for fibrocartilagenous 
joints of the axial skeleton. It causes chronic contiguous osteomyelitis, usually resulting 
from direct inoculation of bone, and is the most common pathogen implicated in 
osteochondritis after puncture wounds of the foot.  
Urinary tract infections. Urinary tract infections (UTI) caused by PA are usually 
hospital-acquired and related to urinary tract catheterization, instrumentation or surgery. 
It is the third leading cause of hospital-acquired UTIs, accounting for about 12 % of all 
infections of this type. The bacterium appears to be among the most adherent of 
common urinary pathogens to the bladder uroepithelium. As in the case of E. coli 
urinary tract infection can occur via an ascending or descending route. In addition, PA 
can invade the bloodstream from the urinary tract, and this is the source of nearly 40 
percent of PA bacteremias.  
Gastrointestinal infections. PA can produce disease in any part of the gastrointestinal 
tract from the oropharynx to the rectum. As in other forms of PA disease, those 
involving the gastrointestinal tract occur primarily in immunocompromised individuals. 
The organism has been implicated in perirectal infections, pediatric diarrhea, typical 
gastroenteritis, and necrotizing enterocolitis. The gastrointestinal tract is also an 
important portal of entry in PA septicemia.  
Skin and soft tissue infections, including wound infections, pyoderma and 
dermatitis. PA can cause a variety of skin infections, both localized and diffuse. The 
common predisposing factors are breakdown of the integument which may result from 
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burns, trauma or dermatitis; high moisture conditions such as those found in the ear of 
swimmers and the toe webs of athletes and combat troops, in the perineal region and 
under diapers of infants, and on the skin of whirlpool and hot tub users. Individuals with 
AIDS are easily infected. PA has also been implicated in folliculitis and unmanageable 
forms of acne vulgaris.  
Respiratory infections. Respiratory infections caused by PA occur almost exclusively 
in individuals with a compromised lower respiratory tract or a compromised systemic 
defense mechanism. Primary pneumonia occurs in patients with chronic lung disease 
and congestive heart failure. Bacteremic pneumonia commonly occurs in cancer 
patients undergoing chemotherapy. Lower respiratory tract colonization of cystic 
fibrosis patients by mucoid strains of PA is common and difficult, if not impossible, to 
treat. 
 
 
 
1.1.2 Pseudomonas aeruginosa modulation of epithelial function 
 
The lung is exposed to a constant barrage of inhaled harmful agents and 
microorganisms. It has therefore evolved both innate and acquired defense mechanisms 
to  combat infections. The innate host defense mechanisms include mucociliary 
clearance, surfactant proteins, antimicrobial peptides and complement, all of which 
have important roles in immune modulation. The airways are also protected by alveolar 
macrophages, neutrophils, lymphocytes and circulating antibodies. A loss of individual 
components frequently results in lung infection. Infection of human airways by PA 
leads to varied pathological responses and lung injury. One extreme is the acute 
nosocomial necrotizing pneumonia that is associated with a high incidence of mortality 
despite antibiotic therapy, due in part to epithelial destruction and bacterial invasion of 
the pulmonary vasculature with resultant bacteremia and its sequellae. At the opposite 
extreme is persistent airway infection in individuals with cystic fibrosis (CF), where 
organisms remain confined to the airway as biofilms, triggering a chronic neutrophilic 
inflammatory response.  
 
 
PA infection of normal and CF airways  
Numerous effects of PA components/products on various aspects of epithelial cell 
function, including direct cytotoxicity, activation of cellular signaling pathways and 
proinflammatory responses, have been examined extensively in vitro and in vivo [1–14]. 
DNA microarray technology has revealed that epithelial gene expression patterns in 
response to different PA-derived products and intact organisms vary considerably [15–
18]. Abnormalities of the cystic fibrosis transmembrane regulator (CFTR), which result 
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Figure 1.2. Models of biofilm formation. (a) In biofilm model 1, planktonic Pseudomonas aeruginosa 
(i) attach to a surface via flagella and/or type IV pili (ii). Structures known as ‘microcolonies’ form 
after significant cell division and biosynthesis of a multi-component exopolysaccharide matrix (iii). 
These microcolonies mature into ‘macrocolonies’ as the biofilm thickens (iv). Signaling molecules, 
nutrient and oxygen gradients or mechanical perturbation trigger release of bound organisms from the 
biofilm, often referred to as biofilm detachment or dispersion (v).  
(b) In biofilm model 2, which occurs in the cystic fibrosis (CF) airways, P. aeruginosa are embedded 
in a layer of thickened mucus and rarely come into indirect contact with epithelial surface (i). Bacteria 
lose their surface appendages, mutate to a mucoidy phenotype with a heavy coat of alginate, and form 
biofilm macrocolonies (ii). Thick mucus layer and biofilm both protect P. aeruginosa from clearance 
by neutrophils and macrophages (iii), enabling them to establish chronic infections. (Taken from 
Hassett D.J., et al.  (2003) Expert Opinion Biol. Ther. 3, 1201-1207). 
 
in CF, enable enhanced Na
+
, Cl
–
 and water reabsorption. CF goblet cells hypersecrete 
mucus to the apical surface. CF epithelial cilia are matted down by thick mucus and 
either do not beat or beat erratically. This mucus becomes a haven for PA [1].  In 
contrast to single cell (planktonic) growth in vitro, the mode of PA growth in CF 
airways is termed ‘biofilm’ [19, 20]. Biofilm is a highly ordered surface-attached mode 
of growth whose formation involves attachment, cell division, differentiation and 
detachment. Biofilm formation requires flagella, pili and other gene products (Fig. 1.2). 
PA in biofilms are associated with high resistance to antibiotics and phagocytic killing 
[20]. Two models of biofilms are known. The first involves a series of steps that lead to 
bacterial attachment to surfaces (Fig. 1.2, a) and the other is characterized by bacterial  
‘rafts’ (Fig. 1.2, b). Model 1 could represent the initial phase of CF airway colonization  
 
Chapter 1 
 
 6 
  
 
Table 1.1. Virulence determinants of Pseudomonas aeruginosa and their impact on lung epithelia. 
(taken from Lau W. G., et al. (2005) TREND Microbiol. 8, 389-397.) 
 
 
by environmental isolates of PA, or acute pneumonias in non-CF airways. As the 
chronic stage of infection ensues, biofilm model 2 predominates. It is associated with  
over production of alginate, loss of flagella, mutations in antigenic B-band O-antigen 
genes, and reduced expression of extracellular virulence determinants [1]. Thus, PA is 
subject to selection towards reduced cytotoxicity and attenuated virulence during 
chronic CF lung infection. Microscopic examination of airways removed from lung 
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transplantation patients strongly argues that PA rarely localizes to the airway epithelial 
surface in end-stage CF [7]. Rather, the bacteria are embedded in thick mucus (biofilm 
model 2). Levels of oxygen within the mucus are low, creating ‘steep  hypoxic 
gradients’ [7]. However, sufficient levels of the alternative electron acceptors NO3
-
 and 
NO2
-
 are present in CF sputa, suggesting that some bacteria might undergo anaerobic 
biofilm formation and respiration [21].  
 
PA products and their effects on the epithelium  
Numerous PA components have been reported to modulate lung epithelial functions 
(Tab. 1.1). Key virulence determinants and areas of controversy are highlighted in the 
subsequent section.  
 
Membrane-bound virulence determinants Lipopolysaccharide.  
The lipid A component of bacterial lipopolysaccharide (LPS) is a potent modulator of 
epithelial cell functions via its interaction with the toll-like receptor 4 (TLR4) signaling 
complex [22] (Fig. 1.2, a). LPS is not important in PA-mediated modulation of airway 
cell functions when compared with other Gram-negative pathogens [23, 24]. However, 
exceptions have been described [13, 25].  
 
Flagella and pili.  
Flagella and pili are appendages required for PA motility and lung infection [26, 27]. 
They enable attachment of PA to cells by binding to respiratory mucin [12] and the 
glycolipid, asialoGM1 [11], inducing release of interleukin (IL)-8 through a Src-Ras-
ERK1/ 2-NF-kB pathway [10]. Interestingly, mucoid isolates of PA from CF patients 
lack flagella, which might enhance their survival by decreasing neutrophil recruitment 
to the airway [15].  
 
Alginate. 
Alginate is not a significant component of biofilms in vitro in PA strains that possess an 
intact mucA allele [28]. Although purified alginate stimulates mucin and lysozyme 
secretion in airway epithelia [29], the primary pathophysiologic role of alginate might 
be to dampen the local immune response towards PA [15]. 
 
Secreted virulence determinants  
Pathogenic interactions between PA and hosts are often guided by exoproducts secreted 
by the bacteria that interact with specific host targets (Tab. 1.1).  
 
Quorum sensing molecules: role in pathogenesis and biofilm formation. 
PA communicates intercellularly via small, diffusible acylated homoserine lactones: 
Pseudomonas autoinducers (PAIs). Local PAI concentrations increase at high cell 
densities, enter bacteria and bind to transcriptional activators to activate or repress the 
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expression of genes.  The precise interaction among these quorum sensing systems 
remains to be defined but they clearly control production of numerous virulence factors, 
including exoproteases, exotoxin A, rhamnolipids, phenazines and hydrogen cyanide 
[30]. Interestingly, PA in CF airway and in vitro biofilms produce higher levels and 
identical ratios of PAI than planktonic bacteria [19].  
 
Type III secretion system (T3SS). 
PA injects four type III secretion system (T3SS) effector proteins, ExoU, ExoS, ExoT 
and ExoY into host cells [31]. ExoU, a lysophospholipase, which inhibits ERK1/2-p38 
survival pathways and activates pro-apoptotic pathways through JNK1/2 [32], probably 
has the greatest role in virulence [33]. N-terminal domains of ExoS and ExoT encode a 
GTPase activating protein activity (GAP) and C-terminal domains have ADP 
ribosyltransferase (ADPRT) activity [31]. ExoY, an adenylyl cyclase, increases lung 
epithelial intracellular cAMP 800-fold, causes cell rounding/detachment, might inhibit 
phagocytosis of PA, and disrupts pulmonary endothelial barrier function [44].  
 
Phenazines. 
Pseudomonas species produce phenazines as secondary metabolites that function in 
microbial competitiveness and virulence [38]. The most studied phenazines are: 
pyocyanin, 1-hydroxyphenazine and phenazine-1-carboxylic acid. Bioactivities of these 
compounds are linked to their ability to affect the redox-cycle, which leads to 
generation of reactive oxygen species and host cell damage [38]. In mice  pyocyanin-
deficient PA mutants are attenuated in both acute and chronic lung infections in mice, 
providing strong evidence that pyocyanin contributes to PA virulence [38].  
 
 
 
Proteases.  
PA secretes elastases (LasA and LasB), alkaline protease and protease IV. These 
exoproteases degrade host defense and immunoregulatory proteins and damage 
epithelia [39–41]. Elastase activates the mitogen-activated protein kinase (MAPK) 
pathway, increasing IL-8 expression and augments respiratory epithelium permeability 
by attacking tight junctions [5].  
 
Phospholipases.  
PA produces several phospholipases: hemolytic PlcH and non-hemolytic PlcN, PlcB 
[42] and PldA [43]. PlcB is responsible for PA chemotaxis toward phospholipid 
gradients [42] and PlcH exhibits sphingomyelin synthase activity [44]. The substrate for 
these enzymes, phosphatidylcholine is abundant in lung surfactant, therefore, 
phospholipases probably have a role in virulence. Anti-PLC antibody is readily 
detectable in CF patients, and the isolation of PA strains capable of secreting PLCs is 
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usually associated with a poor clinical status. A tatC mutant, that fails to secrete 
multiple exoproducts including PlcH and PlcN [45], and the pldA mutant [43], are both 
attenuated in mouse chronic lung infection.  
 
Exotoxin-A (ETA).  
Most clinical PA isolates secrete ETA, a potent inhibitor of protein synthesis via ADP-
ribosylation of elongation factor 2. ETA expression is regulated by QS and by the 
availability of iron, which is chelated by two siderophores pyochelin and pyoverdin 
[46]. ETA levels in bronchial secretions correlate with exacerbation periods in CF. ETA 
binds to 2 macroglobulin receptors located exclusively on the basolateral side of 
polarized epithelia [47]. It increases the permeability of the airway epithelia by 
inhibiting the repletion of tight junction proteins [5], which partially contributes to 
apoptotic cell death [48]. ETA also kills airway epithelia non-apoptotically through 
mitochondrial dysfunction, superoxide production and DNA degradation [49].  
 
 
 
 
 
1.2 Bacterial phospholipase/lysophospholipase and pathogenesis 
 
Phospholipases are a heterologous group of proteins produced by bacteria and their 
eukaryotic hosts. In eukaryotic cells, phospholipases perform the ordinary task of 
phospholipid turnover in addition to their role in signal transduction; similar enzymatic 
activities involved in phospholipid turnover for membrane maintenance also release 
precursors of lipid second messengers. Some mammalian cells also produce secreted 
phospholipases which are present in extracellular fluids including serum and synovial 
fluid; as part of the inflammatory response, secreted phospholipase A2 (PLA2, see 
below) are produced and secreted in response to cytokines during inflammatory events 
[50]. The secreted PLA2 have also been implicated in the progression of damaging 
inflammatory responses, septic shock, acute lung injury, and other inflammatory 
disorders [50]. Bacteria produce membrane-associated phospholipases that are thought 
to function primarily in membrane maintenance, but their function has not been 
definitively established. Escherichia coli mutants lacking a phospholipase have been 
isolated, suggesting these enzymes are not essential for viability [51]. Various bacterial 
genera also produce secreted phospholipases and lipases. In general, secreted 
phospholipases are thought to function in phosphate acquisition, carbon source 
acquisition, and in some cases as virulence factors for pathogenic species.  
The amphipathic nature of phospholipids creates obstacles for the enzymes as the 
substates are assembled into bilayers or even micelles, and are not present in significant 
amounts as single soluble substrates. It should be noted that the amphipathic 
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phospholipid substrates are defined by their polar head group, of which the most 
common in mammalian cells are phosphatidylcholine (PC), phosphatidylserine (PS), 
phosphatidylinositol (PI), and phosphatidylethanolamine (PE) (Fig. 1.3). These 
designations actually define a group of molecules with differing degrees of saturation 
and length of the two fatty acyl groups; only a limited range of degrees of saturation 
and potential acyl chain lengths are found in biological systems. Both the acyl chains 
and the phospho-head groups influence the substrate specificity of phospholipases, 
some enzymes being much more restricted than others. Because the phospholipid 
composition varies with the source of the membrane, i.e., bacterial versus eukaryotes, 
the substrate specificity of a particular phospholipase can suggest or eliminate potential 
target membranes. In contrast to mammalian cells, E. coli membranes are primarily 
composed of PE with some phosphatidylglycerol, cardiolipin (double phospholipid 
joined at the phosphate by glycerol) and trace amounts of PS. Furthermore, only a 
subset of the products of phospholipase activity are direct precursors for second 
messengers in mammalian cells, i.e., the fatty acid arachidonic acid is the precursor for 
eicosanoid biosynthesis. Therefore, given some knowledge of the substrate specificity 
of a particular phospholipase, some inference regarding its function can be made.  
Two major divisions of phospholipase activities can be defined by the site of cleavage, 
whether the cleavage is in the hydrophobic diacylglycerol moiety (PLA) or in the polar 
head group of the amphipathic phospholipid (PLC and PLD; Fig. 1.3). PLAs hydrolyze 
a fatty acid from the glycerol backbone (leaving a lysophospholipid) in a reaction 
similar to lipases hydrolyzing fatty acids from triacylglycerol lipids. In fact, a few 
enzymes have significant PLA activity as well as triacylglycerol lipase activity; 
therefore these enzymes hydrolyze either hydrophobic or amphipathic substrates with 
reasonable efficiency [52]. PLAs can be further defined by their positional specificity, 
preference for the acyl group attached to position 1 or 2 of the glycerol backbone, PLA1 
and PLA2, respectively; PLBs have both PLA1 and PLA2 activity, i.e., little or no 
positional specificity. Lysophospholipases release free fatty acid from lysophospholids. 
The other types of phospholipases cleave on either side of the head group phosphate. 
Cleavage by PLC releases the phospho-head group (e.g., choline phosphate, inositol 
phosphate, and inositol triphosphate) and diacylglycerol, whereas PLD cleaves on the 
other side of the phosphate producing phosphatidic acid and the head group (e.g., 
choline and inositol). Phospholipases of all types have various substrate specificities 
with respect to the polar head group and also with respect to the length and saturation of 
the fatty acyl groups. Some phospholipases are very specific, hydrolyzing a particular 
phospholipids  with greater efficiency.                                          
 
Nevertheless, hydrolysis by any phospholipase type releases products that destabilize 
membranes; if sufficiently active, bacterial phospholipases may initiate further 
degradation of the phospholipids by other cellular enzymes including phospholipases. 
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Figure 1.3. Structures of common mammalian phospholipids and the signaling pathways induced by 
the second messengers released by phospholipases. Portions of phospholipid molecules are color 
coded: polar head groups in green, glycerol backbone in blue and fatty acids in red and purple. 
Diacylglycerol encompasses all of the phospholipid except the green polar head group, and likewise 
the lysophospholipid encompasses everything but the fatty acid shown in red. Arrows do not 
necessarily indicate a direct induction. (Taken from Schmiel D. H., et al. (1999) Microb. Infect. 1, 
1103-1112). 
 
 
Phospholipases are considered virulence factors for bacterial species which cause 
disparate disease syndromes, from infections causing massive tissue destruction, such 
as gas gangrene and the skin and lung infections of Pseudomonas aeruginosa to food-
borne listeriosis (Tab. 1.2) [53-55]. In the disease process phospholipases have been 
implicated in a number of roles, which are considered below (Fig. 1.4). Even though the 
importance of some bacterial phospholipases in pathogenesis is certain and the enzyme  
has been characterized, it is clear that the exact mechanism of the phospholipase action 
in vivo has not been definitively determined. Historically, the first indication that 
bacterial phospholipases were virulence factors was the realization that some bacterial  
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Figure 1.4. Drawing depicting the roles of bacterial phospholipases during infection. The imaginary 
Figure 1.4. Drawing depicting the roles of bacterial phospholipases during infection. The imaginary 
bacterial phospholipase is shown performing most of the well-established as well as proposed 
functions ascribed to all the bacterial phospholipases discussed. From the upper left corner, the 
bacteria depicted as green rods secrete a phospholipase which aids degradation and penetration of the 
mucus layer (H. pylori and P. aeruginosa). Once the bacteria reach the epithelial surface 
phospholipase action triggers engulfment by an epithelial cell, a nonprofessional phagocyte 
(Rickettsia). Phospholipase activity then promotes escape from the vacuole or phagosome in the right-
hand epithelial cell and the macrophage below (L. monocytogenes) and promotes cytolysis in the left-
hand epithelial cell. Cytolysis can be triggered from within or without (C. perfringens and many 
others). Bacteria which have escaped the macrophage phagosome are being carried from the site of 
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infection by the migrating macrophage (L. monocytogenes). Effects associated with the blood vessel, 
bottom right, are depicted in the absence of bacteria because they are mostly indirect effects attributed  
to eicosanoid or cytokine induction (excepting hemolysis). The vessel is drawn partly dilated and 
partly constricted because different eicosanoids have opposite vasoactive properties. When blood 
leukocytes are induced to migrate into tissues, the vessel generally dilates, reducing blood velocity, 
and several different leukocyte adhesion receptors are sequentially induced in the endothelial 
cells.Weaker interactions promote transient binding, and the leukocyte rolls along the endothelial wall. 
Subsequent strong binding stops the rolling and allows the leukocyte to pass between endothelial cells. 
The migrating leukocytes follow the chemokine gradient to reach infected tissues (C. perfringens and 
C. pseudotuberculosis). The bottom left depicts an abnormal state where overexpression of adhesion 
integrins on the endothelium promotes sustained leukocyte adherence; degranulation of the static 
leukocytes could then cause damage to the vessel (C. perfringens). (Taken from Schmiel D. H., et al. 
(1999) Microb. Infect. 1, 1103-1112). 
 
 
 
toxins were in fact secreted phospholipases, for example the Clostridium perfringens  
toxin [56] and Staphylococcus aureus toxin [57]. In general, phospholipase toxicity has 
been linked to cytolytic activity and is presumed to be directly due to phospholipase 
activity on membrane phospholipids and membrane destruction (Fig. 1.4). Cytolysis is 
one of the more common characteristics attributed to bacterial phospholipase virulence 
factors (Tab. 1.2). Whether cytolysis results from the accumulation of membrane 
destabilizing products or by the whole sale destruction of membrane phospholipids, it 
can be caused directly by a very active bacterial phospholipase with broad specificity or 
in concert with host degradative enzymes induced by the bacterial phospholipase. 
Naturally, the cytolytic activity varies greatly amongst bacterial phospholipases. The 
cytolytic properties of the phospholipase itself are dependent on the ability to interact 
directly with and hydrolyze phospholipids in the membrane. Thus the enzymatic 
activity determined using solublized substrates is not indicative of the cytolytic 
potential of a particular phospholipase if it interacts poorly with membranes. 
Frequently, the lytic activity is measured as hemolysis for convenience, regardless of 
the likelihood for a particular pathogen to cause systemic infection or bacterial 
phospholipase to enter the bloodstream. Furthermore, different eukaryotic membranes 
are composed of different phospholipids, even the two leaflets (inner and outer) of a 
particular membrane may have very distinct phospholipid composition. Therefore, an 
extracellular phospholipase would not be expected to lyse a target cell unless the outer 
leaflet phospholipids were efficiently hydrolyzed substrates of the enzyme. Of course, 
this does not exclude possible cooperativity between several phospholipases or between 
a phospholipase and another type of ‘lysin’ (hemolysin or cytolysin) molecule as has 
been proposed for Listeria monocytogenes [57]. Specificity for phospholipids in a 
particular membrane type or leaflet has had some interesting implications. In addition  
to  eukaryotic  cell  cytolysis, bacterial phospholipases have been implicated in the very   
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TAB 
 
Table 1.2. Bacterial phospholipases implicated in pathogenesis. (Taken from Schmiel D. 
H., et al. (1999) Microb. Infect. 1, 1103-1112). 
 
 
 
Chapter 1 
 
 15 
specific destruction of endosomal or phagosomal membranes [58-61]. This particular 
membrane may have a very distinct phospholipid composition. For instance, the plasma 
membrane of most eukaryotic cells contains predominantly PC and sphingomyelin in 
the outer leaflet and PI, PE, and PS in the inner leaflet. Therefore, an extracelluler 
phospholipase would not be expected to lyse a target cell unless the outer leaflet 
phospholipids were efficiently hydrolysable substrates of the enzyme. In addition to 
eukaryotic cell cytolysis, bacteria phosphoipases have been implicated in the very 
specific destruction of endosomal or phagosomal membranes. This releases the 
bacterium into the nutrient-rich host cell cytoplasm and is one method of escape from 
possible annihilation by the lysosome (Fig. 1.4). As some of the more active cytolytic 
phospholipases are linked to diseases characterized by tissue destruction, one could 
speculate that destruction is solely due to lysis of individual cells comprising the 
tissues. However, some of the best-studied examples of phospholipase virulence factors 
implicated in destructive infections, for example the two P. aeruginosa PLC and the C. 
perfringens toxin (see below), have also demonstrated phospholipase dependent 
induction of immunomodulatory cytokines that stimulate the inflammatory response 
[62-64]. Consequently, in these examples tissue destruction has been proposed to be 
partially due to the overstimulation of the inflammatory response indirectly caused by 
the phospholipase. In addition, C. perfringens toxin [65], and the hemolytic P. 
aeruginosa PLC [66] were shown to stimulate the arachidonic acid cascade probably by 
further hydrolysis of diacylglycerol by endogenous cytoplasmic enzymes. Hydrolysis of 
diacylglycerol could release arachidonic acid, the precursor for the eicosanoids, lipid 
second messengers which include prostaglandins, thromboxanes, and leukotrienes [67]. 
Prostaglandins and thromboxanes are vasoactive and modulate platelet activation 
locally [68]. Leukotrienes are important mediators of acute inflammation affecting 
neutrophil migration, superoxide generation, and degranulation. Interestingly, 
hydrolysis of phospholipids by PLA2 releases arachidonic acid directly because it is 
most commonly found in position 2 of mammalian phospholipids. Though bacterial 
PLAs have been implicated as virulence factors, the potential for stimulation of the 
arachidonic acid cascade has not been examined.  
 
 
 
 
 
 1.3 Carboxylesterases 
 
 
Esterases (EC 3.1.1.x) represent a diverse group of hydrolases catalyzing the cleavage 
and formation of ester bonds. They are widely distributed in animals, plants and 
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microorganisms. Many of them show a wide substrate tolerance which led to the 
assumption that they have evolved to enable access to carbon sources or to be involved 
in catabolic pathways. Moreover, esterases also show high regio- and stereospecificity, 
which makes them attractive biocatalysts for the production of optically pure 
compounds in fine-chemicals synthesis [69-74]. The interest in these enzymes also 
resides in the fact that they do not require cofactors, are usually rather stable and are 
even active in organic solvents.  
Two major classes of hydrolases are of utmost importance: lipases (EC 3.1.1.1, 
triacylglycerol hydrolases) and ‘true’ esterases (EC 3.1.1.3, carboxyl ester hydrolases). 
The three-dimensional (3D) structures of both enzymes show the characteristic α/β 
hydrolase fold [75] which is also found in haloperoxidases and epoxide hydrolases (Fig. 
1). The catalytic triad is composed of Ser-Asp-His (Glu instead of Asp for some lipases) 
and usually also a consensus sequence (Gly-X-Ser-X-Gly) is found around the active 
site serine. More recently, esterases have been identified containing a Gly-X-X-Leu 
motif [76] as well as enzymes showing high homology to class C β-lactamases [77].  
Lipases can be distinguished from esterases by the phenomenon of interfacial 
activation, which was only observed for lipases. Whereas esterases obey classical 
Michaelis-Menten kinetics, lipases need a minimum substrate concentration before high 
activity is observed. Structure elucidation revealed that this interfacial activation is due 
to a hydrophobic domain (lid) covering the active site of lipases. Only in the presence 
of a minimum substrate concentration, i.e. a triglyceride phase or a hydrophobic organic 
solvent, the lid moves apart, making the active site accessible. Furthermore, lipases 
prefer water-insoluble substrates, typically triglycerides composed of long-chain fatty  
 
Figure 1.1. Schematic presentation of the prototypic α/β hydrolase fold. β-strands (1-8) are shown as 
blue arrows, α-helices (A-F) as red cylinders. The relative positions of the amino acids of the catalytic 
triad are indicated as red circles. 
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acids, whereas esterases preferentially hydrolyze ‘simple’ esters (e.g. ethyl acetate) and 
usually only triglycerides bearing fatty acids shorter than C6. Both enzymes have been 
shown to be stable and active in organic solvents, but this feature is more pronounced 
with lipases. A comparison of amino acid sequences and 3D-structures of lipases and 
esterases suggested that they can be differentiated by a pH-dependent electrostatic 
`signature' [78]; the active site of lipases displays a negative potential in the pH-range 
associated with their maximum activity (typically at pH 8), whereas esterases show a 
similar pattern, but at pH values around 6, which correlates with their usually lower pH-
activity optimum [78]. Screening of esterases is usually performed either by employing 
chromophoric substances (e.g. p nitrophenyl esters) or by using tributyrin-supplemented 
agar plates. Organisms producing active esterases are then identified by halo formation 
on plates containing dispersed water-insoluble substrates such as triglycerides. 
Hydrolysis of these dispersed lipid droplets leads to a clearing zone around the colonies. 
Then, lipases can be distinguished from carboxyl esterases by their substrate spectra, 
using p-nitrophenyl palmitate (cleaved by lipases) vs. p-nitrophenyl butyrate (cleaved 
by esterases and sometimes also by lipases). In contrast to this traditional approach, 
modern molecular biology techniques allow for DNA library expression screening.  
 
Classification of enzymes can be done either based on their substrate specificity or by 
sequence alignments. The former requires that all enzymes which need to be compared 
have been assayed with the same or at least related substrates, preferentially under 
similar reaction conditions. Although this would allow the biochemist to directly 
identify a suitable enzyme for a given synthetic problem, this is not a common strategy. 
Due to the increasing availability of sequence information in public databases, the 
comparison of amino acid sequences can provide a clearer picture about the 
evolutionary relationship between enzymes of different origin. On the other hand, it 
often turns out that high sequence homology cannot be related to the enzyme’s 
properties (substrate specificity, stereoselectivity, pH and temperature optima, solvent 
stability), and in some cases completely different types of reactions are catalyzed. For 
instance, a bromoperoxidase from Streptomyces aureofaciens shares 55% sequence 
identity to an esterase from Pseudomonas fuorescens [79, 80] but they share little 
substrate specificity. Until a few years ago, it was believed that for all lipases and 
carboxyl esterases only the consensus sequence motif Gly-X-Ser-X-Gly (where X 
represents an arbitrary amino acid residue) occurs around the active site serine. More 
recently, a thorough comparison of 53 amino acid sequences of lipases and esterases 
revealed that other motifs also exist [81]. For instance, some lipases and an esterase 
from Streptomyces scabies contain a GDSL (Gly-Asp-Ser-Leu) consensus sequence. 
Moreover, structure elucidation of this esterase revealed that it contains a catalytic Ser-
His dyad instead of the common Ser-Asp- His triad [76]. The acidic side chain, which 
usually stabilizes the positive charge of the active site histidine residue, is replaced by 
the backbone carbonyl of Trp315 located three positions upstream of the His itself. The 
Chapter 1 
 
 18 
enzyme also has an α/β tertiary fold, which differs substantially from the α/β hydrolase 
fold. Other esterases in the GDSL group includes those from Pseudomonas aeruginosa 
(accession code: AF005091), Salmonella typhimurium (AF047014) and Photorhabdus 
luminescens (X66379), the first two being outer-membrane-bound esterases. Other 
enzymes show high homology to the mammalian hormone-sensitive lipase family. 
Here, conserved sequence motifs were found, which initially have been related to 
activity at low temperature. However, it was found that esterases from psychrophilic 
(e.g. Moraxella sp., X53869; Psychrobacterimmobilis, X67712) as well as mesophilic 
(Escherichia coli, AE000153) and thermophilic (Archeoglobus fulgidus, AAE000985) 
origins belong to this family. Members of family V, such as esterases from Sulfolobus 
acidocaldarius (AF071233) and Acetobacter pasteurianus (AB013096), share 
significant homology to non-lipolytic enzymes, e.g. epoxide hydrolase, dehalogenase 
and haloperoxidase. Rather small (23-26 kDa) enzymes are found in family VI, which 
includes an esterase from P. fluorescens, of which the structure is known [82]. The 
esterase is active as a dimer, has a typical Ser-Asp-His catalytic triad and hydrolyzes 
small substrates, but not long-chain triglycerides. Interestingly, 40% homology to 
eukaryotic lysophospholipases is found for members of this family. In contrast, 
esterases from family VII are rather large (55 kDa) and share significant homology to 
eukaryotic acetylcholine esterases and intestine or liver carboxyl esterases (e.g. pig liver 
esterase). A p-nitrobenzyl esterase from Bacillus subtilis [83, 84] and an esterase from 
Arthrobacter oxydans (Q01470) active against phenylcarbamate herbicides [85] belong 
to this group. In the last family, VIII, high homology to class C β-lactamases is 
observed. These enzymes contain a Gly-X-Ser-X-Gly motif and a Ser-X- X-Lys motif, 
but it has recently been demonstrated by site directed mutagenesis studies of an esterase 
(EstB) from Burkholderia gladioli that the Gly-X-Ser-X-Gly motif does not play a 
significant role in enzyme function [77]. The most prominent member is an esterase 
from Arthrobacter globiformis (AAA99492) [86].  
 
 
 
 
Enzymes belonging to the α/β hydrolase fold family, all contain a catalytic triad 
consisting of a nucleophile, a base, and an orientating acid [2]. 
The existence of the catalytic triad was first established with acetylcholinesterase 
(AChE) a well-studied member of the α/β hydrolase fold family. It has been known for 
some time that both the serine and the histidine are members of the catalytic triad in 
AchE [3–5]. Further investigation via mutagenesis of these amino acids in AchE 
(Torpedo californica) confirmed that they were essential for catalysis [6]. The third 
member of the catalytic triad, the glutamic acid, was identifyed by crystal structure 
analysis of AChE [7]. This was again supported biochemically via the mutation of the 
Glu334 in human AChE in which all catalytic activity was lost [8]. This procedure has 
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been repeated for many lipases and esterases (e.g., [9–11]), including the highly specific 
juvenile hormone esterase [12]. 
Carboxylesterases cleave esters via a two-step process that involves the formation and 
degradation of an acyl-enzyme intermediate. The hydrolysis initially occurs through a 
nucleophilic attack via the serine onto the carbon of the carbonyl group (Fig. 1.2) [2]. 
The catalytic serine is able to accomplish this with the assistance of the histidine acting 
as a general base. In turn, the protonated histidine is stabilized via a hydrogen bond to 
the glutamic acid. These two catalytic amino acids, His–Glu, are often called a “charge 
relay” system because they work together to activate the serine. The initial nucleophilic 
attack produces what is thought to be the first of two tetrahedral intermediates (Fig. 1.2, 
A) that are stabilized by the presence of two main chain amide group in the active site 
(oxyanion hole). 
This tetrahedral intermediate rapidly collapses, aided by the protonated-histidine acting 
as a general acid, to produce an acyl-enzyme complex (Fig. 1.2, B) while the alcohol 
component of the ester is released. The acyl-enzyme complex then undergoes an attack 
by a histidine-activated water molecule (Fig. 1.2, C) which produces the second 
tetrahedral intermediate (Fig. 1.2, D). After rapid rearrangement of this intermediate, 
the enzyme is regenerated and the acid component released. Much debate still surrounds 
the exact nature of the mechanism described above, which includes the possibility of a 
short, strong bond or low barrier hydrogen bond (LBHB) 
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Figure 1.2. Detailed mechanism of the hydrolysis of esters by carboxylesterases. Compounds in boxes 
are the products of the hydrolysis.  
 
between the glutamic acid and the histidine during catalysis [13–16]. By lowering the 
activation energy required for the formation of the first tetrahedral intermediate the 
LBHB is believed to assist in the activation of the catalytic serine. 
 
 
 
 
1.4 Aim of the research project 
 
 
The aim of this work has been the structural and functional study of a putative 
carboxylesterase purified from P. aeruginosa, namely PA3859. The protein has been 
purified from the wild type and a preliminary biochemical charcterization was carried 
out. The PA3859 gene was then cloned and the recombinant protein was expressed in E. 
coli (Chapter 2). 
The recombinant PA3859 was successfully crystallized and its 3D crystal structure was 
determined (Chapter 3 and 4).  
Starting from the enzyme 3D structure, an approach involving in silico, in vitro and in 
vivo assays lead to the reliable determination of the PA3859 physiological function 
(Chapter 5, 6, 7). 
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Chapter 2 
 
 
Isolation, Characterization, and Heterologous 
Expression of Carboxylesterase PA3859 from 
Pseudomonas aeruginosa PAO1 
 
 
 
Abstract. We purified to homogeneity an intracellular esterase from the opportunistic pathogen 
Pseudomonas aeruginosa PAO1. The enzyme hydrolyzes p-nitrophenyl acetate and other acetylated 
substrates. The N-terminal amino acid sequence was analyzed and 11 residues,  EPLILDAPNA, were 
determined. The corresponding gene PA3859 was identified in the P. aeruginosa PAO1  genome as 
the only gene encoding for a protein with this N-terminus. The encoding gene was cloned in 
Escherichia coli, and the recombinant protein expressed and purified to homogeneity. According to  
sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) analysis and analytical gel  
filtration chromatography, the esterase was found to be a monomer of approximately 24 kDa. The 
experimentally determined isoelectric point was 5.2 and the optimal enzyme activity was at 55 ºC and 
at  pH 9.0. The esterase preferentially hydrolyzed short-chain fatty acids. It is inhibited by  
phenylmethylsulfonyl fluoride (PMSF) but not by ethylendiaminotetraacetic acid (EDTA). Native 
enzyme preparations typically showed a Michaelis constant (Km) and Vmax of 0.43 mM and 12,500 U 
mg
-1
 respectively, using p-nitrophenyl acetate as substrate. Homology-based database searches clearly 
revealed the presence of  the consensus GXSXG signature motif that is present in the serine-dependent 
acylhydrolase  protein family.  
 
 
 
 
 
 
This chapter was adapted from: 
Pesaresi A, Devescovi G, Lamba D, Venturi V, Degrassi G. 
Isolation, characterization, and heterologous expression of a carboxylesterase of 
Pseudomonas aeruginosa  PAO1. 
Curr Microbiol. 2005 Feb; 50(2):102-9. 
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2.1 Introduction  
 
 
Esterases catalyzing the hydrolysis of either aliphatic or aromatic ester bonds are widely 
distributed in nature and occur in most living organisms. They have been the subject of 
several studies due to their potential use in applied and medical biotechnology and also 
for the elucidation of their metabolic function, which is mostly unknown. The 
carboxylesterase family EC (3.1.1.1.) comprises a group of esterases hydrolyzing 
carboxylic ester bonds with relatively broad substrate specificity. They show a high 
degree of sequence similarity and are believed to be involved in the detoxification of 
xenobiotics [10], particularly in the detoxification of pesticides [11]. Most of the 
carboxylesterases have been studied from mammalian tissues, confirming their 
important role in the hydrolytic biotransformation of a vast number of drugs [22].  
Since a significant number of drugs are metabolised by carboxylesterases, the alteration 
of this enzymatic activity can have important clinical implications. Indeed, the 
structural basis of heroin, cocaine, and organophosphate chemical weapon metabolism 
by a promiscuous human carboxylesterase has recently been elucidated [15]. 
Microbial esterases are also widely studied because of their potential industrial 
importance. A novel esterase from Burkholderia gladioli has been reported showing a 
high deacetylation activity on cephalosporin derivatives [19], and a thermostable 
carboxylesterase from Sulfolobus solfataricus has been characterized and the gene 
cloned [17]. Another carboxylesterase gene from Acinetobacter lwoffii has also been 
cloned and sequenced [14].  
Pseudomonas spp. seems to be an important source of these enzymes since the presence 
of carboxylesterases has been reported in strain KWI-56 [24], in Pseudomonas 
fluorescens [9, 12], and in Pseudomonas citronellolis [3]. 
Pseudomonas aeruginosa is an ubiquitous environmental bacterium and is one of the 
three major causes of opportunistic human infections. The importance of P. aeruginosa 
as a pathogen is due to its intrinsic resistance to antibiotics and disinfectants. The P. 
aeruginosa PAO1 genome is the largest bacterial genome sequenced so far [23] and the 
sequence provides insights into its versatility and intrinsic drug resistance. It has been 
proposed that the size and complexity of the P. aeruginosa genome reflect an 
evolutionary adaptation to diverse environments, with a large number of genes involved 
in the catabolism of organic compounds as well as in the modification of anti-microbial 
substances. 
Here is reported the purification and characterization of a carboxylesterase from P. 
aeruginosa PAO1. Most of the presently available biochemical data have proved that 
these hydrolytic enzymes have several features in common, such as a similar 
mechanism of hydrolysis and a catalytic triad consisting of serine, histidine, and 
aspartic acid residues, with the serine residue located in the highly conserved motif  
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GXSXG [1, 2]. A large percentage of esterases show sequence similarity to proteins 
with identified biochemical activity, but with uncertain physiological function. The 
integration of structural, bioinformatic, and enzymology data is expected to greatly 
enhance function determination, as has been recently reported for a new 
carboxylesterase from E. coli [21].  
The identification of the correspondent gene from the genome sequence, cloning in E. 
coli, and the purification protocol of the recombinant protein are aimed at developing a 
system for heterologous expression and purification of large quantities of this enzyme, 
not only for its potential biotechnological application but also for its 3D crystal 
structure determination. The enzyme was also characterized from a biochemical point 
of view and compared to similar and previously reported proteins with the same 
activity.  
 
 
2.2 Materials and Methods  
 
 
2.2.1 Growth conditions, enzyme assay and purification of P. aeruginosa PA3859 
  
P. aeruginosa PAO1 was grown aerobically overnight at 37 ºC in Luria–Bertani (LB) 
medium [20]. Acetyl esterase activity was measured using p-nitrophenyl acetate (Sigma 
Chemical Co., St. Louis, MO) as substrate at a concentration of 0.5 mM. Release of  
p-nitrophenol was detected spectrophotometrically at 400 nm at 25 ºC. 
One unit of esterase activity was defined as the release of 1 μmole of p-nitrophenol  
per minute under these conditions. The enzyme was purified from the cell-free crude 
extract prepared from 1.6 L of culture. Cells were lysed as follows: the pellet was  
resuspended in 40 ml lysis buffer (50 mM Tris-HCl, pH 8.0, 0.5 M NaCl, 0.1 % Triton 
X-100, 1 mg ml
-1
 lysozyme), kept on ice for 1 h, and sonicated (three times at 
maximum power for 1 min each) using a Soniprep 150 sonicator (Sanyo). Cell walls 
were removed by centrifugation (12,000g, 15 min). Clear lysate was fractionated by 
(NH4)2SO4 and the fraction precipitating from 30 to 80% saturation was recovered. This 
pellet was resuspended in 20 mM Bis-Tris, pH 6.5, and further dialyzed against the 
same buffer to eliminate residual ammonium sulfate. The sample was applied to a Q 
Sepharose FF column (Amersham Biosciences); the column was washed with 40 ml of 
20 mM Bis-Tris, pH 6.5, and a 200 ml linear gradient from 0 to 0.4 M NaCl at a flow 
rate of 3 ml min
-1
 was applied. The collected fractions were tested for esterase 
enzymatic activity. Active fractions were pooled and the concentration of NaCl reduced 
to 0.2 M by dialysis against 20 mM Bis-Tris, pH 6.5, 0.2 M NaCl. The protein was 
loaded again onto the same column and eluted using a narrower gradient from 0.2 to 0.4 
M NaCl in 200 ml. Active fractions were pooled, concentrated, dialyzed, and 
resuspended in 100 mM Na phosphate, pH 7.0, 1.7 M (NH4)2SO4 before loading onto 
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phenyl Sepharose HP column (Amersham Biosciences). The column was washed with 
40 ml of 100 mM Na phosphate, pH 7.0, 1.7 M ammonium sulfate before eluting the 
protein with a 240 ml linear gradient from 1.7 to 0 M ammonium suflate. The flow rate 
was 3 ml min
-1
 and fractions were 5 ml each. Active fractions were pooled, dialyzed 
against 100 mM Na phosphate, pH 7.0, and concentrated to 1 ml. The sample was 
loaded onto a gel filtration column (Sephacryl HR200, column XK16; Amersham 
Biosciences) previously equilibrated with 100 mM Na phosphate pH 7.0, 150 mM 
NaCl. Proteins were eluted at a flow rate of 0.5 ml min
-1
 and fractions of 2.5 ml were 
collected. The column was calibrated with an MW-GF-200 kit (Sigma).  
 
 
2.2.2 Determination of molecular weight and pI 
 
Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed according to Laemmli [16] using 12% acrylamide. Protein bands were 
stained with Coomassie Brilliant Blue R250 (Sigma). The broad range molecular 
weight marker kit (New England Biolabs) was used to estimate the relative molecular 
weight (Mr) of the purified protein under denaturing conditions. Gel filtration 
chromatography using a Superdex 75 column (Amersham Biosciences) was carried out 
to determine the molecular mass of the purified enzyme, using MWGF- 200 molecular 
weight markers for gel filtration (Sigma Chemicals). Analytical isoelectric focusing of 
the purified enzyme was performed with an Ampholine PAGplate precast 
polyacrylamide gel (Amersham Biosciences), with pH values ranging from 3 to 10, and 
the broad pI calibration kit (Amersham Biosciences) as pI marker.  
 
 
2.2.3 Kinetics 
 
 The kinetic parameters Km and Vmax were determined in 30 mM Tris-HCl, pH 9.0, at 25 
ºC over the substrate concentration range from 0.01 to 5 mM p-nitrophenyl acetate. 
  
 
2.2.4 Temperature and pH effects 
 
 The optimal pH and temperature were determined in the range from pH 3 to pH 11 and 
from 15 to 85 ºC. For the pH stability determination, samples were incubated in buffers 
from pH 2.0 to pH 13 at 4 ºC for 24 h. For the determination of thermal stability, 
protein samples were kept at temperatures of 30, 40, 50, 60, 70, and 80 ºC and at pH 9 
for 2 h, respectively, and the residual activity was detected as described above. 
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2.2.5 Other assays 
 
 Inhibition by PMSF, dithiothreitol (DTT), and EDTA at various concentrations was 
investigated by incubating 10 μg of the purified enzyme at 25 ºC in 1 ml of 30 mM 
Tris-HCl pH 9, for 5 min. The reaction was stopped by chilling on ice and aliquots were 
assayed with p-nitrophenyl acetate in order to determined the residual activity.  
For the determination of substrate specificity, the following substrates were tested: α-
naphthyl acetate, α-naphthyl butyrate, α-naphthyl caprylate, α-naphthyl laurate, and  
α-naphthyl oleate (Sigma Chemicals). Other substrates used were methylumbelliferyl 
acetate, fluorescein diacetate, and carboxyfluorescein diacetate (Sigma Chemicals). 
Esterase activity was assayed spectrophotometrically at 25 ºC. The release of α-
naphthol was measured at 560 nm after the addition of 1 mg ml
-1
 Fast Garnet GBC 
(Sigma Chemicals) (stock solution, 5 mg ml
-1
 in 10% SDS). Methylumbelliferone was 
detected at 354 nm, fluorescein at 470 nm, and carboxyfluorescein at 490 nm. The 
reaction mixtures contained 30 mM Tris-HCl, pH 9.0, 0.5 mM substrate, and 2 μg of 
enzyme. One unit of esterase is defined as the amount of enzyme required to liberate 1 
μmol of p-nitrophenol min-1.  
The effect of various metallic ions on the purified enzyme was tested. The activity was 
assayed at 25 ºC in 30 mM Tris-HCl, pH 9.0, 5 mM p-nitrophenyl acetate, and 1 mM 
cation.  
 
 
2.2.6 
Amino acid analysis and gene identification 
 
The purified protein was resolved by 12% acrylamide SDS-PAGE, blotted onto a 
polyvinylidene difluoride (PVDF) membrane, and subjected to N-terminal amino acid 
sequence analysis by automated Edman degradation on a pulsed liquid-phase protein 
sequencer (Model 470A; Applied Biosystems) equipped with an on-line 
phenylthiohydantoin amino acid analyzer (Model 120A; Applied Biosystems).  
(The protein sequencing was performed by J. Keen, University of Leeds, UK). 
 
 
2.2.7 Cloning 
 
The carboxylesterase gene from P. aeruginosa used in this study was amplified by PCR 
using two oligonucleotides (BamHI-start,  5′-AATGGATCCAAAGAGGAGAAATCC 
GTCATGAGCGAACCC; and HindIII-stop, 5′-GTCTGAGAGAAGCTTCGGGCGTC 
AGAGG).  
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The PCR product was cloned as a BamHI–HindIII fragment into the corresponding sites 
of pBlueScriptSK(+). The resulting plasmid was transformed into E. coli DH5α and the 
PCR product sequenced.  
To obtain the His-tagged protein, the carboxylesterase gene was amplified by PCR 
using the oligonucleotides (Bam EST, 5′-CGCGGATCCAGCGAACCCCTGATCCTC 
GA; and EcoHind EST, 5′-CGGAATTCAAGCTTCAGAGGCGCTTGCGCAG). Once 
the sequence was confirmed, the PCR product was cloned as a BamHI–HindIII 
fragment into the corresponding sites of pQE30, and Escherichia coli M15 (pREP4) 
(Qiagen) transformed with the resulting plasmid. The recombinant protein carries an 11 
amino acid residue extension at the N-terminus (MRGSHHHHHHG–SSEPLI) 
containing a histidine tag.  
 
 
2.2.8 Purification of the P. aeruginosa PA3859 from E. coli 
 
Affinity chromatography purification of the 6xHis-tagged protein was achieved from 
the crude extract of 1 L of E. coli pQE-31 culture grown in LB to OD600 0.6 and then 
induced with 0.2 mM IPTG for 6 h at 25 ºC. For preparation of cell-free crude extract, 
bacterial cells were resuspended in lysis buffer (50 mM Na phosphate, pH 8.0, 500 mM 
NaCl, 10 mM imidazole, 1 mg ml
-1
 lysozyme), incubated on ice for 30 min, and 
sonicated. The lysate was centrifuged at 10,000g for 30 min at 4 ºC to remove the 
debris, and was loaded onto a 5-ml pre-packed HiTrap Chelating HP affinity column 
(Amersham Biosciences) previously equilibrated with 30 mM Na phosphate, pH 7.5, 
500 mM NaCl, 20 mM imidazole. Nickel was used as chelating agent and immobilized 
onto the column following the manufacturer’s instructions. After washing with 14 
column vol of equilibration buffer, the protein was eluted by 8 column vol of a linear 
gradient, increasing the concentration of imidazole from 20 to 500 mM.  
The protein fraction showing activity was further resolved by ion-exchange Q 
Sepharose FF16/10 chromatography (Amersham Biosciences). The resulting peaks 
were analyzed by electron ion spray–mass spectrometry (EIS-MS) using an API 150EX 
mass spectrometer (Applied Biosystem). 
(Mass spectrometry analysis was performed by C. Guarnaccia, ICGEB, Trieste). 
 
 
 
 
 
 
 
 
Chapter 2 
 36 
2.3 Results 
 
 
2.3.1 Enzyme purification and characterization 
 
The P. aeruginosa carboxylesterase is expressed in a rich medium such as LB. The 
purification of this enzyme is summarized in Table 2.1. After Q Sepharose FF column 
chromatography, a major protein peak showing esterase activity on p-nitrophenyl 
acetate as the substrate was eluted during the gradient at 300 mM NaCl. Approximately 
20% of the total activity was found in another peak eluting at 180 mM NaCl. After gel 
filtration chromatography, only a single band of approximately 28 kDa was detected on 
a SDS–12% polyacrylamide gel (Fig. 2.1). The molecular mass of the purified protein 
estimated by Superdex 75 10/30 (Amersham Biosciences) gel filtration chromatography 
was 19.3 kDa. These results suggest the purified protein to be a monomer. The pI of the 
protein was estimated by isoelectric focusing to be approximately 5.2 (Fig. 2.1), in 
agreement with the theoretically predicted pI value of 5.0.  
 
 
 
 
Figure 2.1. SDS-PAGE (A) and analytical isoelectric focusing (B) of the purified carboxylesterase. 
Lanes: 1, molecular mass standard; 2, 2,5 μg of enzyme; 3, 2.5 μg of enzyme; 4, pI markers. 
 
 
The optimal pH and temperature were found to be 9.0 and 55 ºC, respectively (Fig. 2.2). 
The enzyme was found stable in the pH range between 4.0 and 8.0, and when incubated 
at different temperatures for 2 h, at pH 9.0, it showed to be stable up to 50 ºC (Fig. 2.2).  
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Figure. 2.2. Temperature stability, pH stability, optimal temperature, and optimal pH of the purified 
carboxylesterase. 
 
 
The activity of PAO1 carboxylesterase was determined by measuring the hydrolysis of 
p-nitrophenyl acetate. The Lineweaver–Burk plot showed a linear response over the 
concentration range from 0.01 to 5 mM at pH 9.0 and at 25 ºC. The Michaelis constant 
Km for p-nitrophenyl acetate was 0.43 ± 0.02 mM and the maximal velocity Vmax was 
12,500 ± 500 U mg).  
The effect of some esterase inhibitors was also detected and is shown in Table 2.2. The 
enzyme was completely inhibited by phenylmethylsulfonyl fluoride (PMSF) at a 
concentration above 1 mM, thus suggesting the enzyme to be a serine-dependent 
acylhydrolase.  
Dithiothreitol gave a lower inhibition at 1 mM, while EDTA did not have any effect 
even at a higher concentration (10 mM).  
Enzyme specificity was tested at pH 9.0 and 25 ºC on α-naphthyl esters with different 
chain lengths at 5 mM concentration. Results reported in Table 2.3 showed that the 
activity rapidly decreased with the chain length of the acyl group.  
The kinetic parameter kcat was determined using some common acetylated substrates 
and the values are listed in Table 2.4.  
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The activity of the purified enzyme was also tested in the presence of various cations 
and the results are shown in Table 2.5. The carboxylesterase was sensitive to Co
2+
, 
Cu
2+
, Fe
2+
, Fe
3+
, Ni
2+
, and Zn
2+
 metal ions.  
 
 
 
 
Table 2.1. Summary of the purification of carboxylesterase from 1.6 1 of Pseudomonas aeruginasa 
PAO1.  
a
See Materials and Methods for details. 
b
Measured with p-nitrophenyl acetate as the substrate. 
 
 
Inhibitor  Concentration (mM)  Relative activity (%) 
PMSF 
 
 
DTT 
 
EDTA 
  0.01 
0.1 
                   1 
0.1 
                   1 
                   1 
                 10 
94 
48 
     1.5 
84 
58 
                 100 
                 100 
 
Table 2.2. Effects of inhibitors on carboxylesterase 
 
 
   α-Naphtyl ester Relative activity (%) 
   α-Naphtyl acetate   
   α-Naphtyl butyrate 
   α-Naphtyl caproylate 
   α-Naphtyl laurate 
   α-Naphtyl oleate 
100 
  54 
  14 
    9 
    2 
 
Table 2.3. Influence of acyl chain length on carboxylesterase activity. 
 
 
 
 
Purification step
a 
 Total protein 
(mg)  
Total activity 
(U)b  
Specific activity 
(U/mg)  
Purification 
factor  
Yield (%)  
Cell-free crude extract 
(NH4)2SO4 fractionation 
Q Sepharose 
Phenyl Sepharose 
Sephacryl HR200 
 
         777.6 
         516.6 
           45 
             6 
             0.46 
18,900 
17,200 
14,700 
10,100 
  3,360 
  24 
  33 
 320 
           1,680    
           7,310   
           1 
           1.37 
         13.3 
         70 
       304 
      100 
        91 
 77 
 53 
 18 
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Substrate Kcat (s
-1
) 
α-Naphtyl acetate 
α-Naphtyl butyrate 
p-Nitrophenyl acetate  
p-Nitrophenyl butyrate 
4-Methylumbelliferyl acetate 
Fluorescein diacetate 
Carboxyfluorescein diacetate 
3.0 × 10
3
 
1.6 × 10
3
 
6.4 × 10
3
 
1.7 × 10
3
 
8.5 × 10
3
 
1.7 × 10
3
 
2.8 × 10
3
 
 
Table 2.4. Kinetic parameters of purified carboxylesterase. 
 
 
 
Cation Relative activity (%) 
CaCl2 
CoCl2 
CuCl2 
FeCl2 
FeCl3 
MgCl2 
NiCl2 
ZnCl2 
                 105 
34 
59 
40 
38 
                  112 
35 
36 
 
Table 2.5. Cation effects on carboxylesterase activity. 
 
 
 
 
2.3.2 Identification of the PA3859 gene  
 
The N-terminal amino acid analysis of the purified protein identified 11 amino acids: 
SEPLILDAPNA. The only ORF in the genome of P. aeruginosa PAO1 with this N-
terminus sequence is PA3859, which was annotated as a probable carboxylesterase due 
to its similarity to carboxylesterase I (76%) and carboxylesterase II (75%) of P. 
fluorescens.  
 
2.3.3 Heterologous protein purification 
 
The recombinant enzyme was eluted from a HiTrap Chelating affinity column 
following a gradient, at a concentration between 220 and 250 mM imidazole. After the 
HiTrap Chelating column, the heterologous 6xHis carboxylesterase  showed specific 
activity lower than the carboxylesterase purified from P. aeruginosa PAO1 (Tables 2.1 
and 2.6). Due to the presence of some contaminant proteins and to the need of highly 
purified protein for structural and functional studies, the enzyme was further purified by 
ion-exchange Q Sepharose chromatography. Three peaks were identified and further 
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analyzed by EIS-MS: the first corresponded to a protein molecular mass of 24,691 Da 
and showed a specific activity in agreement with that of enzyme from P. aeruginosa; 
the second peak, corresponding to a protein molecular mass of 23,983 Da, showed only 
10% of the expected specific activity; and the third peak corresponded to a protein 
molecular mass of 25,239 Da and did not show esterase activity.  
Protein with a molecular mass of 24,691 Da was recovered, with an overall yield of 6.2 
mg L
-1
 of cell culture (Table 6).  
 
 
Purification step  Total protein 
(mg) 
Total activity (U) Specific activity 
(U/mg) 
Purification factor Yeld (%) 
Cell-free crude extract 
Affinity chromatography 
Q Sepharose 
      962 
        16.6 
    6.2 
96130 
83730 
81840 
    100 
  5044 
13200 
    1 
             50 
132 
100 
  87 
  85 
 
 
Table 2.6. Summary of purification of recombinant carboxylesterase from 1 L of E. coli pQE31 
culture. 
 
 
2.4 Discussion 
 
As part of an ongoing research project aimed at the structural and functional 
characterization of biotechnological and biomedical relevant microbial enzymes, we 
have recently reported the identification of genes encoding for esterase activity. 
Namely, in the yeast Saccharomyces cerevisiae [4] the function of an esterase has been 
identified on the basis of its high sequence identity (41%) to S-formylglutathione 
hydrolase protein of Paracoccus denitrificans, known to be associated with the 
detoxification of formaldehyde [8].  
Hemicellulose substrates (corncob powder or oat spelt xylan) supplied as the only 
carbon source in the growth medium induced an esterase activity in B. pumilus, which 
has been identified to be an acetylxylan esterase [5].  
We now report on the isolation, purification, and identification of an enzyme produced 
by the P. aeruginosa PAO1 opportunistic pathogen showing esterase activity. Its N-
terminal sequence revealed that this enzyme corresponds to the gene product of the 
open reading frame PA3859, the only one among the 15 possible acylhydrolases present 
in the PAO1 genome that has been annotated as a probable carboxylesterase 
(http://www.pseudomonas.com/index.html).  
During the purification procedure one major peak of activity towards p-nitrophenyl 
acetate was identified which accounted for more than 70% of the total esterase activity 
of the crude extract. Part of the residual activity was found in another peak of the ion 
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exchange chromatography step, suggesting the presence of other esterases in P. 
aeruginosa, in accordance with the possible esterases reported in the PAO1 genome and 
with the four esterase activities reported in P. fluorescens [9].  
The biochemical characterization of this enzyme showed that it hydrolyzes short-chain 
fatty acid esters with broad substrate specificity and is not inhibited by EDTA. Its 
hydrolytic activity is inhibited by PMSF and reduced by transition metal ions, 
suggesting that the catalytic histidine may be involved in their coordination shell.  
PA3859 shows 20% identity with respect to a recently characterized carboxylesterase 
from P. citronellolis [3], which has a higher molecular mass of 41 kDa, a lower optimal 
temperature of 37–40 ºC, and a kcat for p-nitrophenyl acetate and p-nitrophenyl 
butyrate 80- and 40-fold lower, respectively.  
A multiple sequence alignment, following a BLAST search based on the PA3859 
sequence, is shown in Fig. 2.3 and includes proteins representative of diverse bacterial 
and eukaryotic species with sequence identity ranging between 25 and 65%. Sequence 
analysis revealed the presence of the conserved Ser His Asp catalytic triad and the 
serine-dependent acylhydrolase signature motif GXSXG [2].  
The in vivo function has only been identified for the human acyl-protein thioesterase I 
(sp|O75608|) and involves the S-palmitoylation of target cysteine residues [7].  
Three-dimensional structural information is presently available only for the human 
acyl-protein thioesterase (sp|O75608|). (PDB ID 1FJ2) [6] and for P. fluorescens 
carboxylesterase II (sp|Q53547|) (PDB ID 1AUO) [13]. They show 33% sequence 
identity and the atomic model reveals profound similarities. Both enzymes exist in 
solution and in solid state as homodimers.  
In their respective crystal structures the active sites are unexpectedly occluded from the 
bulk solvent. Dissociation of the homodimer, probably induced by substrate binding, 
has been proposed as the mechanism for enzymatic activity regulation. It is note worthy 
that P. aeruginosa carboxylesterase exists in solution as an active monomer. Further 
structural and functional studies are required to elucidate the biological significance of 
this finding. The high sequence homology, 76%, found between the carboxylesterases 
from P. fluorescens and P. aeruginosa suggests that a high structural similarity should 
also exist between the human acyl-protein thioesterase and PA3859, and therefore a 
similar in vivo function is expected. The reported heterologous expression system has 
proven to be useful for the production of multimilligrams of recombinant P. aeruginosa 
carboxylesterase suitable for both structural and functional studies aimed at addressing 
some of the questions raised.  
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Fig. 2.3. Sequence alignment of PA3859 and six selected proteins: sp|Q535487|, carboxylesterase 2 
(esterase II family) from Pseudomonas fluorescens; sp|O75608|, acyl-protein thioesterase 1 
(lysophospholipase I family) from Homo sapiens; LmjF24.1840, hypothetical protein from 
Leishmania major; G_YK2298, from Caenorhabditis elegans; sp|P76561|, hypothetical hydrolase 
from Escherichia coli; Ttk003001929, from Thermus thermophilus, obtained with T-Coffee [18]. The 
residues of the conserved catalytic traid are marked with an asterisk and the residues of the signature 
motif are boxed. 
 
 
 
 
 
   * 
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Chapter 3 
 
 
Crystallization, X-ray diffraction analysis and 
phasing of carboxylesterase PA3859 from 
Pseudomonas aeruginosa PAO1 
 
 
 
Abstract. We have recently purified an intracellular carboxylesterase encoded by the open reading 
frame PA3859 of Pseudomonas aeruginosa. Among proteins showing a significant sequence 
homology with PA3859, the in vivo function is only known for the human  acyl-protein thioesterase I 
that is involved in the deacylation of Gα proteins. The crystal structure determination of P. aeruginosa 
carboxylesterase is expected to provide insights into its physiological role. Therefore, the PA3859 
gene was cloned and heterologously expressed in Escherichia coli as N-terminally 6xHis tagged 
recombinant protein. Here, we present the crystallization, X-ray diffraction analysis and phasing of 
this enzyme. Two crystal forms were obtained by the hanging drop vapor diffusion method. Crystals 
of form I belong to the space group P21 with cell dimensions of a =65.65, b =50.55, c =142.55 Å, 
b=92.9° and diffracted, upon flash annealing, up to a resolution of 2.9 Å. 
Two dimers are present in the asymmetric unit. Crystals of form II belong to space group P21212, with 
unit cell dimensions of a =96.42, b =96.36, c =68.04 Å and diffracted up to 2.1 Å resolution. One 
dimer is present in the asymmetric unit. 
 
 
 
 
This chapter was adapted from: 
Pesaresi A, Lamba D. 
Crystallization, X-ray diffraction analysis and phasing 
of carboxylesterase PA3859 from Pseudomonas aeruginosa. 
Biochim Biophys Acta. 2005 1752(2):197-201. 
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3.1 Crystallization, X-ray diffraction and phasing 
 
 
Pseudomonas aeruginosa is an ubiquitous gram negative bacterium and is one of the 
major causes of opportunistic human infections [1]. The ability to degrade complex 
mixtures of organic compounds could provide this bacterium,  characterized by the 
largest bacterial genome sequenced so far [2], with adaptive advantages to hostile 
environments. 
This allows the P. aeruginosa to make use of a wide variety of organic compounds as 
carbon source, thus exploiting its exceptional ability to colonize ecological niches 
where nutrients are limited. 
Among the enzymatic activities required to maintain such a complex catabolism, 
carboxylesterases are thought to play an important role. Indeed, the wide substrate 
tolerance shown by this class of enzymes has led to postulate that they have evolved to 
enable access to carbon sources [3]. 
Furthermore, carboxylesterases are known to be involved in the hydrolytic 
biotransformation of drugs [4] and in the detoxification of xenobiotics [5]. 
Carboxylesterases (E.C.3.1.1.1) are members of the serine esterase super-family [6] that 
hydrolyze carboxylic ester bonds with a relatively broad substrate specificity. They 
show a high degree of sequence similarity and share both conserved sequence motifs 
and secondary structure features with other members of the α/β hydrolase fold super-
family [7]. 
We have recently reported the purification, the heterologous expression and the 
biochemical characterization of a novel 24 kDa esterase identified in P. aeruginosa 
PAO1 (see Chapter 2) [8]. The N-terminal sequence of the purified protein 
corresponded to the product of the open reading frame PA3859 that was already 
annotated as a putative carboxylesterase [http://www.pseudomonas.com]. 
In a genome-wide cloning exploration strategy and characterization of microbial 
esterases, PA3859 was among thirty open reading frames predicted to encode esterases 
and randomly selected from 13 sequenced bacterial chromosomes [9]. 
This enzyme, besides methyl-umbelliferyl acetate and fluorescein and 
carboxyfluorescein diacetate exhibited an ester-hydrolyzing activity also towards          
p-nitrophenyl and α-naphtyl esters of short fatty acid chains [8]. Overall, the 
biochemical characterization did not yet provide insights into its in vivo role. 
Furthermore, to our knowledge, the physiological substrates for most of the PA3859 
homologues are also unknown. Among the proteins showing a significant sequence 
homology with PA3859, the in vivo function has been identified only for the human 
acyl-protein thioesterase I [10]. This enzyme shows a 35% sequence identity with P. 
aeruginosa carboxylesterase and was found to be involved in the deacylation of Gα 
proteins and other thioacyl protein substrates [11]. 
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Structural information is available for human acylprotein thioesterase I (PDB ID 1FJ2) 
[10, 12] and for carboxylesterase II from P. fluorescens (PDB ID 1AUO) 
[13, 12]. Besides the 33% identity in their primary sequence, they show important 3D 
similarities. 
Both the human acyl-protein thioesterase I and the P. fluorescens carboxylesterase have 
been found to be present in solution as well in the solid state as active homodimers [10, 
13]. Instead, PA3859 has been found to be present in solution as a monomer [8]. 
The high sequence homology of 76% between the P. fluorescens and P. aeruginosa 
carboxylesterases would suggest that close structural and functional similarities should 
also exist between PA3859 and the human acylprotein thioesterase I. 
Despite their high sequence homology, PA3859 and P. fluorescens carboxylesterase II 
display to some extent a different substrate specificity. In fact, the former hydrolyzes 
methyl-umbelliferyl acetate but does not hydrolyze triacylglycerides, whereas the latter 
shows a reverse preference, indicating that the diversity in substrate specificity may in 
part reflect differences and/or flexibilities in the residues that encompass the catalytic 
sites and/or the neighbouring residues. 
Furthermore, in the crystal structure of the P. fluorescens carboxylesterase II, a 
hydrogen bonding occurs at the dimer interface involving the main chain nitrogen of the 
catalytic histidine of one monomer and the carboxylate oxygen atoms of an aspartic 
residue which is adjacent to the catalytic aspartate in the facing subunit. Then, it is 
likely that dimerization may play an important role in determining the substrate 
specificity. 
The aim of the present study on P. aeruginosa carboxylesterase is to provide the 
structural determinants that are expected to be essential in the elucidation of its 
substrate specificity as well as to shed light on its in vivo functional role. 
As the first step, we describe here its crystallization, X-ray diffraction analysis and 
phasing. 
PA3859 gene was cloned and the 6x-His tagged recombinant protein was expressed in 
Escherichia coli and purified as described in Chapter 2 [8]. 
Dynamic Light Scattering (DLS) has been proven to be a useful tool for detecting the 
aggregation state of proteins in solution prior to crystallization trials. DLS 
measurements were performed with a 2.2-mg ml
-1
 PA3859 solution in 50 mM NaCl, 
200 mM ammonium sulphate, 100 mM MES pH 6.5, at 25 °C on a DynaPro MS/X 
instrument (Protein Solutions, USA). Samples were filtered through a 0.02-µm Anodisc 
membrane using the NanoFilter Kit (Wyatt Technology, USA) to remove large 
aggregates or dust particles and then injected in a 12-µl quartz MicroCUVETTE (Wyatt 
Technology, USA). Data collection and deconvolution were performed using the 
DYMAMICS 6.2.05 software (Protein Solutions, USA). DLS measurements performed 
on PA3859 indicated an hydrodynamic radius of 2.5 nm and a deduced molecular 
weight of 29.3 kDa, with a polydispersity of 25%. This result well agrees with the 
protein molecular weight obtained by electron ion spray-mass spectrometry of 24691 
Chapter 3 
 49 
Da and estimated by reducing SDS-12% PAGE of 28 kDa, respectively [8]. Overall, 
DLS results indicate the existence in solution of monomer species. 
Prior to crystallization screening, the purified protein was dialyzed against 10 mM 
sodium phosphate pH 7.5 and concentrated to 10 mg ml
-1
 using Centricon 3K 
concentrators (Millipore, USA). 
Crystallization was performed by the hanging drop vapor diffusion method using the 
24-well plates Crystallization Tool (Nextal, Canada). Initial crystallization conditions 
were established at 293 K using crystal screening kits Crystal Screen I and II (Hampton 
Research, USA) [14]. Each drop was prepared by mixing equal volumes (1 μl) of the 
protein and the precipitant buffer, and each hanging drop was equilibrated against 700 
μl precipitant buffer. 
Two different crystal forms were obtained from 200 mM (NH4)2SO4, 100 mM MES pH 
6.5, 30% w/v PEGMME5000 (Fig. 3.1A, B). Long needles (form I) grew within 3 days. 
Squared bipyramidal crystals (form II) were obtained by adding to the same initial drop, 
1 μl of milli-Q water. In this condition, only crystals of form II appeared within 7 to 10 
days. 
 
 
 
 
 
Figure 3.1. Crystals of PA3859 carboxylesterase. (A) Needles like: crystal form I; (B) Squared 
bipyramids: crystal form II. 
 
 
For X-ray data collection, crystals were mounted on nylon loops and were directly flash 
cooled in a liquid nitrogen stream at 100 K, using an Oxford Cryosystems cooling 
device (Oxford Cryosystems Ltd., UK). A prior transferring to a cryo-protecting 
solution was not required for either crystal forms I and II (Fig. 3.2). 
X-ray diffraction data were collected using a MAR CCD detector (MAR USA Inc., 
USA) at the XRD1 beam-line of the ELETTRA Synchrotron Light Laboratory (Trieste, 
Italy). 
Crystal form I (0.2x0.2x0.8 mm) diffracted at first up to 5.0 Å resolution. It is worthy of 
note that a flash annealing step (crystal was warmed for a few second by blocking the 
 
   B 
 
 A 
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cold stream) produced a significant improvement in crystal diffraction up to 3.0 Å 
resolution [15,16]. Crystal form II (0.15x0.15x0.20 mm) diffracted to 2.1 Å resolution. 
Data were indexed, integrated and scaled with DENZO and SCALEPACK [17] and 
further processed by the CCP4 package [18]. Data collection statistics are shown in 
Table 3.1. Assuming a molecular weight of 25 kDa, the unit cell volumes of the two 
PA3859 crystals forms are consistent with the occurrence of four (form I) and two 
molecules (form II) in their respective crystals asymmetric units. The Matthews 
coefficients are 2.4 Å 
3
 Da
-1
 (crystal form I) and 3.2 Å 
3
 Da
-1
 (crystal form II) 
corresponding to a solvent content of 48% and 62%, respectively [20]. 
The structures of either PA3859 crystal form I and II were determined by Patterson 
search techniques (data up to 3.5 Å  resolution) using the monomer of the P. fluorescens 
carboxylesterase II (PDB ID 1AUO) [13,12] as a search model (76% amino acid 
sequence homology) after removal of all solvent molecules. Four (crystal form I) and 
two (crystal form II) rotation and translation function solutions were identified using the 
AMoRe suite [21] with a cumulative correlation coefficient and R factor of 0.52, 0.39 
(crystal form I) and 0.49, 0.42 (crystal form II), respectively. The first noise peak had a 
cumulative correlation coefficient and R factor of 0.42, 0.43 (crystal form I) and of 
0.24, 0.50 (crystal form II), respectively. 
Rigid body refinement was subsequently performed using the CNS suite [22]. The R 
factor including reflections up to 2.98 Å (crystal form I) and 2.09 Å (crystal form II) 
was 0.33 (crystal form I) and 0.49 (crystal form II), respectively. In crystal form I, two 
non crystallographic dimers have been found in the asymmetric unit, while in crystal 
form II, one dimer is present. 
This result is in contrast with the occurrence of a monomeric species in solution as 
prompted by the DLS analysis. Interestingly, dimers have been found in both solution 
and the crystal structures of human acyl-protein thioesterase I [11] and P. fluorescens 
carboxylesterase II [13]. 
A preliminary analysis of the crystal packing revealed that an almost identical dimer 
arrangement is observed in either crystal forms I and II that are characterized by the 
existence of two and four independent molecules in the respective crystals asymmetric 
units.  
Instead, the observed dimer interface significantly differs from those being found in the 
crystal structures of the human acyl-protein thioesterase I [11] and P. fluorescens 
carboxylesterase II [13], respectively. The physiological implications of these findings 
are not clear. 
Current efforts are focused on model building and structure refinement. The 
crystallization and the structure determination of PA3859 in complex with a variety of 
substrate analogs will be also attempted, leading to a structural-based elucidation of the 
enzyme mechanism of action and of its substrate binding specificities. 
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Figure 3.2. X-ray diffraction patterns of crystal form I before (A) and after (B) the  flash annealing 
step. 
 
 
Data set Form I Form II 
X-ray source 
Wavelength (Å) 
Detector 
Space group 
Unit-cell parameters 
a (Å) 
b (Å) 
c (Å) 
β (°) 
Z 
Total φ(°), oscillation range (°) 
Mosaicity (°) 
Resolution range (Å) 
 
No. of measurements 
No. of observed reflections I≥0          
No. of unique reflections I≥0          
Completeness (%) 
Redundancy 
<I/σ(I)> of measured data 
a
Rsym 
a
Rmeas 
ELETTRA-XRD1 
1.200 
marCCD 
P21 
 
65.65 
50.55 
142.55 
92.94 
8 
180, 1.0 
1.12 
24.30-2.98 
(3.00 – 2.98) 
204,325 
53,890 (1196) 
18,812 (423) 
98.3 (98.3) 
2.9 (2.8) 
3.9 (1.7) 
0.13 (0.36) 
0.16 (0.44) 
ELETTRA-XRD1 
1.278 
marCCD 
P21212 
 
96.42 
96.36 
68.04 
- 
8 
240, 0.75 
1.07 
29.05 – 2.09 
(2.10 – 2.09) 
1,219,326 
197,535 (1085) 
36,512 (213) 
96.7 (90.5) 
5.4 (5.1) 
6.4  (2.0) 
0.06 (0.39) 
0.07 (0.43) 
 
 
Table 3.1. Crystal parameters, data collection and processing statistics. Values in parenthesis are for 
the highest resolution shell. 
a
Rsym(I)=ΣhklΣI |Ihkl,i- <Ihkl>|ΣhklΣI|Ihkl,i| with <Ihkl> mean intensity of the multiple Ihkl,i observations 
from symmetry-related reflections. 
b
Rmeas is the multiplicity weighted Rsym. 
 
 
 
B 
  
A 
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Chapter 4 
 
PA3859 Carboxylesterase Structure 
 
 
 
4.1 Structure refinement 
 
 
The structures of the PA3859 carboxylesterase in crystal forms I and II were refined 
using the CNS suite [1]. 10% of the reflections were selected for the cross validation 
procedure. Simulated annealing was performed (slow cooling protocol), followed by 
positional and B-factor refinement and manual inspection of the resulting 2Fc-Fo and 
Fc-Fo maps. For the electron density map visualization the graphical program O was 
used [2]. Several cycles of positional and isotropic B-factor refinement and manual 
model building were performed. A search for water molecules was carried out as well. 
The water molecules were picked in the Fo-Fc electron density map according to the 
CNS protocol. Ligands such as MES (crystal form I) and PEG (crystal form II) were 
identified. Ligand coordinates and stereochemistry library files for CNS were taken 
from the HIC-UP server [3].  
R and Rfree values were computed after every step of the refinement procedure. The 
geometries at the present status were checked [4]. The refinement statistics for PA3859 
carboxylesterase crystal forms I and II are given in the Table 4.1. According to the 
Ramachandran plot (Fig. 4.1) the serine at position 113 (the catalytic serine) had  
backbone angles outside the favored regions of the plot: this is a common feature of 
carboxylesterases. The sharp strand-turn-helix conformation of the catalytic elbow 
forces the serine to adopt unfavorable main chain torsion angles.  
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 Crystal form I Crystal form II 
Resolution range    (Å) 
Final R factor         (%) 
Final R free factor (%) 
Rms deviation 
Bond length (Å) 
Bond angles (°) 
Average isotropic B-factors (Å
2
) 
All protein 
Water molecules 
MES 
PEG-dimer 
PEG-nonamer 
% of main-chain dihedral angles in 
Ramachandran plot found to be in 
fully allowed regions 
additional allowed regions 
generously allowed regions 
disallowed regions 
24.30-2.98 
23.6 
28.4 
 
0.007 
1.3 
 
32.78 
39.31 
52.89 
- 
- 
 
 
84.6 
14.6 
0.3 
0.5 
29.05-2.09 
19.6 
24.1 
 
0.009 
1.4 
 
32.78 
39.31 
- 
60.53 
51.33 
 
 
88.8 
10.7 
0.5 
0 
 
Table 4.1. Refinement statistics of PA3859 crystal form I and II. 
 
 
 
 
 
Figure 4.1. Ramachandran plot of the PA3859 crystal form I and II 
 
 
Figure 4.1. Ramachandran plot of PA3859 of crystal form I and II. 
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4.2 PA3859  structure description 
 
 
 
4.2.1 PA3859 has a α/β hydrolase fold 
 
 
PA3859 shows a typical α/β hydrolase fold with 7 β-strands (β1, β2, β3, β6, β7, β8, β9) 
surrounded by 5 α-helices (α1, α3, α4, α5, α6) (Fig. 4.2 ). With respect to the Prototypic 
Hydrolase Fold (see Chapter 1) the first N-terminal strand is missing and the helix 
between strand β7 and β8 is replaced by two short helices, η3 and η4, that do not interact 
with the β-sheet. Moreover an additional domain is present that encompasses the β-α-β 
motif made by strands β4, β5 and helix α2, and the long loop which connects it to helix 
α3. The catalytic triad is composed of Ser 113, located at the tip of the loop between β6 
and α3, Asp 166, between β8 and α5 and His 197, in the loop that precedes α6. 
No significant differences are present between the structures of the PA3859 monomers 
in   crystal forms I and II, the only significant change being a switch in the orientation 
of the Arg 212 and Trp 61 side chains (Fig. 4.3). In both crystal forms these residues are 
involved in the dimer-dimer interaction and the different orientations of their side chain 
can be considered as a consequence of the different crystal packing. 
 
The enzyme’s active site is located in a long cleft that is present on the protein surface 
(Fig.4.4). The left portion of the cleft encompasses helices α1 and α6 and is bodered by 
the hydrophobic residues Phe 29, Val 32, Leu 36, Val 39, Phe 112, Val 199 and Ile 204. 
The right part of the cleft is a rather polar cavity and is delimited between the α/β core 
(Tyr 140 and Val 168), and the β-α-β-loop extra domain (residues Ile 69 to Ile 78). 
 
In crystal form I one molecule per dimer is inhibited by a MES molecule originated 
from the precipitant solution (fig. 4.5). The MES sulfur atom is covalently bound to the 
catalytic serine Oγ and the MES morpholino moiety is positioned in the polar cavity. 
One of the two sulfate group oxygen atoms points toward the oxyanion hole composed 
of Leu 22 and Gln 114 main chain nitrogen atoms.  
No clear differences are present in the monomer structures or in the crystal packing that 
could explain why only one of the two molecule was inhibited by MES in each dimer.  
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Figure 4.2. A, PA3859 topology. Yellow triangles: β-strand. Red circles, α-helix. B, PA3859 / fold. 
One extra -- motive is present between strand 3 and helix 3. The catalytic triad residues are  shown 
in stick format. This picture, as well as all the other ones present in this chapter, was made using the 
program PyMol (http://www.pymol.org). 
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Figure 4.3. Different Trp 61 and Arg 212 
side chains orientation. Red, crystal form 
I. Blue, crystal form II.       
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. The PA3859 active site, here indicated by the position of the catalytic Ser 113 (magenta) 
is located roughly in the middle of a groove. The left part of the groove is composed of hydrophobic 
residues (red) and the right part is made up of the side chains of residues Tyr 140 and Val 168 of the 
α/β protein core, and the main chain of residues Ile 69 to Ile 78 located in the extra domain (green).  
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Figure 4.5. (A) PA3859 surface. Ser 113 (green), hydrophobic cleft (yellow), polar cavity (red). PEG 
nonamer (blue), PEG dimer (cyan), MES (white). 1σ level of the 2Fo-Fc electron density map is 
shown for the PEG nonamer in the hydrophobic cleft (B), and the MES molecule in the active site (C). 
 
 
In crystal form II two PEG strands of different length are visible. PEG is a very flexible 
molecule and thus often is completely disordered within the crystal. Here, due to the 
strong interaction with the protein surface, the PEG strands are induced to assume an 
ordered structure that gives rise to clear electron densities. The PEG present in the 
precipitant solution had a mean molecular weight of 5 kDa that corresponds to a 
polymerization degree of 110. In the crystal structure a nonameric PEG strand is lining 
the hydrophobic portion of the cleft and a shorter strand, roughly a dimer, is located 
nearby the end of the cleft (fig. 4.5). 
A 
B C 
Leu 22 
Ser 113 
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Figure 4.6. The Dimer-dimer interaction mediated by PEG strands. PEG nonamer (yellow),  PEG 
dimer (red). 
 
Interestingly interaction between dimers in adjacent unit cells is mediated by these PEG 
strands (Fig. 4.6): the nonamers protrude toward the dimer-dimer interface and the short 
strand makes a bridge between the long ones, as if PEG would have driven the protein 
crystallization. 
 
 
 
4.2.2 Structures comparison 
 
The Cα trace superimposition (Fig. 4.7) reveals that an almost identical fold is shared 
between PA3859 and both P. fluorescens carboxylesterase (76% sequence homology, 
RMSD = 0.96 Å) [5]  and human thioesterase (33% sequence identity, RMSD = 1.47 Å) 
[6].  
Among all of the three enzymes, the hydrophobic cleft is a very well conserved feature, 
while the extra domain, and thus the polar cavity, differ to a greater extent. In terms of 
sequence β2, which forms the bottom of the cleft, is the overall most conserved region 
next to the active site loop, while α1 and α6 are much less conserved (Fig. 4.8). High 
sequence identity is also found around the β4-α2-β5 motif that is present in the extra 
domain, while the final part of the long loop that connects it to α3 displays a lower 
degree of homology:  
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the shape of the polar cavity displays the most structural divergence among the three 
enzymes and the most remarkable differences, corresponding to PA3859 residues 70 to 
78,  are found in this variable loop (Fig. 4.7 and Fig. 4.9). This finding probably 
accounts for the different substrate specificities displayed by these enzymes. 
 
 
 
 
 
Figure 4.7. Cα trace superimposition of PA3859 (red), P. fluorescens carboxylesterase (cyan), and 
Human acyl-protein thioesterase (yellow).  
 
 
  
Figure 4.8. Multiple sequence alignmen produced by ENDscript  
(http://espript.ibcp.fr/ESPript/ENDscript/index.php) of PA3859, P. fluorescens carboxylesterase 
(1AUR) and Human acyl-protein thioesterase (1FJ2). Identity regions are highlighted in red, 
homology regions in yellow. The solvent accessibility (acc) and hydrophobicity (hyd) are also 
indicated. 
Variable  
   Loop 
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Figure 4.9. Protein surface electrostatic potential of PA3859 (A), Pseudomonas fluorescens 
carboxylesterase (B) and human thioesterase (C), computed by PyMol. Red, negatively charged 
residues. Blue, positively charged residues. The catalytic serines are highlighted by a green mark.  
 
As is shown in Fig. 4.9, the protein surfaces of PA3859 and P. fluoescens CE display a 
very similar shape and electrostatic potential: in both molecules, two higly acidic 
regions are present above and below the hydrophobic cleft. In P. fluorescens CE an 
extra acidic region is found at the end of the hydrophobic cleft. Furthermore in this 
enzyme, the Met 73 that replaces the Phe 72 of PA3859, is in van der Waals’ contact 
with the Val 170, thus making a bridge between the extra domain and the α/β core.  
The protein surface of human thioesterase is significantly different from those of the 
bacterial enzymes: the hydrophobic cleft is much less outspoken and the polar cavity is 
reduced to a narrow hole with the catalytic serine positioned at the edge of this hole. 
Here the acidic regions that in the other two enzymes flank the hydrophobic cleft are 
missing.  
 
 
 
 
• 
 
   • 
   
     •        • 
A B 
C 
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4.2.3 Dimerization interface 
 
The PA3859 dimerization interfaces, involving helix α5 and the loop between β5 and α3, 
are very similar in the two crystal forms even though the Cα traces superimposition  
(Fig. 4.10) reveals some slight differences in the positioning of the molecules within the 
dimer. In crystal form II the α5 helices interact more tightly than in crystal form I. This 
produces a rigid body-like rotation of one monomer with respect to the other and a more 
packed overall structure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10. Dimerization interface.  Crystal form II ( Red),  Crystal form I ( White). 
 
 
Despite their high sequence homology carboxylesterase from P. aeruginosa and P. 
fluorescens show a quite different dimeriaztion interface (Fig. 4.11 and Fig. 4.12). In 
the P. fluorescens dimer the catalytic sites are facing each other and, as a result, the 
dimerization interface is much larger than in PA3859.  In both dimers however the 
substrate binding sites are exposed to the solvent.  
The dimerization mode in the human acyl-thioesterase is still different: here both the 
catalytic serine and the hydrophobic cleft are buried. The interaction is much tighter 
than in the other two enzymes and dimer dissociation has been hypothesized to occur 
upon substrate binding [7].  
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Figure 4.11. Dimerization modes: A, PA3859 dimer. B, P. fluorescens carboxylesterase dimer. C, 
PA3859 Human thioesterase dimer. The catalytic serines are depicted as spheres. 
 
 
According to a structure analysis performed using PISA [8], in PA3859 only 3.8% of 
the protein surface is involved in the dimer formation (corresponding to 377 Å
2
). In the 
carboxylesterase from P. fluorescens  the portion of the protein surface involved in the 
dimerization is 6.9% (corresponding to 667 Å
2
), and in the  human thioesterase 11.9% 
(1225 Å
2
) (Fig. 4.12).  
It is worthy to remark however that while in carboxylesterase from P. fluorescens and 
in human acyl-protein thioesterase the dimerization mode could play a significant  role 
in the accomplishment of the physiologic function, it should not have any functional 
relevance in the case of PA3859, since this protein was demonstrated to be present in 
solution as a monomer (see Chapter 2 and 3). 
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Figure 4.12. Protein surface involved in the dimerization determined by PISA: PA3859 (A), 
carboxylesterase from P. fluorescens (B), human thioesterase (C). Yellow, hydrophobic residues. 
Green, neutral residues. Red, negatively charged residues. Blue, positively charged residues. The 
catalytic serine is highlighted in magenta.  
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Chapter 5 
 
 
Docking simulations 
 
 
 
5.1 Introduction 
  
In PA3859 the location of Ser 113, the catalytic residue, in a cleft present on the protein 
surface prompted us to hypothesize that this cleft is the enzyme’s substrate binding site. 
This hypothesis was also supported by the finding in crystal form I, of a MES molecule 
covalently bound to Ser 113 and positioned in the polar cavity, and in crystal form II of 
a nonameric PEG strand lining the hydrophobic cleft (Fig. 5.1). 
 
The first step in the enzymatic catalysis is the recognition of the substrate and its 
binding to the enzyme. The highly specific substrate-enzyme interaction can only occur 
if a significant structural and chemical complementarity exists between the substrate 
and the enzyme active site. This implies that given the 3D structure of an enzyme 
whose function is unknown, following this “complementarity rule”, it should be 
possible, at least in principle, to chase its physiologic substrate(s). 
In order to obtain insights into the PA3859 in vivo substrates, and thus in vivo  function, 
its active site was explored by means of automated docking simulations. Two different 
sets of simulations were performed to separately probe the binding properties of the 
hydrophobic cleft and polar cavity, using the automated docking AutoDock 3.05 
program suite [1, 2], (see Appendix 2). 
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5.2 PA3859 Docking Simulation 
 
The substrates PDBs were generated using the Dundee PRODRG2 Server 
(http://davapcl.bioch.dundee.ac.uk/programs/prodrg/). Atomic partial charges for both 
substrates (Gasteiger charges) [3] and protein (United Kollman charges) [4] were 
assigned using the Automated Docking Tool (ADT). 
Protein atomic fragmental volume and atomic solvatation parameters were assigned 
with ADT. Substrate torsion values, defining bonds allowed to rotate, were assigned 
using the AutoTors feature in AutoDock. 
Electrostatic and van der Waals’ interaction energy grids were calculated by the 
AutoGrid module of Autodock. The grid was centered on the CD2 carbon atom of His 
197, that is positioned roughly in the middle of the protein binding site. Grid 
dimensions were 65, 60 and 100 points for the X, Y and Z axes respectively (390,000 
overall points). Grid point spacing was set to 0.375 Å, roughly a quarter of a carbon-
carbon single bond length. 
 
The searching space was explored using the Lamarckian Genetic Algorithm (LGA).  
The docking of each substrate (docking job) is the result of 20 docking cycles. Each 
docking cycle was made up of 50 LGA runs with 2×10
6 
energy evaluations per run. 
Thus overall 1000 LGA runs were conducted for each docking job (Fig. 5.2). The 
population size was set to 50 (default value).  Crossover and mutation rate were set to 
80 and 2 respectively (default values). The number of best individuals that 
automatically survive was set to 1.  
The best docking solution produced in a cycle was used to seed the successive cycle: it 
means that the random populations produced at the beginning of the LGA runs were 
made up of 49 random solutions plus the best solution produced along with the 
precedent cycle. 
 
 
The sulfur atom of the MES molecule found in crystal form I was used to validate the 
docking results: a substrate was considered to be docked if after repeated redockings its 
carbonylic carbon atom was within 1.5 Ǻ from the MES sulfur atom covalently bound 
to the catalytic serine. 
If after 10 LGA runs the obtained structure did not meet these criteria, the ligand was 
considered undockable.  
 
Two sets of docking simulations were performed in order to separately assay the 
binding potentiality of the hydrophobic cleft and polar cavity (Fig 5.1). The same grid 
was used for both simulation sets. 
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Figure 5.2. Schematic representation of the docking job. The docking of each substrate is the result of 
20 cycles. In each cycle 50 LGA runs were performed. The LGA runs start with a population of 49 
random solutions (50 for the first cycle) plus the best solution produced by the previous cycle. Thus the 
docking of each substrate is the result of 1000 LGA runs and overall 2x10
9 
energies evaluation. 
Figure 5.1. PA3859 surface. The 
hydrophobic cleft is highlightd in yellow 
and the polar cavity in red. The catalytic 
Ser 113 is highlighted in green. The 
sulfur atom of  the MES molecule (white 
stick)  was used for the validation of the 
docking results. The PEG nonamer found 
within the hydrophobic cleft is depicted 
as a blue stick.  
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5.2.1 Hydrophobic cleft 
 
The geometry of the hydrophobic cleft and the finding in crystal form II of a PEG 
strand positioned into the cleft, prompted us to hypothesize that this cleft is the portion 
of the substrate binding site involved in the accommodation of the substrate alkyl chain. 
To assay this possibility, the docking of p-nitrophenyl esters (p-NP) of several 
carboxylic acids with different chain length was attempted: p-NP derivatives are often 
used as non-physiologic substrates to determine the kinetic properties of hydrolases 
since the release of p-nitrophenol can easily be measured spectrophotometrically. Here 
these substrates were chosen in order to compare the automated docking results and the 
results of the kinetic study of PA3859 (see Chapter 6).  
 
 
NO
2
O C R
O
  
 
 
 
The docking of twelve substrates with the carboxylic acid acyl chain “R” spanning from 
1 carbon atom (p-NP acetate, C2) to 21 (p-NP behenoate, C22) was attempted. 
Among the tested substrates only p-NP acetate could not be successfully docked. In 
table 5.1 are reported the interaction energies and the binding constants for each 
solution and in Figure 5.3 the docked substrates conformations are shown. In all of the 
found solutions the p-nitrophenyl moiety is positioned in the polar cavity and the acyl 
chain lays, completely or partially, within the hydrophobic cleft. Distances between the 
substrate carbonylic carbon atom ad the MES sulfur atom ranges between 1.33 and 1.48 
Å and the carbonylic oxygen atoms always point toward the oxyanion hole (see Chapter 
4 and Fig. 5.3.G). 
Two different conformations are found for the p-NP moiety: in substrates C4, C6, C8, 
C12, C18, C20 and C22 hydrogen bonding occurs between the nitro group oxygen and 
the Tyr 140 hydroxyl, whose distances range from 2.93 to 3.49 Å. For substrate C10, 
C14 and C16 in the overall minimum energy solution the aromatic ring seems to have a 
less tight interaction with the polar cavity and the distance between the nitro group 
oxygen and Tyr 140 hydroxyl is roughly 6 Å. Solutions with the aromatic ring 
positioned deeper into the polar cavity were also found. 
The most valuable information produced by this set of docking simulations however 
arise from the analysis of the interaction mode of the acyl chains with the hydrophobic 
cleft: for substrates C4, C6, C8 and C12 an almost identical conformation is observed, 
with the chains that assume an extended conformation perfectly fitted into the cleft (5.3.A, 
   General structure of a p-NP ester 
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Figure 5.3. Docked p-nitrophenyl esters.The catalytic Ser 113 is highlighted in green, the oxyanion 
hole in cyan. Hydrophobic cleft is highlighted in yellow and the polar cavity in pink. A, p-NP C4 (red) 
and p-NP C6(blue). An almost identical conformation is found for these substrates, with the p-nitrophe   
A 
C D 
B 
E F 
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nitrophenyl moiety positioned into the polar cleft and the acyl chains into the cleft. B, p-NP C8 (red) 
and p-NP C12 (blue). The conformation is very similar to that found for the shorter substrates in A.  
nitrophenyl moiety positioned into the polar cleft and the acyl chain into the cleft. B, p-NP C8 (red) 
and p-NP C12 (blue). The conformation is very similar to that found for the shorter substrates in A. 
The alkyl chains perfectly fit the hydrophobic cleft. C, p-NP C10 (red) and p-NP C14 (blue). The p-
nitrophenyl moieties have a conformation that differs from those of shorter substrates and that gives 
rise to a weaker interaction with the polar cavity. In p-NP C10 the tail makes a turn to interact with 
Phe 112 aromatic ring. D, p-NP C16 (red), p-NP C18 (blue). The proximal parts of the acyl chains 
display a torsion that allows the entire molecules to fit within the cleft. E, p-NP C20 (red), PEG 
nonamer (blue). p-NP C20 chain undergoes a torsion in order to fit the cleft. Its final conformation is 
similar to that of the PEG nonamer found in crystal form II. F, p-NP C22 (red). The chain is too long 
to be entirely accommodated in the cleft. G, details of the interaction between p-NP C8 (yellow) and 
the PA3859 active site: the substrate carbonylic carbon atom accepts a hydrogen bond from the 
catalytic Ser 113, the carbonylic oxygen interacts with the main chain nitrogen atoms of the oxyanion 
hole residues Leu 22 nad Gln 114 and the nitro group oxygen atoms of the nitrophenyl moiety interact 
with the Tyr 140 hydroxyl. H, comparison of the conformations of the docked p-NP C8 (yellow) and 
p-NP C18 (cyan) While  the p-nitrophenyl moiety and the carbonylic group of the two substrates 
assume an almost identical position within the PA3859 active site, the conformation of the acyl chains 
differ significantly: in comparison to p-NP C8 acyl chain, the chain of p-NP C18  assume a less tight 
interaction with the protein.  
 
B). In C10 and C14 the different positioning of the p-NP moiety does not interfere with 
the chain conformation, because it is the proximal part, which perfectly superimposes to 
that of the shorter chains.  However the C10 tail does not lay for all of its length at the 
bottom of the cleft but makes a turn that is stabilized by an interaction with the aromatic 
ring of  Phe 112 (Fig. 5.3.C). For substrates C16 and C18 a weaker interaction between 
the proximal part of the chain and the cleft is found: in C16 the first three atoms of the 
chain are positioned furhter apart from the protein surface if compared to those of 
shorter substrates. In C18 this less tight interaction is extended up to the sixth chain 
carbon atom (Fig. 5.3, H): this bending allows the chain, that otherwise would be too 
long, to be positioned entirely within the cleft (Fig. 5.3.D). The conformational 
deviation from the short chain substrates conformation becomes larger for C20 and C22: 
G  H 
Tyr 140 
  Gln 114 
     Ser 113 
    Gln 114      Ser 113 
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                                                      Intermolecular          Ligand             Torsional          Binding           Binding 
                                                Energy          Internal energy     Free energy      Free Enrgy        Constant        
                                 (Kcal mol-1)        (Kcal mol-1)       (Kcal mol-1)    (Kcal mol-1)         (μM-1) 
p-nitrophenyl C4    n                -6.41                   -0.06                    1.56                -4.85                 276 
p-nitrophenyl C6                      -7.41                   -0.16                    2.18                -7.56                 148 
p-nitrophenyl C8                      -8.32                   -0.14                    2.80                -5.52                   89 
p-nitrophenyl C10                    -9.38                   -0.31                    3.42                -5.96                   43                           
p-nitrophenyl C12                  -10.13                   -0.35                    4.05                -6.08                   35 
p-nitrophenyl C14                   -10.80                   -0.22                   4.67                -6.13                   32 
p-nitrophenyl C16                   -11.25                    0.13                    5.29                -5.96                   43 
p-nitrophenyl C18                   -11.79                   -0.10                    5.91                -5.88                   49 
p-nitrophenyl C20                   -12.55                   0.13                    6.54                -6.01                  39 
p-nitrophenyl C22                   -12.61                    0.78                   7.16                -5.45                 101 
 
 
Table 5.1. Interaction energies and binding constants for p-nitrophenyl esters of different chain length 
carboxylic acids. The estimated free energy of binding is the summation of the Intermolecular Energy 
and the Torsional Free Energy that accounts for the loss of ligand conformational degree of freedom 
occurring upon binding. 
 
 
 
here the interaction of the proximal part of the chains with the protein surface is very 
similar to that found for substrates C4 - C10 but the tails assume a completely different 
conformation: in order to be fitted into the cleft the chain of C20 assumes a cork like 
conformation, similar to those of the PEG strand found in crystal form II, and the tail 
makes a sharp hook. The C22 chain is however too long to be accommodated into the 
cleft: the  chain torsion that is required to let it fit within the cleft would probably 
produce a too high internal energy and in all of the obtained docking solutions its 8 or 9 
tail carbon atoms are located outside of the groove (Fig. 5.3.D). This constrained 
conformation gave rise for both C20 and C22 substrates to a positive internal energy 
(Tab. 5.1). 
 
In Fig. 5.4.A the binding constants estimated by Autodock are reported for each 
substrate as a function of the alkyl chain length (see also Tab. 5.1). For the substrates 
with chain length from C10 to C20 the binding constant values were found to be within 
the range 32 to 49 μM-1. In this region of the plot the chain length does not affect 
significantly the strength of the binding. For substrates either shorter than C10 or longer 
than C20 a rapid increase in the binding constants is observed. It is worthy to note that 
this plot is in clear disagreement with that reported in Fig. 5.4.B: here the energetic 
contribution of the acyl chain to the binding, averaged over the number of carbon atom 
present in the chain (specific energy of interaction), are reported.  These values can be 
considered as a goodness quantification of the acyl chain – protein interaction.  
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Figure 5.4. In A the estimated binding constants are plotted against the alkyl chain length: the lowest 
values are obtained for substrates between C10 and C20. For substrates with the alkyl chain either 
shorter than C10 or longer than C20, the binding free energy, and thus the binding constant, increases 
rapidly. 
In B the mean energy contribution to the binding of the aliphatic carbon atoms is plotted  as a function 
of the chain length: lowest values are found for substrates C6, C8 and C10.  
 
 
 
For each substrate the mean energy of interaction per methylene group is plotted against 
the chain length. The overall minimum value, corresponding to –0.59 Kcal mol-1 per 
methylene group is obtained for substrate C6. Similar low energies, -0.57 and -0.58 
Kcal mol
-1
,
 
were found for substrates C8 and C10 respectively. From substrate C12 to 
C22 the values increase linearly with the chain length. The maximum specific energy 
value is obtained for C22 and corresponds to –0.40 Kcal mol-1 per methylene group.  
This result is in agreement with the acyl chain – protein interaction mode that was 
found to be tight for short substrates and to become weaker and weaker with the 
increasing chain length (Fig. 5.3). On the other hand it seems to be in contrast with the 
binding constant plot (A): for example C6, the substrate with the overall minimum 
energy value, has a binding constant that is significantly higher than substrates C10 – 
C20, and C20 that shows a small binding constant has a high mean energy per 
methylene group.  
To explain this apparent paradox the torsional free energy loss that occurs up on ligand 
binding has to be taken into account (Tab. 5.1): upon binding the ligand is forced to 
assume one specific conformation that is chosen among all the possible ones. Thus a 
dramatic loss of the ligand torsional degree of freedom occurs. Since the torsional 
degree of freedom increases exponentially with the alkyl chain length, the extent of the 
binding ordering effect will also increase exponentially with the chain length. This 
entropic effect, according to the AutoDock free energy function, corresponds to +0.31 
Kcal mol
-1
 per methylene group. Thus, even thought the interaction between the 
substrate acyl chain and protein becomes weaker as the chain length increases, as long 
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as the specific energy of interaction is larger than the entropic loss per methylene group, 
the increase in the substrate chain lengths will end up in stronger binding (Fig. 5.5).    
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Figure 5.5. The estimated free energies are plotted against the acyl chain lengths: the free energy of 
binding (red triangles) is the combination of the internal energy (green squares) and the torsional free 
energy (blue circles). As long as the internal energy decreases faster than the increase of the torsional 
free energy, the increase of the chain length will end up in a stronger ligand – protein interaction. 
 
 
Among the twelve substrates whose docking has been attempted, only those for the p-
NP C2 failed. Actually a strong binding to PA3859 active site was also achieved for this 
substrate but it was not possible to dock it in the active 
conformation: in all of the found docking solutions, strong 
hydrogen bonding interaction occurs between the 
substrate’s nitro group oxygen and the active site hydrogen 
bond donors, Ser 113 hydroxyl and main chain nitrogen 
atom of the oxyanion hole residues Leu 22 and Gln 114. 
This is not surprising since the negatively charged nitro 
group oxygen atoms are a much stronger hydrogen bond 
acceptors than a carbonyl oxygen atom.  
Interestingly, even though substrate C4 and C6 could be docked in the active 
conformation, the overall lowest binding energies achieved were obtained for this non-
active conformation, with the nitro group oxygen positioned in the catalytic site. The 
shorter substrate whose lowest binding energy was obtained for its active conformation 
is p-NP C8, suggesting that an acyl chain of at least 7 carbon atom is required to 
stabilize the productive positioning of  p-NP substrates within the active site. 
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Structure of  p-NP acetate  
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5.2.2 Polar cavity 
 
While the function of the PA3859 hydrophobic cleft could be inferred from the 
significant structural similarity shared with the human acyl-protein thioesterase, no 
information were available that could suggest the binding specificity of the polar cavity. 
The only indication came from the PAO1 genome sequence: the PA3859 locus was 
found to be located in the vicinity of two genes involved in the lipid/phospholipid 
metabolism: PA3857 has been demonstrated to be a phosphatidylcholine synthase [5] 
and PA3860 is hypothesized to be involved in lipid biosynthesis due to its 59% 
sequence homology to a long chain fatty acid – CoA ligase of Archaeaglobus fulgidus 
(http://www.pseudomonas.com). 
Since genes sharing a similar function are often clustered in the same chromosomic 
region, this finding prompted us to hypothesize that PA3859 could also be involved in 
the metabolism of phospholipids. Furthermore, the presence in this protein of an 
hydrophobic binding site whose structural features are suited for the accommodation of 
only one acyl chain, suggested lysophospholipids to be the possible PA3859 
physiologic substrates (see Chapter 1 ).   
To assay this possibility the docking of the six polar head groups found in the most 
common phospholipids was attempted. Since the aim of this docking simulation was the 
evaluation of the binding properties of the enzyme polar cavity, the long 
lysophospholipid alkyl chain was replaced by a methyl group in order to speed up the 
searching space exploration.  
The structures of the six 1-acetyl-sn-glycerophospholipids used in these docking 
simulations, namely 1-acetyl-sn-glycerophosphatidyl -serine (Ac-PS), -choline (Ac-
PC), -ethanolammine (Ac-PE), -glycerol (Ac-PG), -inositol (Ac-PI) and 1-acetyl-sn-
glycerophosphatidic acid (Ac-PA), are reported in Fig. 5.6.  
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Figure 5.6. Structure of the 1-acetyl-sn-glycerolphosphatidates used to assay the polar cavity binding 
properties. R is replaced by the headgroup A in acetyl-phosphatidylserine (Ac-PS), B in acetyl-
phosphatidylcholine (Ac-PC), C in acetyl-phosphatidylethanolammine (Ac-PE), D in acetyl 
phosphatidylglycerol (Ac-PG), E in acetyl-phosphatidylinositol (Ac-PI), F in acetyl-phosphatidic acid. 
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Acetyl-phosphatidyl -serine, -ethanolamine, -choline and -glycerol were successfully 
docked while it was not possible to dock phosphatidic acid and the inositol derivate. 
The binding energies for the docked substrates are reported in Tab. 5.2 and in Fig. 5.7 
their binding within the PA3859 polar cavity are shown. 
The distance between the reference MES sulfur atom and the substrates carbonylic 
carbon range between 1.21 and 1.31 Å, and the carbonylic oxygen is always found to 
interact with the nitrogen main chain of the oxyanion hole residues Leu 22 and Gln 114. 
 
In the polar cavity a deep gorge is present that is delimited by the Tyr 140 hydroxyl and 
main chain carbonyl groups of residues Ala 71, Pro 74, Ala 75 and Ala 77. As is shown 
in Fig. 5.7.A, the polar head of Ac-PE is positioned within this gorge, where strong 
hydrogen bonding occurs between its positively charged amino group and the main 
chain carbonyl oxygen atoms of Ala 71, Pro 74 and Ala 77. The phosphate group is 
located exactly in the middle of the cavity and is stabilized by the phosphorus - protein 
van der Waals’ interaction. An hydrogen bond is also present between the catalytic Ser 
113 Oγ and the free hydroxyl of the glycerol moiety: this interaction was indeed found 
in all of the four successfully docked substrates. 
 
The overall structure of the docked Ac-PS is similar to that of Ac-PE (Fig. 5.7.B), but 
the positive Ac-PS amino group, being the polar cavity gorge occupied by the serine 
carboxylate, is positioned at the edge of the hole, where it is stabilized by hydrogen 
bonding with Ala 71 and Phe 72 main chain carbonyls. Within the hole hydrogen bonds 
are present between the substrate carboxylate oxygen atoms and Ala 77 main chain 
nitrogen and Tyr 140 hydroxyl. Due to the disadvantageous phosphate oxygen atoms – 
protein electrostatic interaction, the binding contribution of the phosphate moiety is 
estimated to be only of -0.14 Kcal mol
-1
. 
 
An almost identical structure with respect to that of Ac-PS is found for Ac-PG (Fig. 
5.7.C), where the sn-2 and sn-3 hydroxyls of the glycerol headgroup replace the Ac-PS 
amino and carboxyl group respectively. Here the absence of a charged polar head 
capable to form strong hydrogen bonds with the polar cavity results in a weaker protein 
– substrate interaction (Tab. 5.2). 
 
Being the positively charged choline headgroup too big to be accommodated within the 
polar cavity hole, a completely different conformation is adopted by Ac-PC (Fig. 
5.7.D).  Here the phosphate group is stabilized by the formation of a strong hydrogen 
bond with Tyr 140 hydroxyl, while the choline headgroup is positioned in the center of 
the polar cavity, mainly stabilized by a cation-π stacking with Tyr 140 aromatic ring 
and van der Waals’ interaction with Val 168 and Phe 72 main chains.  
The choline headgroup interaction in most of the phosphatidylcholine binding protein is 
driven by the cation-π stacking: typically, the quaternary ammonium is placed between 
two aromatic rings at a distance of 4.5 - 5 Å. [6]. 
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In PA3859 this stabilization mode could arise from the rotation of Phe 72 side chain. In 
this modified orientation, the Phe 72 and Tyr 140 aromatic rings face one each other at 
a distance of 10 Å and the choline ammonium is located in the middle, roughly at the 
same distance between each of them.  
In order to evaluate the effect of this protein structure modification on the binding of 
Ac-PC, a modified protein PDB file was generated using the program O, where the Phe 
72 aromatic ring was rotated as shown in Fig. 5.7.D. A further docking job was then 
carried out using this modified PA3859 structure. The final solution displayed a very 
small conformational deviation from the previously obtained conformation, 
corresponding to a RMSD of 0.78 Å, with the quaternary ammonium displaced of 0.17 
Å but the binding energy dropped from -4.61 Kcal mol
-1 
to -5.34 Kcal mol
-1
, with a gain 
in term of binding constant from 416 μM-1 to 122 µM-1  (Tab. 5.2). 
 
 
 
                                             Intermolecular         Ligand              Torsional          Binding           Binding 
                                         Energy          Internal energy     Free energy      Free Enrgy        Constant        
                           (Kcal mol-1)        (Kcal mol-1)       (Kcal mol-1)     (Kcal mol-1)         (μM-1) 
Ac-PS                                -9.01                   -1.39                   3.11                 -5.90                   48 
Ac-PE                                -8.73                   -0.69                   2.80                 -5.93                   45 
Ac-PG                               -8.23                   -0.23                    3.11                 -5.11                 179 
Ac-PC                               -7.72                   -0.45                    3.11                 -4.61                 416 
Ac-PC*                             -8.78                   -0.33                    3.11                 -5.34                 122 
 
Table 5.2. Binding energies and constants for acetyl-phosphatidates. The strongest  binders resulted to 
be Ac-PE and Ac-PS. Phe 72 side chain re-orientation allowed a significant drop in the Ac-PC binding 
free energy (Ac-PC*). 
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Figure 5.7. Docking of the acetyl phosphatidates. For all of the docked substrates (yellow) the 
carbonylic carbon is placed in the catalytic site (Ser 113 is shown as green stick) with the carbonyl 
oxygen oriented  toward the oxyanion hole. A: the positively charged amino headgroup of Ac-PE is 
located into a deep gorge present in the bottom of the polar cavity and is stabilized by the formation of 
hydrogen bonds (highlighted in yellow) with the main chain carbonyl oxygen atom of Ala 71, Phe 72, 
Pro 74  and Ala 77. An overall similar interaction mode is also achieved for both Ac-PS and Ac-PG. In 
B the Ac-PS binding is shown: the headgroup carboxyl is positioned withino the hole, where it accepts 
hydrogen bonds from Ala 77 main chain nitrogen and Tyr 140 hydroxyl. The serine moiety amino 
group is instead located at the border of the hole and is stabilized by the hydrogen bond formation with 
Ala 71 and Phe 72 main chain carbonyl oxygen atoms. In C the binding mode of Ac-PG is reported: 
the conformation is almost identical to those achieved for Ac-PS: the sn-2 hydroxyl of the glycerol 
headgroup moiety is positioned at the border of the hole and forms hydrogen bond with Phe 72 and 
Pro 74, while the sn-3 hydroxyl is located into the hole where forms hydrogen bond with Ala 71 and 
Pro 74.  
The completely different binding mode obtained for Ac-PC* is shown in D: the positively charged 
quaternary ammonium is positioned in the middle of the polar cavity, roughly 5.5 Å apart from the Tyr 
140 aromatic ring. The docking run carried out using a modified structure of PA3859, in which the 
Phe 72 was rotated (rotated Phe is highlighted in green) produced a very similar solution (RMSD 0.78 
Å ) but with a significantly lower binding energy. The choline headgroup is mainly stabilized by 
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cation-π stacking with the aromatic ring of Tyr 140 and Phe 72 that in this modified structure are 
roughly 10 Å far one from the other. The distance between ammonium and Phe 72 aromatic ring is 
roughly 4.5 Å. 
Furthermore an hydrogen bond is formed between Tyr 140 hydroxyl and the phosphate group oxygen.  
 
 
 
 
5.3 Conclusions 
 
 
According to the results produced by AutoDock, acyl chain as long as 20 carbon atoms 
can be bound by PA3859 hydrophobic cleft, even thought the cleft seems to be suited to 
accommodate somewhat shorter chains.  
Moreover these docking simulations have provided insights into the binding mechanism 
of the polar cavity: the lipid polar head are mainly stabilized by hydrogen bonding 
between their carboxyl and/or amino group and the protein main chain carbonyl oxygen 
atoms and nitrogen atoms. In the case of choline headgroup the binding is likely to be 
achieved by the classical cation-π staking between quaternary ammonium and two 
aromatic residues side chains. The lack of a strong interaction between binding site and 
the substrate phosphate moiety is probably the reason of the unsuccessful docking of  
Ac-phosphatidyc acid, while phosphatydilinositol polar head is likely to be simply too 
big to fit within the protein polar cavity. 
 
Overall, the docking simulations so far presented suggested that PA3859 protein 
binding site indeed possesses the structure feature required to likely be a 
lysophospholipase. 
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Enzymatic characterization 
 
 
 
6.1 Introduction 
 
A wealth of information on PA3859 based on the P. aeuginosa genome sequence, its 
3D X-ray crystal structure and the results of automated docking simulations with 
possible substrates, led to hypothesize PA3859 to be a lysophospholipase rather than a 
carboxylesterase, with a preference for ethanolamine and serine over choline and 
glycerol polar headgruop and an optimal substrate alkyl chain between 16 and 20 
carbon atom. 
In order to confirm the real function and to shed light on this enzyme specificity and 
mechanism of action, enzymatic assays were performed. 
 
As a first step better targeted studies compared to those reported in Chapter 2 were 
carried out using p-nitrophenyl esters in order to empirically evaluate the enzyme 
specificity with respect to the substrate acyl chain length. 
 
The ability of PA3859 to release free fatty acid from lysophospholipids was assayed by 
TLC analysis and the kinetic parameters for the hydrolysis of lysophopshatidyl choline 
were then determined. 
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6.2 Hydrolysis of p-nitrophenyl esters 
 
 
In the preliminary PA3859 biochemical characterization reported in Chapter 2, the 
influence of the substrate acyl-chain length was evaluated simply by incubating the 
enzyme with the α-naphtyl esters of five carboxylic acids and measuring their overall 
velocity of hydrolysis (Tab. 2.3). The information provided by these experiments 
however, even though useful to make comparison with other carboxylesterases, do not 
allow a reliable evaluation of the enzyme substrate specificity. 
 
As reviewed in the milestone paper by Berg et al “Interfacial Enzymology: the Secreted 
Phospholipase A2-Paradigm” [1], the accurate and detailed studies of a lipolytitc 
enzyme kinetic are far more complex than those of the classical homogeneous-phase 
catalysis in which water-soluble substrate are implicated: difficulties arise from the 
presence of a two phase system, with reactions occurring at the water-lipid interface. 
The resolution of all the kinetic details required to fully describe the enzyme – substrate 
interaction in such system are thus out of the scope of the present work.  
However, in order to gain deeper inside into the PA3859 substrate specificity, and thus 
into its physiological function, a further kinetic study was attempted using p-
nitrophenyl esters as substrates. 
 
 
 
The PA3859 ability of hydrolyzing p-nitrophenyl ester of acetic (C2) to stearic acid 
(C18) was assayed. While acetic, propionic and butyric acid display a water-solubility 
large enough to allow the Kcat and Km determination in a homogeneous phase system, 
the low solubility of substrate carrying a longer acyl chain required the presence of a 
detergent in the reaction mixture. Thus, the hydrolysis of p-nitrophenylesters of 
carboxylic acids longer than C4 occurred mainly at the water-micelle interface. This 
implies a completely different mechanism of action, making problematic a meaningful 
comparison between the kinetic parameter found for the two classes of substrates. 
Furthermore, as will be discuss later on, the presence of a detergent in the reaction 
mixture where soluble substrates were assayed, produced a non-competitive-like  
inhibition of PA3859. 
 
For the soluble substrates p-nitrophenyl acetate, propionate and butyrate, the obtained 
data fit the Michaelis-Menten equation. The Lineweaver-Burk plot was found to be 
linear in the range between 0.01 to 5 mM for all three substrates. 
For the water-insoluble substrates (C5 to C18) the classical Michaelis-Menten model is 
not adequate to describe the reaction mechanism. Since the enzyme-substrate 
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interaction occurs at the water-micelle interface, the reaction rate can not be considered 
to be simply dependent on the substrate concentration in the bulk solution.  According 
to the micellar surface dilution model [2, 3], to describe this micellar catalysis, one 
additional step has to be included in the classical Michaelis-Menten model:   
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The first step consists in the interaction of the enzyme (E) with the micelle surface (M) 
and the formation of the EM complex. Once the EM complex, also called the 
penetration complex, has formed, the enzyme-substrate interaction takes place, with the 
formation of the active complex EMS that will end up in the hydrolysis of the substrate 
and the release of the product P. Thus, the Michaelis-Menten equation results modified 
as reported in equation 1, where [M] represents the total molar concentration of the 
mixed micelle (detergent + substrate) in the bulk solution and χs is the molar fraction of 
the substrate on the micelle surface. Calculation of the amount of the detergent in the 
micelle has to take into account the amount of detergent present in solution (for Triton 
X-100 the critical micelle concentration is assumed to be 240 μM). The fitting 
parameter Ks represents the dissociation constant (K-1/K1) for the micelle-enzyme 
complex, Km is the Michaelis constant ((K3+K-2)/K2) on the micellar surface and Vmax is 
the catalytic turnover rate (K3).   
It is useful to consider the expression for V as a function of [M] when χs is held constant 
(2) and its reciprocal form (3): 
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Equation 3 shows that if the initial rate studies are performed under condition in which 
the substrate molar fraction within the mixed micelle χs is held constant while the total 
micellar concentration [M] is varied, the plot of 1/V versus 1/[M] gives linear curves 
(Fig. 6.1.A). Replot of the these slopes and intercepts as a function of χs allows the 
determination of Vmax, Ks and Km. Specifically, a plot of the 1/V intercepts obtained in 
Fig. 6.1A for each value of χs plotted as a function of 1/ χs , is linear and the intercept on 
the 1/V axis is 1/Vmax  and the intercept on the 1/χs axis corresponds to -1/Km (Fig. 
6.1.B). The plot of the slope obtained for each χs  value in Fig. 6.1.A as a function of 
1/[M] is also linear and the slope is KsKm/Vmax (Fig. 6.1.C). Thus the value of Ks can be 
determined from this curve slope and the values of Km and Vmax  can be derived from the 
plot in Fig. 6.1.B.  
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Figure 6.1. A, plot of 1/V as a function of 1/[M] measured for constant substrates molar fraction (χs). 
B, Intercepts on the 1/V axis obtained in A for each χs value are plotted as a function of 1/χs. C, The 
slopes of the curves obtained in A for each χs value are plotted as a function of 1/χs. 
 
 
For the water-soluble substrates p-NP C2, C3 and C4 the increase of the acyl chain 
length gives rise to a rapid decrease of the Km value (Tab. 6.1, Fig. 6.2A). The presence 
in the reaction mixture of a 0.2% Triton X-100 does not affect significantly the enzyme 
affinity for these substrates but produce a  reduction of the reaction rate of roughly 
70%, mimicking a non competitive-like inhibition (Fig. 6.2.B). Being these short chain 
substrates not expected to interact with the hydrophobic interior of the micelles, the 
reduction of the observed Kcat suggests that a strong interaction between  PA3859 and 
the micelle surface occurs, thus reducing the real concentration of the available enzyme 
active sites. 
 
 
 A  B  C 
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Substrate Km (μM) Ks (μM) Kcat (S-1) Kcat/Km (M-1S-1 × 106) 
p-NP C2 
p-NP C2 +Tx-100 
p-NP C3 
p-NP C3 +Tx-100 
p-NP C4 
p-NP C4 +Tx-100 
 
p-NP C5 
p-NP C6 
p-NP C8 
p-NP C10 
p-NP C12 
p-NP C14 
p-NP C16 
p-NP C18 
  486 ± 116 
  475 ± 154 
315 ± 93 
332 ± 82 
233 ± 74 
246 ± 61 
 
179 ± 42 
113 ± 55 
  75 ± 26 
  80 ± 32 
  85 ± 35 
  91 ± 34 
  96 ± 21 
  98 ± 32 
 - 
 - 
 - 
 - 
 - 
 - 
 
 84 ± 13 
 98 ± 17 
 83 ± 12 
             75 ± 13 
 96 ± 19 
           106 ± 32 
 91 ± 30 
 76 ± 11 
6400 ± 880  
2130 ± 430 
5700 ± 920 
1900 ± 310 
1700 ± 350 
 700 ±120 
 
1900 ± 190 
4500 ± 320 
4600 ± 280 
1800 ± 100 
180 ± 40 
         120 ± 20 
           50 ± 20 
           50 ± 20 
13.3 ± 2.1  
  4.4 ± 0.9  
18.1 ± 2.8 
   6.0 ±  1.2 
  7.3 ± 0.8 
  3.0 ±  0.7 
 
10.8 ± 1.6  
39.4 ± 3.1 
61.3 ± 3.8 
22.8 ± 3.4 
  1.5 ± 0.2 
  1.2 ± 0.3 
  0.5 ± 0.1 
  0.5 ± 0.2 
 
Table 6.1. PA3859 kinetic parameters for the hydrolysis of p-nitrophenyl esters. For soluble substates 
p-NP C2, C3 and C4, the data obtained in the presence of 0.2% Triton X-100 are also reported. Ks 
values corresponds to the micellar concentration exceeding the Triton X-110 CMC (240 μM): a Ks of 
roughly 90 thus corresponds to a micellar concentration of 330 μM. 
 
 
For substrates longer than C4, due to their low water-solubility, the assays were 
conducted in the presence of a detergent according to the surface dilution model 
described above. Triton X-100 was used to allow the substrate solubilization. The 
highest Kcat/Km ratio value is achieved by p-NP C8 that displays the lower Km and the 
highest Kcat. Km values do not differ significantly for substrates with chain length 
ranging between C8 to C18, while a dramatic reduction in the Kcat values are found for 
substrates longer than C10 (Fig. 6.2). The affinity for the micelle, as estimated by the Ks 
parameter, is also independent from the substrate chain length and roughly corresponds 
to a overall micellar concentration of 340 μM. However, being the critical micelle 
concentration (CMC) for Triton X-100 in the assay condition equal to 240 μM, the 
relevant value for Ks is roughly 100 μM (Tab. 6.1). 
 
These data are consistent with those found for many other lipolytic enzymes [4, 5, 6, 7], 
where the optimal substrate chain length was found to be 8 carbon atom. Interestingly, 
to the best of ours knowledge, when the kinetic studies of lipases or phospholipases 
were carried out using p-nitrophenyl esters in a detergent mixed micelle system, the 
optimal substrate chain length has never been found to be longer than C8, suggesting 
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that some kind of artifact is likely to occur. This hypothesis is also supported by another 
consideration: the fatty acids found in the membrane are long at least 16 carbon atoms, 
thus lipids and phospholipids carrying 8 carbon atom alkyl chains are not expected to 
have any physiological relevance,. Furthermore, according to the docking simulation 
presented in Chapter 5, the PA3859 hydrophobic cleft seems to be suited to interact 
with substrates much longer than C8. All this suggest that the Kcat/Km ratio determined 
for the mixed micelle system is not likely to provide a reliable evaluation of the in vivo 
enzymes substrate specificity. 
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Figure 6.2. PA3859 kinetic parameters for the hydrolysis of p-nitrophenyl ester plotted as a function 
of the substrate chain length. The parameters concerning the hydrolysis of soluble substrates 
determined in the absence of Triton X-100 are shown in red. 
 
 
6.3 PA3859 hydrolysis of lysophospholipids 
 
The kinetic study presented above, even though is likely to be affected by an artifact 
that does not allow to clearly asses the protein preference for the substrates chain 
length, showed that PA3859 is able to hydrolyze esters of fatty acids as long as 18 
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carbon atoms. Furthermore, the binding site study carried out by means of automated 
docking simulations suggested PA3859 to be a lysophospholipase. In order to assay its 
ability to hydrolyze lysophospholipids the enzyme was extensively incubated with the 
following lysophospholipids: 1-palmitoyl-sn-phosphatidyl -choline, -serine, -
ethanolamine, -glycerol, -inositol and 1-palmitoyl-sn-phosphatidic acid. To evaluate the 
enzyme activity against phospholipids the hydrolysis of 1,2-dipalmitoyl 
phosphatidylcholine was also assayed. The release of palmitic acid was evaluated by 
TLC analysis. As it is shown in Fig. 6.3, a significant release of palmitic acid was 
detected when the enzyme was incubated with lysophosphatidyl ethanolammine, serine, 
choline and glycerol while no activity was found with lysophosphatidic acid, 
lysophosphatidylinositol, and phosphatidylcholine as substrates. 
 
 
 
 
 
 
 
Figure 6.3. TLC analysis of the PA3859 lysophospholipolytic activity: l-PS, lysophosphatidylserine. l-
PE, lysophosphatidylethanolamine. l-PC, lysophosphatidylcholine. l-PG, lysophosphatidylglycerol. 
PA, palmitic acid. PC, phosphatidylcholine. PI, lysophosphatidylinositol. l-PA, lysophosphatidic acid. 
Each substrate was incubated for 5 hours at 37 °C with 1 μg of PA3859 (lanes +) and without the 
enzyme (lanes –). 
 
This result shows that PA3859 is indeed able to hydrolyze lysophospholipids and 
suggest a specificity for the polar headgroups that well agrees with the docking 
simulation results. This experiment however, being merely qualitative, does not provide 
any information on the kinetic. Thus it is not possible to evaluate the enzyme specificity 
for the different phospholipid polar headgroups nor the reaction kinetic parameters. 
 
To further investigate the enzyme hydrolysis of lysophospholipids a preliminary kinetic 
study was perfomed using radiolabeled 1-palmitoyl-sn-phosphatidylcholine as substrate 
  l-PS         l-PE           l-PC         l-PG       PA         PC           l-PI             l-PA 
   +     –       +      –       +     –        +     –                 +     –       +      –       +      – 
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(see paragraph 6.4.2). With respect to long chain p-nitrophenyl esters, 
lysophospholipids displays a higher water-solubility and, more important, can form 
pure micelle with no need for the addition of a detergent. This allowed the 
determination of the kinetic parameter according to the classical Michaelis-Menten 
model. As shown in Fig. 6.4, the PA3859 catalytic activity against 
lysophosphatidylcholine exhibits saturation kinetics. However, the data did not fit well 
the Michaelis-Menten equation (red curve). There seems to be some cooperativity 
effect, since the data fit to the Hill equation with n=1.58 ± 0.12, Vmax  0.76 ± 0.05 μmol
 
min
-1
mg
-1
 protein and substrate concentration at half-maximal saturation is 24.0 ± 2.3 
μM. Furthermore, there is no dramatic increase in the enzyme activity near the CMC of 
the substrate (7 μM), indicating that the enzyme hydrolyzes the substrate both in 
monomeric and micellar form.  
To determine the dependence of the enzyme activity on the substrate surface 
concentration, measurements with Triton X-100 - lysophosphatidyl choline mixed 
micelle were also performed. When the bulk l-PC concentration is held constant and the 
detergent concentration is varied, the enzyme activity increases as the molar fraction of 
the substrate within the micelle increases and the data fit the Michaelis-Menten 
equation with a Vmax  of 0.92 ± 0.11 μmol min
-1
mg
-1
.  
Furthermore, the surface dilution kinetic model was also tested. The parameter values 
obtained are: Vmax = 0.83 ± 0.06 μmol/min/mg, Km = 21.1 ± 3.7 μM and Ks = 85.4 ± 4.4 
μM.  
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Figure 6.4. PA3859 activity as a function of l-PC concentration. Data were fitted to Michaelis-Menten 
equation (red curve) and to Hill model (blue curve). Each point represents the average of five 
independent experiments, each in triplicate. The l-PC critical micelle concentration (CMC) is indicated 
by the arrow. 
 
Overall the kinetic data so far reported are consistent with the following three 
conclusions: first, even though the Vmax is achieved for a substrate concentration above 
the CMC, no interfacial activation seems to occur. This finding is in agreement with the 
lack in PA3859 structure of a lid domain as those typically found in the real lipases (see 
    CMC 
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Chapter 1) that are though to be responsible for their interfacial activation mechanism. 
Second, the fact that a similar value of Ks fits all the experimental data suggests that 
PA3859 binds to the mixed-micelles with the same affinity regardless of the micellar 
composition. Third, the dependence of the apparent Vmax on l-PC molar fraction within 
the mixed micelle is consistent with a single binding site for the substrate. This 1:1 
stoichiometry of substrate-enzyme complex suggests that the apparent cooperativity 
observed in the kinetics of PA3859 on pure l-PC micelles results from the change in the 
substrate presentation (monomers vs premicellar aggregates vs micelles) rather than a 
cooperative binding of two or more substrate molecules to catalytic or allosteric sites 
[8].  
 
 
 
6.4 Materials and methods 
 
 
6.4.1 Hydrolysis of p-nitrophenylesters 
 
Reaction were carried out at room temperature in Tris-HCl 50 mM, pH 9.0 in the 
presence of 2 µg ml
-1
 of PA3859. Formation of the reaction product p-nitrophenol was 
followed measuring the increase in the absorbance at 400 nm using a ULTRASPEC 
3000 spectrophotometer (Pharmacia Biotech). 
To measure the activity as a function of the overall micelle concentration [M] and at a 
constant molar fraction (χs), substrates were first dissolved in chloroform and than 
aqueous solutions in Tris-HCl 50 mM, pH 9.0 and Triton X-100 5 mM were prepared. 
For each substrate 10 different solutions were prepared with a substrate molar fraction 
χs spanning the range 0.2% to 10% (corresponding to a substate concentration between 
10 µM and 500 µM). Reactions were started adding to the reaction mixture 10 µl of a 
0.2 µg µl
-1
 PA3859 solution. 
Substrates were purchased from Sigma Chemicals, Triton-X100 from Fluka. 
 
 
6.4.2 Hydrolysis of lysophospholipids  
 
To assay the PA3859 ability to hydrolyze lysophospholipds, 200 µg of substrates were 
incubated with 1 µg of enzyme in 80 µl of Tris-HCl 50 mM, pH 9.0, at 37 °C for 5 
hours. Lipids were than extracted in an organic solvent according to the Bligh protocol 
in order to remove buffer and protein [9]. The chloroform phase was subsequently 
spotted on the TLC plate (Silica Gel Plates, Merck). Before use, the plate was wetted 
with a 2.3% (w/v) boric acid solution and then dried for 15 min. at 100 °C in an oven. 
The TLC plate was developed in a tank containing a solvent mixture of chloroform-
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methanol-water in ratio 65:25:4 (vol/vol/vol). For lipid visualization the plate was 
sprayed with a primuline solution (5 mg/100ml in acetone-water 80:20 (v/v)) and lipids 
were detected under UV light as fluorescence quenched spot. 
Lysophosphatidyl -serine, -ethanolamine, -glycerol and -inositol were purchased from 
Avanti Polar Lipids. Lysophosphatidylcholine, phosphatidyl choline, phosphatidic acid, 
palmitic acid and primuline were from Sigma Chemicals. 
 
To determine the PA3859 lysophospholipase activity the radiolabeled substrate  
1-[
14
C]palmitoyl-sn-phosphatidyl choline was used (Amersham Biosciences, 112  µCi 
mg
-1
). Reactions were carried out at room temperature in 50 µl Tris-HCl 50 mM, pH 
9.0. The assay was started by adding 50 ng of enzyme to the reaction mixture. The 
released fatty acid was extracted by the Dole method [10]: the reaction was stopped by 
adding to the reaction mixture 250 µl of a isopropanol:heptane:sulfuric acid (25:85:1 
v/v). The solution was heated at 60 °C for 3 min and then chilled on ice for 2 min. 
Subsequently 150 µl of heptane and 125 µl of water were added. The mixture was then 
vortexed, centrifuged for 1 min at 13000 rpm in a bench centrifuge and 350 µl of the 
upper organic phase containing the released radiolabeled palmitic acid was finally 
recovered. To quantify the content of palmitic acid, the recovered organic phase was 
mixed with 5 ml of scintillation liquid Ready Safe (Beckman) and the β emission 
measured using a TRI-CARB TR β-counter (Packard). 
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Chapter 7 
 
Study on the PA3859 in vivo function 
 
 
 
7.1 Introduction 
 
 
The enzymatic assays described in Chapter 6 demonstrated that PA3859 is indeed 
capable to hydrolyze lysophospholipids in vitro. In order to assess the role played in 
vivo by PA3859, further experiments were performed using a Pseudomonas aeruginosa 
mutant in which the expression of the PA3859 gene was suppressed (knock out mutant).  
Moreover, being lysophospholipids and lysophospholipases known to be involved in 
the bacterial infective process (see Chapter 1), a collaboration was initiated with an 
external laboratory in order to evaluate the possible involvement of PA3859 as a 
virulence factor. Here the preliminary results are reported. 
 
 
 
 
 
The Pseudomonas aeruginosa PA3859 knock out (K.O.) mutant was purchased from the 
University of Washington Genome Center: within their “Pseudomonas Aeruginosa 
Project” a near-saturated library of mutant PAO1 strains was generated, each with a 
unique gene suppression, by means of a high-throughput methods for producing 
sequence-defined transposon insertion mutation (http://www.genome.washington.edu/U 
WGC/pseudomonas/index.cfm). All the produced mutants are freely available. 
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7.2 PA3859 involvement in the phospholipids metabolism 
 
The fact that the PA3859 knock out is viable lead to the first conclusion that this protein 
does not accomplish any essential function or that in P. aeruginosa other enzymes with 
similar activity exist.  
Anyway, if as expected PA3859 acts in vivo as a lysophospholipase, the knock out 
mutant should display some deficiency in the phospholipids metabolism. This 
possibility was assayed by growing both the PAO1 wild type and the K.O. mutant in a 
minimal medium containing phospholipids as the unique carbon source. Bacteria were 
first grown in LB at 37 °C to an O.D.600 of 0.4 and diluited 1:10 in a minimal medium 
(M9) containing the required inorganic nutrients and 0.2% Asolectin (Sigma 
Chemicals) as carbon source, and incubated for 32 hours at 37 °C. Asolectin is a 
mixture of phospholipids extracted from soybean containing roughly an equal 
proportion of phosphatidyl -choline, -serine and -inositol. As shown in Fig. 7.1, almost 
no difference was found in the growth rate on LB (A). On the contrary when bacteria 
were fed with phospholipids as the sole carbon source, a clear reduction in the growth 
rate of the PA3859 K.O. mutant was found with respect to the PAO1 wild type (B), 
suggesting a role of PA3859 in the phospholipids metabolism.   
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Figure 7.1. Growth curve of wild type PAO1 (blue curve) and PA3859 knock out mutant (red curve) 
on LB (A) and on a minimal medium containing phospholipids as the sole carbon source (B). The 
density of the bacterial cultures was quantified measuring the light scattering at 600 nm. The plots are 
the mean of three independent experiments.  
 
Furthermore the final bacterial density reached by the wild type culture was roughly 1.5 
fold higher than the K.O. mutant. A possible explanation for this finding could reside in 
the cytolytic effect of lysophospholipid: lysophospholipids are known to be toxic due to 
their membrane-perturbing properties. The incorporation of these molecules into a 
phospholipidic bilayer provokes a membrane destabilization that lead to free ion 
permeation and subsequent osmotic rupture of the cell [1]. Indeed, it has been suggested 
that one of the roles of lysophospholipases, besides to the implication in the 
A B 
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phospholipids catabolism, is the maintenance of the lysophospholipids at safe levels [2, 
3].  Thus the lower density reached by the PA3859 K.O. mutant culture could be due to 
its impossibility to scavenge the lysophospholipids produced along with the 
phospholipid catabolism.  
 
To assay the possible involvement of PA3859 in the lysophospholipid detoxification, 
both PAO1 wild type and the PA3859 K.O. mutant were plated on LB-agar containing 
up to 500 µM phosphatidylcholine and grown overnight at 37 °C.  
If PA3859 function concerned the lysophospholipid detoxification a much slower 
growth, or even the complete impossibility to grow, would have been expected. No 
differences were observed in the growth of wild type and the K.O. mutant. This result 
however does not mean that PA3859 is not involved in the detoxification of 
lysophospholipids: in the P. aeruginosa genome in fact, the ORF PA2856 
(http://www.pseudomonas.com) codifies for a protein that has been supposed to be a 
lysophospholipase due to its 65% sequence identity with the acetyl-CoA thioesterase 
I/lysophopsholipase of E. coli [4]. This protein is secreted in the periplasm and could be 
responsible for the detoxification of the exogenous lysophospholipids. Thus, besides its 
involvement in the phospholipids catabolism, a role of PA3859 in the detoxification of 
endogenous lysophospholipid is still possible. 
 
 
7.3 PA3859 as a possible P. aeruginosa virulence factor 
 
Pathogen microorganisms are known to secrete lytic enzymes. Among these, 
phospholipase play a predominant role, being involved in the partial digestion of the 
host cell plasma membrane [5,6]. Specifically, in Pseudomonas aeruginosa, one of the 
most important secreted virulence factor, ExoU, has a phospholipase/lysophospholipase 
activity [7, 8, 9]. Furthermore, among the enzymatic activity required for the P. 
aeruginosa persistence in the lungs of the infected host, an essential role is also played 
by phospholipases of type C and D, suggesting an involvement of the phospholipids 
metabolism in the bacterial infectivity [10, 11], (see Chapter 1). 
To evaluate the possible contribute of PA3859 to the P. aeruginosa pathogenicity, we 
started a collaboration with a laboratory involved in the in vivo study of the P. 
aeruginosa - host interaction (Dr. Roger C. Levesque group at Facultè de Mèdecine, 
Universitè Laval, Stefoy, Quebèc, Canada). The ability of the PA3859 knock out 
mutant to compete with the wild type PAO1 was examined in a model of infection. The 
rat lung model of chronic infection was chosen for these studies [12]: young adult 
Sprague-Dawley rats were used. The animals were anaesthetized using isofluorane and 
inoculated into the left lobe of the lungs with 100 µl of a suspension of agar beads 
containing 10
5
 - 10
6 
bacterial cells. A healthy rat typically clears the P. aeruginosa 
infection within two weeks. After 7 days lungs were removed from sacrificed rats and 
homogenized tissues were plated on agar with and without chloramphenicol: the 
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transposon used for PA3859 K.O. mutantation carries the resistance for 
chloramphenicol. Thus the number of POA1 wild type and K.O. mutant could be 
evaluated by plate counts on media with and without the antibiotic. 
Nine rats were infected for this experiment and, on average, a five fold higher amount 
of wild type bacteria were found in the rat lungs with respect to the PA3859 K.O. 
mutant. This result, even thought still preliminary, demonstrates that the mutant is 
reduced in its capacity to persist in the rat in competition with the PAO1 parental strain, 
suggesting that PA3859 is indeed necessary for Pseudomonas aeruginosa to thrive in 
the host lungs and thus for its pathogenicity to be exploited. 
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Chapter 8 
 
 
Discussion and final remarks 
 
 
 
8.1 Introduction 
 
The broad substrate specificity typically shown by microbial carboxylesterases 
prompted to hypothesize that these enzymes have evolved in order to allow the 
utilization of a wider variety of organic compounds as carbon source [1]. However, it 
does not necessarily implicate that the physiological function of the carboxylesterases is 
limited to this trophyc role.  
The hydrolysis of an ester is a relatively simple reaction. For instance, esters undergo a 
spontaneous hydrolysis under basic condition due to the nucleophilic attach by 
hydroxyls to the carbonylic carbon. Furthermore, a nucleophile as hydroxylamine is 
able to increase the carboxylesterase-catalyzed reaction rate by providing an alternative 
route for the substrate hydrolysis, further confirming the relatively intrinsic instability 
of carboxyl esters [2]. The relatively broad substrate specificity often displayed by 
carboxylesterases could thus be considered as a somewhat unavoidable consequence of 
the substrates intrinsic instability rather than an enzyme feature evolved to accomplish a 
specific function.  
 
Among the PA3859 homologous sequences many others carboxylesterases have been 
found. It does not come as a surprise of course, but it is worthy of note that for none of 
them the physiological function has been unambiguously assessed. All of these 
enzymes are simply considered to be “general carboxylesterases”. This is also true for 
the carboxylesterase II of Pseudomonas fluorescens, that was extensively studied and 
whose 3D structure was determined [3, 4, 5]. Besides a sequence homology of 76%, 
this protein shares an extremely similar structure with PA3859 (see Chapter 4), 
suggesting that the same in vivo function is also shared.  
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Since experimental data are missing, so far the above mentioned hypothesis about 
carboxylesterases function has a merely speculative meaning. However it is not unlikely 
that the broad substrate specificity often assigned to carboxylesterases rather than 
defining an enzyme feature represents a statement of the lack of information about their  
physiological substrate(s).  
 
The work reported in this thesis represents an example of how the 3D structure 
determination of an enzyme can help to unveil its function:  the presence on the PA3859 
surface of a groove that encompasses the catalytic site was in fact supposed to be the 
possible enzyme binding site.  Its binding properties were evaluated by means of 
automated docking simulations and the obtained results were subsequently validated by 
enzymatic assays. Furthermore, experiments carried out with a Pseudomonas 
aeruginosa mutant in which the expression of PA3859 was suppressed, allowed the 
determination of the enzyme role in vivo. 
Thus, starting from the enzyme 3D structure determination, an approach involving in 
silico, in vitro and in vivo assays lead to the reliable determination of the PA3859 
physiological function. 
 
 
 
8.2 PA3859 in silico and in vitro  study 
 
 
The PA3859 binding site can be considered as build up by two distinct part, a long 
groove mainly hydrophobic, here called the “hydrophobic cleft” and a polar part, named 
the “polar cavity”, with the catalytic Ser 113 positioned exactly in between these two 
elements (Fig. 8.1). The finding in PA3859 crystal form I of a MES molecule 
covalently bound to Ser 113 and positioned within the polar cavity and in crystal form 
II of a PEG strand lying within the hydrophobic cleft, further suggested this grove to be 
the enzyme binding site (See Chapter 4). 
 
According to the docking simulations, the hydrophobic cleft should be involved in the 
interaction with the substrates acyl chain. The cleft seems to be suited for the binding of 
alkyl chain as long as 18 - 20 carbon atoms, chains longer than 20 carbon atoms in fact 
could not be docked completely into the cleft. The docking simulation results are in a 
good agreement with the enzymatic assays. As shown in Fig. 8.2, the Km values for the 
hydrolysis of p-nitrophenyl esters experimentally determined and the theoretical 
binding constants, produced by the docking simulation, display a very similar 
dependence on the substrate chain length. 
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Figure 8.1. PA3859 surface. Hydrophobic cleft, yellow. Catalytic Ser 113, green. Polar cavity, red. 
The PEG nonamer positioned into the polar cavity is shown in blue stick format and the MES 
molecule bound to Ser 113 is depicted as cyan stick.  
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Figure 8.2. The Km values for the hydrolysis of p-nitrophenyl esters (blue curve) and the theoretical 
binding constants produced by the docking simulation (red curve) are plotted as a function of the 
substrate alkyl chain length. 
  
 
The almost perfect numerical overlap between these values however has to be 
considered as occasional due to the different conceptual meaning of binding constant 
and Km: binding constant is a thermodynamic parameter, while Km, even though 
representative of the enzyme affinity for the substrate, results from a combination of 
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kinetic constants. The former represents the ratio between the concentration of products 
and reagents once that the thermodynamic equilibrium is achieved, the latter 
corresponds to the substrate concentration that give rise to a reaction rate equal to 50% 
of the maximal velocity. 
The Km minimum value is obtained for p-NP C8 (75 µM). For longer substrates Km 
values slightly increase up to 98 µM obtained for p-NP C18 (see Chapter 5). 
Theoretical binding constant values of roughly 40 µM
-1
 are instead obtained for 
substrate p-NP C10 to C20, with a minimum of 32 µM
-1
 achieved for p-NP C14 (see 
Chapter 6). Thus in both curves a plateau is observed, where the measured (or 
computed) values dependence from the substrates chain length is reduced.  
 
The enzymatic hydrolysis of water-insoluble substrate embedded in a micelle is a quite 
complex process. For example, it could be argued that if the enzyme-substrate 
interaction requires the substrate to be extracted from the micelle into the bulk solvent, 
then the measured Km values could be affected by this “extraction process” and thus 
would be no longer representative of the real enzyme affinity for the substrate. The 
extraction of a p-nitrophenyl ester from a micelle to the water solvent is an 
unfavourable process whose positive ΔG becomes larger and larger as the substrate 
chain length increases [6]. Thus in such case, an increase in the apparent Km values 
would be expected for the longer chain substrates that is regardless of the real enzyme-
substrate affinity. Moreover, a completely different dependence on the substrate chain 
length would be expected for the measured Km and the theoretical binding constant 
values. In the AutoDock Free Energy Function indeed, the binding energies are 
evaluated considering a process in which the substrate, monomolecularly dispersed in 
the bulk solution, binds to the enzyme (see Appendix 2). Thus, being the complications 
that arise from the presence of the substrate in the micelle completely ignored by the 
docking simulations, the final result is indicative of the real enzyme-substrate affinity. 
In conclusion, the almost perfect agreement between Km and the theoretical binding 
constants, suggests that the measured Km are really indicative of the PA3859 affinity for 
the p-nitrophenyl esters. Furthermore, it suggests that a tight interaction occurs between 
enzyme and micelle and allows the direct transfer of the substrate from the micelle to 
the enzyme binding site without the formation of a substrate solvated intermediate.   
 
For substrates p-nitrophenyl C2 to C6, Km values much higher than those of longer 
chain substrates were found (Fig. 8.2). Also in this case the automated docking provides 
a possible explanation. The PA3859 oxyanion hole, whose 
function consists in the stabilization of the oxyanion 
intermediate formed along with the catalytic process (see 
Chapter 1) obviously displays a high affinity for negatively 
charged oxygen atoms. Thus, when the docking of short 
chain p-nitrophenyl esters was attempted, in the lowest 
N
+
O
O
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3
O
 
Structure of  p-NP acetate  
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energy solutions, the substrate nitro group oxygen atom, rather than the carbonylic 
carbon, was positioned in the active site (see Chapter 5 and Fig. 8.3). Indeed, for this 
reason p-NP C2 could not be docked in the productive conformation. The shorter 
substrate whose lowest binding energy was obtained for its active conformation is p-NP 
C8, suggesting that an alkyl chain of at least 7 carbon atom is required to stabilize the 
productive positioning of  p-NP substrates within the active site. Thus, the low Km 
values for substrate C2 to C6 could be the consequence of their preferential non-
productive interaction with the PA3859 active site that would mimic a reduced substrate 
concentration. 
 
 
 
 
 
Figure 8.3. The overall minimal energy docking solution for the p-NP C6: the substrate is positioned 
with its nitro group into the active site, where hydrogen bonds occur between the nitro group oxygen 
atoms and the Ser 113 (green) and the main chain nitrogen atom of the oxyanion hole residues Leu 22 
and Gln 114 (blue). 
 
 
 
Another interesting question, that arose by the study of PA3859 hydrolysis of p-
nitrophenyl esters, has been the enzyme specificity as a function of the substrate chain 
length. According to the experiments reported in Chapter 6, the higher PA3859 catalytic 
efficiency, quantified by the Kcat/Km ratio, is achieved for esters of octanoic acid and 
decreases sharply for substrates with alkyl chain either shorter or longer than 8 carbon 
atoms (Fig. 8.4). 
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Figure 8.4. Plot of the PA3859  Kcat/Km ratio for the hydrolysis of  p-nitrophenyl ester as a function of 
the substates alkyl chain length.  
 
This result is in a clear disagreement with the PA3859 structure feature and with the 
results of the docking simulation: the hydrophobic cleft present on the enzyme surface, 
that is believed to be involved in the accommodation of the substrate alkyl chain, is in 
fact long enough to accommodate chains as long as 18 - 20 carbon atoms, suggesting its 
physiological substrates alkyl chain to be much longer than octanoic acid. Furthermore, 
naturally occurring lipids and phospholipids typically derive from the esterification of 
fatty acid at least 16 carbon atom long (palmitic acid). Thus a hypothetical phospholipid 
derived from octanoic acid is not likely to have any physiological relevance. 
 
When the specificity of lipolytic enzymes has been assayed using mixed micelles 
containing p-nitrophenyl esters as substrate, an optimal alkyl chain length of 8 carbon 
atoms is often found [7, 8, 9, 10]  Actually, to the best of our knowledge, these 
experiments have never lead to the finding of an optimal substrate chain length longer 
than 8 carbon atom, suggesting that some kind of artifacts probably occurs. A possible 
explanation is the following: the enzymatic hydrolysis of a p-nitrophenyl ester is a two 
step process (see Chapter 1). The first step leads to the release of the p-nitrophenol and 
to the formation of the acyl-enzyme. Subsequently, the acyl-enzyme is hydrolyzed and 
the free fatty acid is released. This second step has been demonstrated to be the rate 
limiting step.  The release of the fatty acid from the enzyme hydrophobic cleft into the 
bulk solvent is an energetically disadvantageous process, whose positive ΔG is expected 
to increase as the fatty acid chain length increases. As a consequence, the release of 
long chain fatty acids is likely to be slower than the release of shorter ones, resulting in 
a considerable reduction of the Kcat values for the longer chain substrates (Fig. 8.4). 
This hypothesis however is only valid if the leaving fatty acid would be released into 
the aqueous phase rather than directly into the micelle.  
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A further possible explanation has also been suggested. For many interfacial enzymes a 
so called “scouting” mode of action has been proposed (see Chapter 1) [11]. According 
to this mechanism the enzymes associate to the micelle interface and then processively 
carry out the catalytic turnover without detaching from the surface. In this case the free 
fatty acid reaction product is directly released into the micelle.  
A limitation of the detergent-substrate mixed-micelle method for the study of such 
lipolytic enzymes is that if the substrate replenishment rate, that is the rate for the 
substrate to exchange between micelles, is not much faster than the turnover rate, the 
reaction rate will be limited by the replenishment rate rather than by the catalytic 
efficiency of the enzyme. The replenishment rate for a long chain p-nitrophenyl ester is 
exceedingly slow via the exchange mechanism where the substrate desorbs into the 
aqueous phase because the aqueous concentration is in the subnanomolar range [12, 
13]. Thus the observed Kcat rather than a measure of the enzymatic process is a measure 
of the micelle component exchange.  
 
When the hydrolysis of the soluble p-nitrophenyl ester was carried out in the presence 
of a detergent, a non-competitive like inhibition was clearly observed (see Chapter 6). 
This finding can be interpreted as a consequence of a tight interaction between PA3859 
and the micelle. The trapping of the enzyme on the micelle surface can be supposed to 
reduce the concentration of the available active sites and thus the overall reaction rate. 
On the other hand, as will be discussed later, PA3859 is not an interfacial activated 
enzyme and is able to hydrolyze its substrates in both the aggregated and the 
monodispersed form. Furthermore, while both lipase and phospholipase, when loaded 
on a gel filtration chromatography column together with a detergent, tipically coelute 
with the micelles [2], the PA3859 elution was not found to be affected by the presence 
of Triton X-100 or phospholipids. These results suggest that PA3859 interaction with 
the micelle surface is much weaker than those of real interfacial enzymes. 
 
Thus it is possible that both the above suggested mechanisms could contribute to the 
observed PA3859 substrate specificity. The disadvantageous release of the free fatty 
acid in the aqueous phase could affect the turnover rate of the enzyme molecules that 
are not bound to the micelle surface, and the turnover of the enzyme bound to the 
micelle could be limited by the substrate replenishment rate.  
In any case, the apparent optimal substrate chain length of 8 carbon atom found for 
PA3859, rather than being representative of a real substrate specificity is likely to be 
merely the consequence of the substrates intrinsic properties.  
These considerations also suggest that for lipolytic enzymes, unless a very careful and 
detailed kinetic study is performed, the substrate alkyl chain specificity can be inferred 
with more reliability from the protein binding site structure than from a preliminary 
enzymatic assay. 
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Studies carried out on the 14-kDa family of secreted phospholipase A2, have lead to the 
identification of the residues involved in the protein-micelle surface interaction. The 
portion of the enzyme surface that interacts with the micelle, called i-face, is mainly 
made by hydrophobic or positively charged residues [14, 15]. The i-face cationic 
residues Lys and Arg have been demonstrated to be directly involved in the protein 
micelle interaction [16, 17, 18, 19]. Specifically, the positively charged side chains of 
these residues are thought to be involved in the interaction with the negatively charged 
phosphate moiety of the phospholipids. 
In PA3859, the portion of the protein surface around the binding site is mainly made by 
hydrophobic residues, however two negatively charged patches positioned next to the 
hydrophobic cleft are also present (fig. 8.5). Study to explicitly evaluate the interaction 
of PA3859 with the micelles surface have not been performed, however kinetic data 
indicated that this enzyme interacts with the micelle and that this interaction is weaker 
than the one displayed by the prototypic phospholipases A2 [15, 18]. This finding allow 
to hypothesize that the interaction between PA3859 and the micelle surface could be 
mediated by the negatively charged residues, thus involving the cationic phospholipids 
headgrup exposed on the micelle surface rather than the anionic phosphate moiety 
positioned deeper inside. This different interaction mode would cause PA3859 to 
“float” on the micelle surface, thus explaining the observed weaker protein-micelle 
interaction.  
In a model for membrane binding of human pancreatic phospholipase A2, a Trp residue 
present on the enzyme i-face is suggested to stabilize the membrane anchoring of the 
protein by both non-ionic interaction with the lipid alkyl chains and by hydrogen 
bonding between the imino group of the Trp indole ring and carbonyl oxygen atoms of 
membrane lipids [16]. Interestingly, in  PA3859 the Trp 61 is positioned next to the 
active site and its side chain protrudes from the protein surface, suggesting that 
similarly to what has been found for the human pancreatic phospholipase A2, the 
protein anchoring to the micelle could also  be mediated by this Trp residue (Fig. 8.5). 
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Figure 8.5. PA3859 electrostatic potential surface: red, negatively charges, blue, positively charges. 
The hydrophobic cleft is flanked by two acidic regions, composed by Asp 167, Asp 170 and Glu 198 
(the bigger one) and Asp 25 and Asp 289 (the smaller one). The portion of the protein surface around 
the hydrophobic cleft is rather flat, and residue Trp 61 sticks out sharply into the solvent. Figure 
produced with PyMol (http://www.pymol.org). 
 
In Pseudomonas aeruginosa PAO1 genome the PA3859 locus is positioned in the 
vicinity of two genes involved in the phospholipids metabolism: PA3857 was 
demonstrated to be a phosphatidylcholine synthase [20] and PA3860 is hypothesize to 
be involved in the lipid biosynthesis, due to its 59% sequence homology with a long 
chain fatty acid – CoA ligase of Archaeaglobus fulgidus (see Chapter 5) 
(http://www.pseudomonas.com).This finding prompted to hypothesize PA3859 to be 
implicated in the phospholipids metabolism. The ability of the polar part of the PA3859 
binding site, named the “polar cavity”, to bind to the phospholipids polar headgroup 
was checked by automated docking. These simulations suggested the enzyme to be 
specific for phosphoryl -serine, -ethanolamine, -choline and -glycerol headgroups. 
Subsequently, the PA3859 activity against 1-palmitoyil-sn-phosphatidyl -serine, 
ethanolamine, -glycerol and choline was confirmed by an enzymatic assay and TLC 
analysis (see Chapter 6).  
 
Of a certain interest is the finding that PA3859 is able to hydrolyze choline based 
lysophospholipid: phosphatidylcholine in fact, up to few years ago, was thought to be 
present only in the membrane of eukaryotic cells. Now it is known that several highly
 
specialized groups of bacteria, mainly photosynthetic bacteria
 
containing extensive 
internal membrane structures or those living
 
in association with eukaryotes, such as 
pathogen or symbiotic bacteria, contain phosphatidylcholine as a membrane lipid [21]. 
Even though the requirement of phosphatidylcholine in these bacteria has not been 
Polar cavity 
 Hydrophobic cleft 
Polar cavity 
Hydrophobic c 
cleft 
Trp 61 
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clearly determined, it is believed to play an important role in the bacterium-eukaryotic 
cell interaction [22]. 
In most of the phosphatidylcholine binding protein, the choline headgroup stabilization 
is achieved by cation-π stacking: typically the quaternary ammonium is placed between 
two aromatic rings at a distance of 4.5 - 5 Å, [23]. As suggested by automated docking, 
in PA3859 this interaction mode could arise from the rotation of Phe 72 side chain (see 
Chapter 5). As will be discussed later on, the binding site of carboxylesterase II from 
Pseudomonas fluorescens is very similar the one of PA3859, suggesting that these 
enzymes are probably involved in the same physiologic function. However, in the polar 
cavity of carboxylesterase II from P. fluorescens, Phe 72 is replaced by a methionine, 
(Met 73). Thus the classical choline stabilization can not be exploited, suggesting that 
this enzyme is probably unable to efficiently hydrolyze phosphatidylcholine. This 
hypothesis is in agreement with the different physiology of these bacteria: despite their 
phylogenetic closeness, P. fluorescens is not a pathogen and, as far as it is known, its 
plasmatic membrane does not contain phosphatidylcholine. 
 
The PA3859 hydrolysis of lysophospholipid was further characterized by using 
radiolabeled lysophosphatydilcholine as substrate. The result of this study suggests that 
PA3859 is indeed a lysophospholipase, being its kinetic parameters in agreement with 
those found for other lysophospholipases (see Chapter 6) [24, 25, 26]. 
Furthermore, this study has shown that the enzyme is not interfacially activated, that is 
able to hydrolyze its substrates in both monodisperse and micellar form and that its 
affinity for the micelle surface does not depend significantly from the micelle 
composition, suggesting that the protein-micelle interaction is mainly due to aspecific 
hydrophobic interaction. 
 
 
 
The availability of a P. aeruginosa mutant in which the expression of PA3859 was 
suppressed allowed to set up some preliminary experiment to assay the role of this 
enzyme in vivo.  
 
As reported in Chapter 2, PA3859 was firstly purified from P. aeruginosa PAO1 grown 
on LB, with no need for any special induction. Thus the enzyme is constitutively 
expressed, suggesting that it is probably involved in a so called “house-keeping” 
process. When the wild type and mutant bacteria growth rates on LB were compared, 
no significant difference was found (see Chapter 7), indicating that PA3859 is not an 
essential enzyme, or possibly that in P. aeruginosa other enzymes with similar function 
are present. However, when bacteria were grown on a minimal medium containing a 
mixture of phospholipids as the unique carbon source, the PA3859 KO mutant was 
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found to grow much slower than the wild type, suggesting an involvement of PA3859 in 
the phospholipids metabolism (see Chapter 7).  
 
Lysophospholipids are known to be toxic due to the destabilization effect that they exert 
on plasma membranes [27]. 
The observation that the final density reached by the PA3859 KO mutant culture is 
roughly equal to 60% of the cell density reached by the wild type culture is probably the 
consequence of the mutant incapacity to scavenge the toxic lysophospholipids that are 
produced along with the bacterial growth on the phospholipids containing medium. 
Thus the lower culture density reached by the PA3859 knock out mutant could be due 
to an increased cytolysis rate that would be produced by the accumulation of 
intracellular lysophospholipids (see Chapter 7, Fig. 7.1) 
 
 
 
Given these interesting results, the possible contribution of PA3859 in the 
Pseudomonas aeruginosa lung infection was also assayed. 
Infection of mammalian airways by Pseudomonas aeruginosa leads to varied 
pathological responses and lung injury. At one extreme there is the acute nosocomial 
necrotizing pneumonia that is associated with a high incidence of mortality despite 
antibiotic therapy, due in part to epithelial destruction and bacterial invasion of the 
pulmonary vasculature with resultant bacteremia and its sequellae. At the opposite 
extreme there is the persistent airway infection in individuals with cystic fibrosis, where 
microorganisms remain confined to the airway as biofilms, triggering a chronic 
neutrophilic inflammatory response (see Chapter 1). 
To assay the possible role played by PA3859 along with the Pseudomonas aeruginosa 
lung infection, the rat chronic lung infection model was used: a healthy rat typically is 
able to clear a P. aeruginosa infection within two weeks. In order to study the 
pathogen-host interaction a model was developed that allows the lung infection to 
continue for longer time [28]. Bacteria, embedded in agar beads, are directly inoculated 
in the rat lungs. The beads will then provide a source for “fresh” bacteria that is able to 
let the infection persist for longer than one month.  
The experiment, carried out in the laboratory of Dr. Roger C. Levesque at Facultè de 
Mèdecine, Universitè Laval, Stefoy, Quebèc, Canada, consisted in the inoculation in the 
rat lungs of en equal amount of wild type and PA3859 knock out mutant. After 7 days 
from inoculation, the lungs were recovered and the amount of both wild type and 
mutant bacteria was quantified. On average, the amount of the recovered mutant 
bacteria resulted to be 5 fold smaller than the wild type, indicating that PA3859 
contributes to the ability of P. aeruginosa PAO1 to persist in a chronic pulmonary 
infection in rats model.  
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Along with the Pseudomonas aeruginosa lung infection, at least 5 different virulence 
determinants are secreted, that are known to possess a phospholipase and/or 
lysophospholipase activity [29]. ExoU is a phospholipase/lysophospholipase that is 
directly injected into the host cell cytoplasm via the type III secretion system [25, 30, 
31]. It is involved in the inhibition of the eukaryotic cell survival pathways [32] and in 
the activation of the proapoptotic pathways [33]. 
Three phospholipase C (PlcH, PlcN and PlcB) secreted trough the inner membrane via 
the arginine translocase pathway [34], and a phospholipase D, named PldA [35], are 
also known to be involved in the P. aeruginosa lung infection. PlcB is required for the 
bacterium phospholipids chemotaxis, but details about the role of the PlcH, PlcN and 
PldA in the pulmonary infection have not been yet provided. A possibility is that these 
enzymes are involved in the host cell membrane degradation and possibly in the 
hydrolysis of the phosphatidylcholine that is present in the lungs as a surfactant.  
 
Overall an involvement of phospholipases/lysophospholipases and phospholipids 
metabolism in the P. aeruginosa chronic lung infection has been clearly demonstrated. 
Even though so far it is not possible to unambiguously asses the role of PA3859 in the 
bacteria-host interaction, some hypothesis can be made. As suggested by the growth 
rate of PA3859 knock out mutant on the minimal medium containing phospholipids as 
the unique carbon source, a possibility is that PA3859 is required to scavenge the 
lysophospholipids produced by the partial digestion of the host cell membrane or to 
hydrolyse the phosphatidylcholine present in the lungs.  
Moreover, being PA3859 involved in the phospholipids metabolism, in the knock out 
mutant the phosphatidylcholine metabolism is likely to be altered. Since 
phosphatidylcholine is required for an optimal bacterium-eukaryotic cell interaction 
[22] the reduced persistence of the knock out mutant with respect to the wild type 
PAO1 in the chronic lung infection model, could be the consequence of a modified lipid 
content of the bacterium cell membrane. 
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8.2 Conclusion and perspectives 
 
Overall, the results reported in the present work, demonstrate that the putative 
carboxylesterase from PA3859 of Pseudomonas aeruginosa is indeed a 
lysophospholipase. The experiments carried out with the PA3859 knock out mutant 
indicate that this enzyme is involved in the phospholipids metabolism and perhaps in 
the detoxification of lysophospholipids. Furthermore, it has been demonstrated that 
PA3859 is necessary for the bacteria to thrive in the rat lungs and thus a role for this 
enzyme as a virulence factor can be hypothesized.  
These results also suggest that PA3859 could be a possible therapeutical target protein 
for the development of new anti – P. aeruginosa antibiotics. Further investigation 
however would be required in order to determine the enzyme specificity with respect to 
the lysophospholipid polar headgroup and to provide details into its in vivo role and its 
implication in the Pseudomonas aeruginosa pathogenicity. 
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Appendix 1 
 
 
Protein X-ray crystallography 
 
The first published observation of the crystallization of protein was authored by 
Hünefeld in 1840. The protein was haemoglobin from the earthworm. Flat, plate-like 
crystals were obtained when the blood of an earthworm was pressed between two slides 
of glass and allowed to dry very slowly. Until the 1930s, and indeed for many years 
beyond that, the motivation for crystallising proteins, particularly enzymes, was to 
purify a specific macromolecule from a complex extract, or to demonstrate, in the 
classical chemist’s sense, the homogeneity of a preparation. Throughout this period, 
crystallinity was associated with purity. In the late 1930s, however, X-ray 
diffractionists, such as Atsbury, Bernal, Crowfoot, Fankuchen, Kendrew and Perutz, 
turned their attention to protein crystals as a source of structural information concerning 
biological macromolecules [1]. 
 
 
A1.1 Crystal definition  
 
Crystal is a solid having regularly repeating (periodic) internal arrangements of atoms, 
molecules or ions and is a result of their cooperative, self-promoted, three-dimensional 
ordering [2, 3]. 
 
A1.2 The uniqueness of macromolecular crystals  
 
Protein crystals, as all macromolecular crystals, rarely exceed a millimeter on an edge 
and are generally much smaller.  
They are extremely fragile and have very weak mechanical properties.  
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Most, but not all, macromolecular crystals demonstrate only weak birefringence. The 
extent of optical activity can serve as preliminary but not definite test, whether a crystal 
is of a macromolecule or of some other mother liquor component such as a salt or a 
buffer. 
Most protein crystals exhibit rather poor diffraction properties in comparison with 
organic or inorganic small molecule crystals. The number and the relative strengths of 
interactions securing macromolecules in the crystal lattice are far fewer and 
significantly weaker in proportion to the molecular mass (hydrogen-bonds, van der 
Waals contacts, salt-bridges). For that reason the macromolecules in the lattice tend to 
be less well ordered. They do not generally produce Bragg reflections to resolution 
approaching the theoretical limit, but decline substantially as a function of the scattering 
angle. Macromolecular crystals, depending on the mass of protein, usually have cell 
dimensions in the range of thirty to several hundred angstroms. Because the number of 
unit cells in a crystal (the effective scattering units) is inversely proportional to the 
volume of the unit cell, a macromolecular crystal produces far less scattering intensity 
than conventional crystals of the same size. Moreover, proteins consist mainly of C, N, 
O, which are light elements with only a few electrons (6-8) per atom that scatter X-rays 
much more weakly than do heavier elements.  
The symmetry groups available are limited, because macromolecules lack inversion 
symmetry (see paragraph 4). 
The protein crystals have high solvent content, at minimum this is usually no less than 
30% by volume, for most cases it is 40% to 60%, and in the extreme cases it can be as 
high as 90%. Thus, macromolecules in a crystal are like islands, isolated from one 
another in a sea of water, but all interconnected by a network of delicate contacts. 
Macromolecules in the crystal bind their ligands just as they would in solution, except 
in those rare cases where lattice interactions interfere. This is what makes 
macromolecular crystals such an outstanding system to perform biochemical 
experiments. It is this feature of protein crystals that has made them invaluable tools in 
enzymology and for structural based drug design [1]. 
 
 
 
A1.3 Protein crystallization 
 
 
A1.3.1 The phase diagram  
 
If a protein-solvent system is at a concentration of the solute below its solubility limit 
for a particular set of conditions, it is considered to be in the undersaturation state. If it 
is exactly at the limit, then the solution is called saturated. At this unique concentration 
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of the material in solution, the rates of loss and gain of both the solid and solution 
phases are equal, and the system is at the equilibrium. Crystals, therefore, cannot grow 
from a solution that is simply saturated. When there are more protein molecules in a 
solution than solubility limit would allow, the solution is called a supersaturated one 
(fig. A1.1). We would expect molecules in solution to rejoin the solid state due to a 
thermodynamic driving force that pushes the system back to the solubility limit. In this 
way the system will tend to reestablish the equilibrium. This is from non-equilibrium, 
saturated solutions that crystals are grown. If conditions are adjusted in a tranquil 
manner, in the absence of any preexisting solid state, and if no sudden impulses of 
energy are provided to the system that could raise anomalously its overall energy and 
generate critical nuclei, then supersaturation will result. Certain amount of activation 
energy is required to initiate the formation of the solid state. There are two approaches 
to helping the system to overcome the activation barrier: putting energy into the system 
by increasing the supersaturation of the solution, or effectively lowering the energy 
barrier by seeding the solution with preexisting crystals. If no adequate amount of 
energy becomes available, the system will remain in metastable, non-equilibrium state 
of supersaturation. No nuclei will form and no crystals will grow. In the metastable 
zone crystals may grow only if nuclei are present. The high probability of spontaneous 
critical nuclei or amorphous precipitate formation in solution is present in the extreme 
supersaturation zone called labile region. The latter corresponds to an increased energy 
state of the system (fig. A1.1).  
 
 
Figure A1.1 Phase diagram. 
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The ideal approach for protein crystallization would be to induce nuclei at the lowest 
level of labile region. As these few nuclei begin to grow, the supersaturation will fall 
and the solution will gradually enter the metastable region where the crystal growth will 
be slow and ordered. A few and larger crystals will be produced. No competition for 
new nuclei or precipitate will be observed [1].  
 
A1.3.2. Main factors influencing supersaturation 
 
Protein crystallization is mainly a trial-and-error procedure in which the protein is 
allowed slowly to precipitate from its solution as a result of the achievement of the 
supersaturation. Generally the protein supersaturation is obtained by a slow increase in 
the concentration of some precipitants, or by changes in pH and/or in temperature. The 
solubility effects of a precipitant and the protein behavior (electrostatic character, 
surface features, conformation) depend on the pH and on the temperature at which the 
experiment is performed. Proteins may be crystallized from a solution equally well, by 
increasing the precipitant concentration at constant pH and temperature (Ks 
fractionation), or at constant precipitant concentration by variation of pH and 
temperature (β fractionation). In practice, mutually unrelated premixed crystallization 
conditions are used (sparse matrix kits) for an initial screening of successful conditions 
to grow crystals. During the optimization, the precipitation point of a protein is 
determined at sequential precipitant concentrations with a given pH value. Different pH 
values are also checked keeping the precipitant concentration constant. The procedure is 
repeated at different temperatures (4 °C – 20 °C), and then the effect of different 
precipitating agent is examined. The precipitating (crystallization) agents could be 
divided in four main categories: salts (sulfates, phosphates), organic solvents (ethanol, 
acetone, propanol), long-chain polymers (polyethylene glycol 1000, 3350, 6000) and 
low-molecular-weight polyethylene glycols (PEG-400) and non-volatile organic 
alcohols (2-methyl-2,4-pentanediol, hexanediol). The role of macromolecular 
precipitants is to increase the effective protein concentration by dehydrating proteins 
through competition for water molecules (mainly salts, salting-out/in effects), by the 
reduction of the electrostatic screening effectiveness of the solvent (mainly alcohols), or 
by size-exclusion or crowded-out effect (PEG) [1].  
 
A1.3.3 Methods for promoting supersaturation 
 
Vapor diffusion 
The method of vapor diffusion is the most widely used approach. It has produced more 
crystallized macromolecules than all other methods combined [7]. To initiate the trial, 
the sample drop is dispensed onto a siliconized surface, in this way it is spatially 
separated from a reservoir solution. When the drop is supported by some surface, the 
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method is called sitting drop (5 μl to 25 μl drop); when the drop is suspended from 
some surface- hanging drop (1 μl to 5 μl drop). The drop is prepares by mixing the same 
amount of protein and reservoir solution (fig. A1.2). 
 
 
 
 
 
 
 
 
 
 
 
Figure A1.2 Sitting and hanging drop vapor diffusion method. 
 
The reservoir solution is larger in volume (1 ml usually) and contains the precipitant and 
a buffer. The crystallization agent in the drop is in lower amount than that required for 
the formation of crystals. The entire system must be sealed out from air, so no solvent is 
lost to the environment and the only transport of water or any other volatile component 
is between droplet and reservoir solution. Over time, equilibration takes place through 
the vapor phase. It will be complete when the concentration of the precipitant in the 
droplet is equal to that in the reservoir. In the case of non-volatile precipitant, this 
occurs by the evaporation of water from the protein drop and its incorporation into the 
reservoir. When the precipitant is a volatile one, equilibrium takes place through the 
transport of solvent from the reservoir to the drop, due to its absence in the latter at the 
beginning of the experiment. Because the volume of the reservoir is much bigger than 
that of the droplet, the ultimate concentration of the precipitant in the drop of mother 
liquor will correspond to the initial, experimentally established conditions of the 
reservoir. When water is lost by the droplet to the reservoir, there is a volume decrease 
of the drop with an increase of protein and non-volatile components concentration (fig. 
A1.3). Vapor diffusion simultaneously provides at least two ways to drive the system 
toward supersaturation: increase in precipitant concentration and increase in protein 
concentration too.  
In almost any vapor diffusion experiment, there will be some volume of air in the 
system between protein sample and reservoir. One of the first things to happen when the 
experiment is initiated is air enrichment in water. Thus, in the initial stages there will be 
a particularly pronounced loss of water and subsequent fast increase of supersaturation. 
Hanging-drop vapor diffusion is among the most popular methods now in use [1]. 
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Figure A1.3. Phase diagram based on the vapor diffusion method. 
  
 
Batch crystallization 
This is one of the oldest techniques used for the crystallization of proteins [1]. It 
consists of direct mixing of an undersaturated protein solution with a precipitant. The 
latter alters the protein solubility or the electrolyte properties of the solution giving 
immediately saturated mother liquor. Thus, the protein and the precipitating agent are 
mixed at their final concentrations at the start of the experiment. There is less 
exploration of the phase diagram (fig. A1.4), and several microbatch trials may be 
required to replace a single vapor diffusion experiment. The introduction of the 
microbatch technique, where the crystallization samples are dispensed as small drops 
under oil, has overcome the requirement for large quantities of material (protein 
solution and precipitant). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1.4. Microbatch method. 
 
In fact, numerous crystallization conditions could be screened as 1-2 μl trials. Setting up 
microbatch trials is simpler and speedier than vapor diffusion trial even when 
performed manually because it is mechanically less complicated. The oil, also, protects 
the samples from evaporation (small-volume trials), airborne contamination and 
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physical shock. It was observed, as well, that the presence of oil might act as a stimulant 
for the crystallization of membrane proteins (chlorophyll binding protein 43 of the 
photosystem II membrane protein complex from spinach): the oil slowly absorbs the 
detergent from the aqueous drop, encouraging the protein to crystallize gradually [4]. 
The microbatch is not useful when volatile organic compounds are involved in the 
protein crystallization due to their interaction with the oil. The most frequently used oil 
is the paraffin one (a purified mixture of liquid saturated hydrocarbons obtained from 
petroleum). In a typical microbatch experiment, crystallization takes place within a 
couple of weeks or a month. During this time the drop is well sealed by the paraffin oil. 
Since oil and water are essentially immiscible, evaporation during this time is 
negligible. However, slow evaporation could occur (there is not absolute immiscibility), 
which can proceed until the drop dries out. Such slow evaporation cannot take place 
using a diffusion trial. It is, also, possible to control the rate of the vapor diffusion, even 
in the microbatch setup, introducing different types of oil (silicone, Al’s oil). Silicone 
oil consist of polymers of repeating dimethylsiloxane units, that permit a freely 
diffusion of water. A mixture of paraffin and silicon oil (Al’s oil: 50% paraffin and 50% 
silicon oil) allows partial diffusion. This is what is called modified microbatch. 
Combinations of the microbatch and diffusion methods are beginning to emerge that 
resulted very useful in the optimization of the crystallization conditions. Another 
example of possible combination is to place an oil barrier (mixture of paraffin and 
silicon oils in different ratio, 0.3 ml to 0.7 ml final volume) over a reservoir of a vapor 
diffusion trial in order to slow down the equilibration rate and thus to approach 
supersaturation more slowly [5, 1]. 
 
 
 
 
 
 
 
 
 
 
Figure A1.5. Modified microbatch and hanging drop methods. 
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A1.4 Protein crystal structure determination 
 
The crystal structure analysis by X-ray or neutron diffraction is a method unique in 
providing an unambiguous and complete three-dimensional representation of the atoms 
in a crystal. In order to “see” the fine details of a molecular structure, it is necessary to 
use radiation of a wavelength comparable to, or smaller than, the distance of the atoms. 
That’s why X-rays, an electromagnetic radiation with wavelengths of 10 –7 m to 10 -11 m 
(1000 Å to 0.1 Å) are used for the crystal structure determination. A succesfull high-
resolution diffraction analysis requires that the sample is organized or prepared as an 
ordered array. It is because of this regular arrangement that the crystals diffract X-rays. 
The condition that determines the existence of the diffracted beam is provided by the 
Bragg’s law: 
 
              nλ = 2d sinθ 
 
with λ, the wavelength of the radiation used, n an integer, nλ is the path difference 
between waves scattered from adjacent lattice planes with equivalent indices (hkl), d, 
perpendicular spacing between the lattice planes (hkl) in the crystal, and θ, angle of 
incidence of the X-ray beam (fig. A1.6). The diffraction maxima (hkl) occur when the 
path difference between waves scattered from adjacent parallel lattice planes are 
integral number of wavelength, or when the scattered waves are in phase. The angular 
distribution of the scattered radiation could be described as considering that diffracted 
beams behave like if they are reflected from planes passing through points of the crystal 
lattice.  
 
 
 
Figure A1.6. “Reflection” of X-rays by imaginary planes (hkl) through points in the crystal lattice. hkl 
are called Miller indices. 
 
According to the Bragg’s equation, if a monochromatic beam of X-rays hits a single 
crystal (particular sets of lattice spacing are present), diffraction maxima will occur only 
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for discrete values of the angle of incidence of the X-rays beam. If the crystal is rotated 
in the beam, additional diffracted beams will originate at given angles. In practice, more 
reflections could be observed due to the static disorder present in the real crystals (as if 
composed of minute blocks of unit cells, each one misaligned with respect to its 
neighbors), and due to the fact that the X-ray radiation is never truly monochromatic. 
Diffraction pattern is the output from the diffraction experiment and consists in a 
distribution of spots (diffraction maxima). The diffraction pattern of a crystal is 
arranged as a new lattice related to the lattice of the crystal (reciprocal lattice). 
X-rays are scattered by the electrons in atoms and unfortunately can not be focused by 
presently known experimental technique to give an appropriately magnified image of 
the scattering matter. It is possible, however, to simulate the recombination of the 
scattered X-rays (transformation of the intermediate reciprocal space image to the real 
space image), just like the lens does, by a mathematical tool; the Fourier synthesis.  
 
   ρ(xyz) = 1/VcxΣΣΣall hkl F(hkl)exp[-2πi(hx+ky+lz)]  
 
   F(hkl)=|F(hkl)|exp[iα(hkl)] 
 
   ρ(xyz) = 1/VcxΣΣΣall hkl|F(hkl)|exp[-2πi(hx+ky+lz)+ iα(hkl)] 
 
ρ(xyz) is the number of electrons per unit volume or electron density at any point x,y,z. 
Vc is the volume of the unit cell and F(hkl) is the structure factor for the particular set 
of indices hkl. The diffracted radiation has a particularly combination of amplitude 
(|F(hkl)|) and phase (α(hkl)) known as the structure factor F(hkl). The diffracted 
(scattered) X-radiation is intercepted by a detecting system. In this way only the 
intensities (I) of the diffracted waves could be measured and the phases are lost. The 
amplitude of the diffracted beam is easily derived from the measured intensity.  
 
 
   I(hkl)= K|F(hkl)|
2
 (Lp)(ABS) 
 
 
For the intensity general expression, Lp is Lorentz-polarization factor, ABS is the 
absorption factor and K is a scale factor. 
In order to compute the Fourier synthesis, the relative phase of the diffracted beams 
should be determined (solving the “phase problem”). The aim of an X-ray diffraction 
study is to obtain the electron density map of the structure, using the measured 
amplitudes for each of the diffracted waves and their respective phase angles derived by 
one of the available methods. Then, assuming atomic nuclei to be at the centers of peaks 
maxima, we would know the entire structure. Since a crystal is build up of an extremely 
large number of regularly stacked unit cells, each of which has identical content, the 
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problem of determining the structure of the crystal is reduced to that of determining the 
spatial arrangement of the atoms within a single unit cell, or within the asymmetric unit. 
Thus, the required calculations for the electron density map estimation will be greatly 
simplified. The calculation of the Matthews coefficient [6] allows estimating the 
number of protein molecules present in an asymmetric unit and the percentage of its 
solvent content. The asymmetric unit is the smallest part of the crystal structure from 
which the complete structure can be obtained by applying the space group symmetry 
operations. The 230 space groups represent the distinct ways of arranging identical 
objects on one of the 14 Bravais lattices (corresponding to 7 different crystal systems) 
by the use of symmetry operations. From the 230 possible space groups, only the 65 
non-centrosymmetric space groups are possible for protein crystals, because of the 
chirality of the amino acids presented in proteins (L-enantiomers). Thus, the allowed 
symmetry operations are rotation, screw axis and translation, but not mirror plane and 
inversion center [3].  
The basic steps towards the structural determination are: 
1  Collection, processing and reduction of X-rays diffraction data; 
2  Phase determination; 
3  Interpretation of electron density maps (model building); 
4  Refinement of the molecular model. 
 
A1.4.1 Collection processing and reduction of X-rays diffraction data 
 
Once a diffraction pattern was visualized and a sufficient number of frames collected, 
data processing is carried out. It consists of: assigning an index (hkl) to each spot 
(indexing) and calculation of the cell dimensions with a preliminary identification of the 
crystal class and Bravais lattice. Intensity estimation for each diffraction maximum 
(integration). After the intensity adjustment on a common scale is derived, the 
symmetry equivalent reflections are merged, according to the crystal symmetry. The 
space group may be determined at this point, on the basis of merging statistics (Rsym) 
and the list of systematic absences. Rsym is an indicator of the intrinsic data quality. It is 
the reability factor of intensities.  
 
  Rsym(I)= ΣhklΣi| Ii(hkl)-Imean(hkl)|/ΣhklΣi|Ii(hkl)| 
 
The result of the X-ray diffraction data collection is a list of relative intensity, I, for 
each reflection with indices h, k, l and an error estimate. Only after the intensities have 
been put on absolute scale the amplitudes for all reflections measured can be computed 
as square root of I.  
Intensities can be put on an absolute scale by using a scaling factor and the temperature 
factor B obtained from the Wilson plot. The temperature factor or Debye-Waller factor 
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is a consequence of the atomic motion in the crystal caused by temperature-dependent 
vibration of the atoms in the structure.  
 
   B=8π2<u2> 
 
The mean square displacement of the atomic vibration is indicated as <u
2
>. Taking into 
account the thermal vibrations, the atomic scattering factor and F(hkl) are expressed as 
follows: 
 
   fj
2
 =exp(-2Bjsin
2θ/λ2)(fj
0
)
2
 
 
   F(hkl) = Σifi exp [2πi(hx+ky+lz)] 
 
where j is a specific atom, and fj
0 
is the scattering factor of the atom j at rest. 
 
 
 
 
A1.4.2 Phase determination 
 
To compute ρ for all values of x, y, z and to plot ρ(xyz) in order to obtain a three-
dimensional electron density map, not only the |F(hkl)| values should be known, but the 
phase angle α(hkl) as well. The four existing techniques for solving the phase problem 
in protein X-rays crystallography are: 
 
 Direct methods 
Statistical and probabilistic techniques for deriving an approximate set of phases from 
which the electron density map can be calculated. The atomicity and the fact that the 
electron density in a real crystal can not be negative are used. Required characteristics 
are 1.1-1.2 Å data, 100% completeness in the last shell, the number of non-H atoms in 
the asymmetric unit should be less than 200. This is a method indicated especially for 
small molecule crystallography [2, 7]. 
 
 
 Isomorphous replacement 
Requires covalent or non covalent binding of heavy atoms to the protein molecules 
(heavy atom derivatives). The crystal space group, cell dimensions and the 
arrangements of the protein atoms should be essentially identical (isomorphism). In 
practice, the cell dimensions of two isomorphic crystals should not differ more than 1.0 
%. Differences in the diffraction intensity pattern are due to the presence of the heavy 
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atom. Once the position of the heavy atom is determined (by difference native-
derivative Patterson map), the difference in the intensities for the two isomorphs can be 
used to refine the initial phase angle for each reflection. At least two pairs of isomorph 
compounds are required. 
 
 Multiple wavelength anomalous dispersion 
The effect of anomalous scattering (dispersion) is an intensity difference between 
reflection with indices hkl and  those with indices  -h-k-l. It is due to absorption of X-
rays on an atom (anomalous scatter) in the structure and results in phase and intensity 
change for the X-rays scattered from that atom. This is the equivalent of advancing or 
delaying the radiation for a short time. The intensity difference due to the presence of 
anomalous scatters in the protein molecule could be used for the phase angle 
determination. Usually the diffraction pattern is measured at wavelength near to and far 
from the absorption edges of an anomalous scatter presented in the structure. 
 
 Molecular replacement (MR) 
Particular attention is dedicated to this method, because of its application in the 
Pseudomonas aeruginosa  PA3859 structural determination. The method is based on 
the observation that homologue proteins show a similar folding. If the structure of a 
homologue protein is known, it could be used as a model for the refinement procedure. 
Thus, the estimates of the phases can be computed and electron density calculated. The 
success of MR depends largely on the similarity between the model and the protein of 
interest. The model should be complete and has to share at least 40 % sequence 
homology with the unknown structure. The molecular replacement is a six dimensional 
search, in which the model is placed (orientated and positioned), in the target unit cell. 
In practice, it involves two steps: rotation and translation. In the rotational step, the 
spatial orientation of known (search model) and unknown molecule with respect to each 
other is determined, while in the second step the translation that superimposes the 
already correctly oriented model to the molecule is calculated. These steps are carried 
out by Patterson search technique. The Patterson map is basically a Fourier map 
calculated with the square of the structure factor amplitudes and phases set to zero.  
 
P(u,v,w) = 1/VcxΣΣΣall hkl|F(hkl)|
2cos[2π(hx+ky+lz)] 
 
The function is evaluated at each point u,v,w, of a three-dimensional grid that fills a 
space with the size and shape of the unit cell [3]. 
The Patterson map gives a vector representation of the atomic contents of the unit cell. 
It is a signature for a protein structure. The peaks in the map occur at points whose 
distances from the origin correspond in magnitude and direction with distance between 
atoms in the crystal. The vectors in the Patterson map can be divided in two categories: 
Appendix 1 
 129 
intramolecular (fig. A1.7, from one atom in the molecule to another atom in the same 
molecule) and intermolecular (between atoms of symmetry related molecules). The 
intramolecular vectors depend only on the orientation of the molecule and are involved 
in the rotation function.  
 
 
 
Figure A1.7. A molecule and its Patterson intramolecular vector representation.  
 
The observed Patterson map can be computed from the experimental diffraction 
intensities. The model Patterson map, on the other hand, can be calculated from the 
search model structure factors, and compared with the observed Patterson by 
superposition. The model is placed in a P1 unit cell. In this way it is represented in the 
model Patterson map only by peaks arising from intramolecular vectors and from those 
intermolecular vectors that connect copies of the molecule generated from the lattice 
translations. Since the two vector types are spatially intermixed (fig. A1.8A, [8]), they 
could be separated placing the search model in the artificially enlarged unit cell (fig. 
A1.8B). The intramolecular vectors are thus concentrated around the origin of the 
Patterson map and the intermolecular vectors are concentrated around the other lattice 
points. It is possible to cut out the spherical region around the origin that contains the 
isolated intramolecular vectors and to use it as a partial Patterson map in the rotational 
search (fig. A1.8C). The radius of the spherical region is chosen to be similar to the 
largest intramolecular vector. To improve the signal-to-noise ratio, the region around 
the large Patterson origin peak is omitted.  
 
 
 
 
 
 
 
 
 
Appendix 1 
 130 
 
 
 
Figure A1.8. A. A molecule and the corresponding Patterson peaks translated to each lattice point; B. 
The molecule and the corresponding Patterson peaks in an artificially enlarged unit cell. The molecule 
is scaled down instead of enlarging the cell; C. Superposition of the model and calculated Patterson 
maps [8]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1.9. Traditional rotation search, A, and direct rotation search, B [8]. 
 
 
In the direct rotation search (CNS), on the other hand, the model is rotated directly and 
the structure factor calculations are carried out for each sampled angular orientation 
(fig. A1.9).  
To describe an orientation, three parameters are required. In the kappa/phi/psi 
description, the rotation axis is defined in the x,y,z coordinate system by the angles psi 
(y) and phi (z). The angle kappa gives the rotation around the rotation axis. Another 
convention makes use of Eulerian angles. The coordinate system is rotated by an angle 
α around the original z axis, then by an angle β, around the new y axis and in the end by 
 A  B  C 
A B 
Appendix 1 
 131 
an angle γ around the final z axis. In CNS package both a “traditional” and “direct” 
approach to the rotational search are possible. Traditional rotation search is carried out 
in the real space and the rotation Rot(Ω), which has to be maximized, is a Patterson 
correlation integral. Given a specific angular orientation Ω, Rot(Ω) assumes the 
following form:  
   Rot(Ω) = ∫Po (u)Pc(Ω, u)du 
          
U 
 
Where U is the Patterson space u is a location vector and Po is the observed Patterson 
function and Pc is the search-model Patterson function. 
 
In direct rotation search, which is carried out in reciprocal space, the rotation function is 
evaluated as the linear correlation coefficient of the observed and calculated  
normalized structure factors. For a given angular orientation Ω of the search model 
CC(Ω) assumes the following form: 
 
CC(Ω)=[Σhkl (Xhkl, o –mean Xo)(Xhkl, Ω – mean XΩ)]/{[ Σhkl(Xhkl, o –mean Xo)
2
]
1/2
 [Σhkl 
(Xhkl, Ω – mean XΩ)
2
]
1/2
} 
 
Where X=|E|
2
. 
 
Reciprocal and direct space approaches do not normally differ in results in absence of 
approximations, nonetheless the much more computationally intensive direct search 
gives, in general, better results, especially in difficult cases, because of the lack of the 
approximations which are instead normally used in traditional rotational search (limited 
numbers of Patterson peaks considered and grid points interpolation). 
 
 
Usually a Patterson correlation (PC) refinement is carried out before performing the 
translation search. It could be useful in enhancing the discrimination between correct 
and incorrect rotation function points, improving the search model, and in enhancing 
the signal-to-noise ratio. A drastically reduction in the number of noise peaks in the 
translation function could be obtained [8]. 
Once the angular orientation of the search model is assumed to be known, the location 
of the oriented search model should be determined with respect to the symmetry 
elements. The unit cell is subdivided in a regular grid and the search model is moved to 
each grid point in turn. The translation search is evaluated by the standard linear 
correlation coefficient (modified for translation) of the structure factor amplitudes and 
by the crystallographic factor R. 
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  R= 100x Σhkl |(|Fo| - k|Fc|)|/ Σ (|Fo|) 
 
In order to evaluate the R factors and correlation coefficients for the translation search, 
structure factors need to be calculated for the search model, with a given orientation, at 
different positions in the unit cells. In the case of the correct solution, the correlation 
coefficient should be as high as possible, and the R-factor as low as possible.  
In the case of the traditional translation search, the correct position of a search model in 
the crystal unit cell should lead to the maximal overlap of both the intra- and 
intermolecular vectors (maximal overlap between the observed and the calculated 
Patterson maps) throughout the entire unit cell.  
 
   T= ∫Po (u)Pc(u)du 
                   Ω 
 
The results of the calculations are on the arbitrary scale and this makes difficult to 
compare results from different calculations. The R factor or the correlation coefficient 
can be calculated for the top peaks to place the results on the absolute scale. The 
intramolecular vectors can be removed from the Patterson maps by subtracting, after 
appropriate scaling, the structure factors calculated from individual molecules. 
When the orientation and the position of the search model within the unit cell is know, 
the phases and the electron density map could be calculated.  
 
A1.4.3 Model building 
 
This is an interpretation of the calculated electron density map, consisting in tracing 
protein backbone of the model through the electron density map and in insertion of the 
ordered water molecules as well.  
 
A1.4.4 Refinement 
 
By a three-dimensional Fourier synthesis of the observed structure factor amplitudes 
with a starting phases that is an approximation of the true electron density map can be 
calculated. Once the approximate positions and identities of the atoms in the 
asymmetric unit are known (model building), the amplitudes and the phases of the 
structure factors can be calculated. The calculated amplitudes |Fc| may be compared 
with the observed ones |Fo|. If the structure model is a correct one and the 
experimentally observed data are reasonably accurate, the agreement should be good. 
The refinement is a systematical variation of the positional parameters (x, y, z) and of 
the temperature factors (B) for all atoms in the structure (except hydrogen atoms) in 
order to obtain the best possible agreement of the observed structure factor amplitudes 
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with those calculated for the proposed structure. Some additional information are also 
incorporated in the refinement process like stereochemical data derived from high 
resolution small molecule structures, assuming that bond length and angles determined 
with high precision in amino acids and small peptides are also valid in proteins. The 
refinement is performed in successive cycles until a convergence is reached. This is a 
stage at which the shifts from cycle to cycle in the parameters being refined are 
negligible with respect to the energy gradient. If the starting model is not too different 
from the real structure the refinement converges easily to the correct solution. If the 
distance between the atoms in the model and in real structure is large, the refinement 
may be trapped in a local minimum instead of reaching the true, global energy 
minimum of the target:  
 
E= Echem + wx-ray Ex-ray 
 
Echem comprises empirical information about chemical interactions. It is a function of all 
atomic positions, describing covalent and not bonded interactions. The energy for 
strereochemical terms is evaluated by considering the difference between the actual 
value and the ideal value in a way that if the atom deviate more from the ideal geometry 
the energy increases. The crystallographyc term, Ex-ray comes from the difference 
between observed and calculated data; wx-ray  is a chosen weight. 
To avoid a local (false) minimum, an optimization technique called simulated 
annealing, that uses molecular dynamics, is carried out. In molecular dynamics, the 
dynamic behavior of a system of particles is simulated. In the simulated annealing 
technique, the system temperature is raised sufficiently high for the atoms to overcome 
energy barriers and then they are cooled slowly to approach the energy minimum. Large 
errors in the starting model could be corrected and this will speed up the refinement 
procedure. Usually the simulated annealing protocol is performed at the beginning of 
the refinement. Model modifications that are needed to give better agreement with 
observation, can be deduced just by comparing the calculated maps with |Fo-Fc| and 
|2Fo–Fc| coefficients respectively. The maps are inspected visually and model 
corrections are done manually in agreement with the observation. A Fo-Fc difference 
Fourier map (difference between the observed and calculated structure features) will 
show positive electron density at atom sites not included in the model and negative 
density at atom sites present in the starting model, but missing in the real structure. 
The water molecules are added automatically in the end of the refinement process by 
analyzing both the 2Fo-Fc and Fo-Fc maps.  
One measure of the correctness of the structure is the so-called discrepancy index, or 
crystallographic R value, defined as: 
  
   R=Σhkl |(|Fo| - k|Fc|)|/ Σ (|Fo|)         (hkl) 
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It is a measure of how closely the observed structure factor amplitudes are matched by 
the values calculated for the model. A more objective version of this quality indicator is 
obtained if the calculation extends over a set of (5 - 10)% of the reflections only, chosen 
randomly and excluded from refinement (Rfree). If the structure is improving during the 
refinement, the R and Rfree will decrease. For a structure determination with data 
resolution up to 2.0 Å, the final R factor should be close to 20% with Rfree a few 
percent higher. The calculated r.m.s.d. value is an estimation of the accuracy of the 
results. It is an assessment of the covalent geometry of the model by comparing the 
bond lengths and angles to a library of ideal values [2, 3, 9].  
 
The purpose of refinement and rebuilding is to detect and fix the errors in order to 
obtain the best possible final model. Some of the model quality indicators like the 
crystallographic R factor, Rfree and r.m.s.d for the covalent bond angles and lengths, 
have been already discussed. They are global indicators used to obtain an impression of 
the overall quality of the model and the overall fit of the model to the data. The 
Ramachandran plot, on the other hand, is one of the local model quality indicators. 
Ramachadran plot investigates the stereochemistry of the main chain folding and 
especially of the main-chain dihedral angles. The angles φ and ψ for each amino acid 
residue are plotted in 2D diagram. The Ramachadran plot classifies the residue in one of 
the three categories: “allowed”, “partially allowed” and “disallowed” conformations. 
The “partially allowed” conformations give rise to modestly unfavorable repulsion 
between non bonded atoms and might be overcome by attractive effects such as 
hydrogen bonds. The “disallowed” interactions give highly unfavorable non-bonded 
interatomic distances. Since the Ramachadran plot can identify unacceptable clusters of 
φ-ψ angles, it is used to reveal possible errors made during model building and 
refinement. As opposed to covalent bond angles and bond lengths, the main-chain 
dihedral angles are usually weakly restrained during X-ray refinement and therefore can 
be used to validate the structure model independently. In practice, the Ramachandran 
plot is one of the simplest most sensitive tools for assessing the quality of a protein 
model [9].  
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Appendix 2 
 
 
Automated docking simulations 
 
 
 
 
 
In any protein-ligand docking scheme two conflicting requirements must be balanced: 
the desire for a robust and accurate procedure and the desire to keep the computational 
demands at a reasonable level. The ideal procedure should find the global minimum for 
the energy of interaction between the substrate and the target protein, by exploring all 
available degrees of freedom for the system. However, it must also run on a computer 
within an acceptable amount of time. In order to meet these demands a number of 
techniques simplify the docking procedure. The method developed for AutoDock 3.05 
[1, 2] tackles the search space exploration and the energy evaluation separately. 
Configurational exploration is performed by a genetic algorithm (see paragraph A2.3) 
and energies are evaluated using grid-based molecular affinity potentials (see paragraph 
A2.1). It thus combines the advantages of exploring a large search space and a robust 
energy evaluation.  
 
 
 
 
A2.1 Energy evaluation 
 
Rapid energy evaluation is achieved by precalculating atomic affinity potentials for 
each atom type in the substrate. The protein is embedded in a three-dimensional grid 
and a probe atom is placed at each grid point (Fig. A2.1). The energy of interaction of 
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this single atom with the protein atoms is assigned to the grid point. An affinity grid is 
calculated for each type of atom in the substrate. The energetics of a particular substrate 
configuration is then found by interpolation of affinity values of the eight grid points 
surrounding each of the atoms in the substrate.                                            
The electrostatic interaction is evaluated similarly, by interpolating the values of the 
electrostatic potential and multiplying it by the atom charge.                                        
The time to perform an energy calculation using the grids is proportional only to the 
number of atoms in the substrate, and is independent of the number of atoms in the 
protein. Each point within the grid map stores the potential energy of a probe atom that 
is due to all the atoms in the macromolecule. 
 
 
  
. 
             
 
Figure 5.1. Grid map main features: the ligand is in the centre of the grid map, buried inside the active 
site of the protein. In this case, the grid map encompasses the whole protein.  
 
 
The pairwise potential energy, V(r) between two non-bonded atoms can be expressed as 
a function of internuclear separation, r, as follows, 
6
6
r6
r
C
r
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)r(V 

 
Graphically, if reqm is the equilibrium internuclear separation and ε is the well depth at 
reqm, then: 
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attractive, dispersion energy -C
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The exponential, repulsive, exchange energy is often approximated to, 
12
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hence pairwise-atomic interaction energies can be approximated using the following 
general equation, 
m
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)r(V   
where m and n are integers, and Cn and Cm are constants whose values depend on the 
depth of the energy well and the equilibrium separation of the two atoms’ nuclei. 
Typically the 12-6 Lennard-Jones parameters (n =12, m =6) are used to model the Van 
der Waals’ forces experienced between two instantaneous dipoles.  
In addition to the atomic affinity grid maps, AutoDock requires an electrostatic 
potential grid map. Partial atomic charges must be assigned to the macromolecule. The 
electrostatic grid can be generated by the program AutoGrid, which calculates 
Coulombic interactions between the macromolecule and a probe of charge e, 
+1.60219×10
-19
 C; there is no distance cutoff used for electrostatic interactions. A 
sigmoidal distance-dependent dielectric function is used to model solvent screening. 
KBr
Ke1
B
A)r(

  
Where B = 0  A; 0 is the dielectric constant of bulk water at 25 C; A, l and K are 
constants. 
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The atomic partial charges are written in PDBQ format that is an augmented form of the 
standard PDB format, in which an extra column is used to store the partial atomic 
charges (hence the "Q" in "PDBQ"). In addition a new utility program is used to specify 
the atomic fragmental volume and atomic solvation parameters for each atom in the 
macromolecule. The macromolecule solvation parameters are stored in a PDBQS file. 
This resembles a PDBQ file, but in addition gives the solvation parameters for each 
atom. Default solvation parameter values are instead assigned to the ligand probe 
atoms. 
 
A2.2 Overview of the Free Energy Function 
 
A scoring function based on the principles of QSAR (quantitative structure-activity 
relationships) is applied in order to rank the docking solutions. It was parameterized 
using a large number of protein-inhibitor complexes for which both the structures and 
inhibition constants, or Ki, were known. 
 
 
 
Figure A2.2. Cicle for enzyme substrate binding. 
 
 
According to the Gibbs free energy equation, the change in the free energy for a given 
process is given by ΔG = ΔH -TΔS.  
Figure A2.2 shows the thermodynamic cycle for the binding of an enzyme, E, and a 
ligand, I , in both the solvated phase and in vacuo . The solvent molecules are indicated 
G binding,vacuo 
G solvation(E+I) G solvation(EI) 
   Gbinding,solution      
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by filled circles: they tend to be ordered around the larger molecules, but when E and I 
bind, several solvent molecules are liberated and become disordered.  
This entropic effect is the basis of the hydrophobic interaction. The solvent ordering 
around E and I in either the bound and unbound state is strongly influenced by 
hydrogen bonding: hydrogen bonds between solvent and E, and solvent and I, 
contribute an enthalpic stabilization that can be estimated by Autodock.  
According to the Hess law of heat summation, the change in free energy between two 
states will be the same, no matter what the path. So the free energy of binding in 
solution we can be calculated by the following equation: 
 
G binding,solution = G binding,vacuo + G solvation(EI)  G solvation(E+I)  
 
Since G binding,vacuo can be calculated from the docking simulation, and is possible to 
estimate the free energy change upon solvation for the separate molecules E and I and 
for the complex, EI , G solvation(EI) and G solvation(E+I) respectively, then it is also possible 
to calculate the free energy change upon binding of the ligand to the enzyme in 
solution, G binding,solvation. Thus, the binding constant, Ki, for the ligand, I can be 
estimated. 
In this free energy scoring function various terms in the molecular mechanics energy 
function are scaled by coefficients derived using a linear regression model that most 
closely fit the experimentally observed inhibition constant data. Furthermore, a term for 
the evaluation of the ligand loss of conformational degrees of freedom up on binding is 
also applied. 
 
 
A2.3 Search Space Exploration 
 
The set of feasible docking solutions among which the desired solution resides is called 
search space. Each point in the search space is a possible protein-ligand interaction 
mode. Each solution is characterized by a defined free energy of binding that can be 
evaluated as described above. Thus the docking simulation goal is to find the overall 
minimum energy point within the search space.  
In the case of a docking problem the search space is extremely wide and its exhaustive 
exploration is not feasible due to the huge amount of calculations, and thus time, that it 
would require. A number of different methods have been developed in order to speed up 
the search of the overall minimum. In Autodock a Genetic Algorithm (GA) is used. 
 
Genetic algorithms are a part of evolutionary computing, which is a rapidly growing 
area of artificial intelligence: they are inspired by Darwin's theory of evolution.  
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Each docking solution is codified in a numeric string in which the ligand position, 
orientation and conformation are stored. In analogy with biologic systems, the string 
can be regarded as a chromosome and the single variables within the string as genes. 
The algorithm begins with a set of random solutions (represented by chromosomes) 
called population. Solutions from one population are taken and used to form a new 
population by means of crossover. This is motivated by a hope, that the new population 
will be better than the old one. The probability for a solution to transmit its genotype to 
the next generation is a function of its fitness, the higher is the fitness (low free energy 
of binding) the more chances it has to reproduce. Thus the offspring arise from a 
random combination of translation, rotation and dihedral values of the best individuals. 
Furthermore, the new solution can be subjected to a random mutation: this feature has 
been demonstrated to be important in order to avoid the system getting trapped in a 
local minimum. 
The user has to specify 4 parameters:  
crossover probability, that is how often crossover will be performed. If there is no 
crossover, offsprings are exact copies of the parents. If there is crossover, offsprings are 
made from parts of both parent's chromosomes. If crossover probability is 100%, then 
all offsprings are made by crossover. If it is 0%, whole new generation is made from 
exact copies of chromosomes from the old population. Crossover is made in hope that 
new chromosomes will contain good parts of old chromosomes and therefore the new 
chromosomes will be better. However, it has been shown that leaving some part of old 
population survive to next generation is necessary in order to guarantee a big enough 
genetic diversity and thus the possibility, for future generations, to produce better 
individuals. 
 
When the crossover rate is high, the probability of loosing the best solution is also high. 
To avoid this a feature called eliticity is used, and the user has to specify how many of 
one generations’ best individuals have to be directly copied in the next generation. 
 
Mutation probability: how often parts of the chromosome will be mutated. If there is no 
mutation, offspring are generated immediately after crossover (or directly copied) 
without any change. If mutation is performed, one or more parts of a chromosome are 
changed. If mutation probability is 100%, whole chromosome is changed, if it is 0%, 
nothing is changed.  
Mutation generally prevents the GA from falling into local minima. It should not occur 
very often, otherways the GA will turn in a random search.  
 
Population size: big population size usually does not improve performance of GA. The 
best population size, that is the size that allows the fastest search, depends on the size of 
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the encoded string (chromosome). In AutoDock it has been evaluated to be between 50 
and 100 individuals, depending on the ligand size and torsional degree of freedom. 
 
 
In AutoDock version 3.05 a new hybrid search technique is employed that implements 
an adaptative global optimizer with a local search [3]. The global search method is a 
genetic algorithm with a 2-point cross over (Fig. 5.3) and random mutation. The local 
search method, that is made to improve the fitting of a single docking solution rather 
than the entire population, is based on the optimization algorithm of Solis and Wets [4].  
The local searcher modifies the phenotype, which in turn updates the genotype: clearly 
this contravenes Mendelian genetics observed in nature, but it does improve the overall 
performance of the method. This hybrid genetic algorithm with phenotypic local search 
has been called Lamarckian Genetic Algorithm (LGA), since it utilizes the discredited 
Lamarckian notion that an adaptation of an individual to its environment can be 
inherited by its offspring. 
 
 
 
 
Chromosome 1 ABCD | EFGH | ILMN 
Chromosome 2 ABCD | EFGH | ILMN 
Offspring 1 ABCD | EFGH | ILMN 
Offspring 2 ABCD | EFGH | ILMN 
 
 
Figure A2.3. Example of a 2 point crossover. 
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